Child Protection and Rehabilitation Trust Charity
MedExcell Interview Skills & Acute Medicine Update & Critical Appraisal Courses
ABCD The National organisation of Diabetes specialists
YDF The trainee and young consultants wing of Diabetes UK
Diabetes UK the leading charity that cares for, connects with and campaigns on behalf of every person affected by or at risk of diabetes
Society for Endocrinology is the major British Endocrine society
Abbott Caroline A., Malik Rayaz A., van Ross Ernest R.E., Kulkarni Jai and Boulton Andrew J.M.
Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K. Diabetes Care 34. 2220-2224. 2011. Neuropathy
http://care.diabetesjournals.org/content/34/10/2220.abstract
Abuissa Hussam, Jones Philip G., Marso Steven P. and O'Keefe Jr James H.
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials. Journal of the American College of Cardiology 46. 821-826. 2005. Meta-analysis
http://www.sciencedirect.com/science/article/pii/S0735109705012714
Adler A. I., Levy J. C., Matthews D. R., Stratton I. M., Hines G. and Holman R. R.
Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67). Diabetic Medicine 22. 306-311. 2005. UKPDS 67
http://dx.doi.org/10.1111/j.1464-5491.2004.01418.x
Adler A.I., Stevens R.J., Neil A., Stratton I.M., Boulton A.J.M. and Holman R.R.
UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25. 894. 2002. UKPDS 59
http://care.diabetesjournals.org/content/25/5/894.full.pdf+html
Adler A.I., Stratton I.M., Neil H.A.W., Yudkin J.S., Matthews D.R., Cull C.A., Wright A.D., Turner R.C. and Holman R.R.
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. British Medical Journal 321. 412. 2000. UKPDS 36
http://www.bmj.com/content/321/7258/412.short
Adler Amanda I., Neil H. Andrew W., Manley Susan E., Holman Rury R. and Turner Robert C.
Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47). American Heart Journal 138. s353-s359. 1999. UKPDS 47
http://linkinghub.elsevier.com/retrieve/pii/S0002870399700359?showall=true
Adler Amanda I., Stevens Richard J., Manley Sue E., Bilous Rudy W., Cull Carole A. and Holman Rury R.
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63. 225-232. 2003. UKPDS 64
http://dx.doi.org/10.1046/j.1523-1755.2003.00712.x
Admiraal Wanda M., Celik Funda, Gerdes Victor E., Dallal Ramsey M., Hoekstra Joost B. and Holleman Frits
Ethnic Differences in Weight Loss and Diabetes Remission After Bariatric Surgery. Diabetes Care 35. 1951-1958. 2012. Bariatric
http://care.diabetesjournals.org/content/35/9/1951.abstract
Agardh Elisabet and Tababat-Khani Poya
Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy. Diabetes Care 34. 1318-1319. 2011. Retinopathy
http://care.diabetesjournals.org/content/34/6/1318.abstract
Aggarwal Vikas, Schneider Andrea L.C. and Selvin Elizabeth
Low Hemoglobin A1c in Nondiabetic Adults. Diabetes Care 35. 2055-2060. 2012. HbA1c
http://care.diabetesjournals.org/content/35/10/2055.abstract
Ahmedani M. Y., Haque M. S., Basit A., Fawwad A. and Alvi S. F. D.
Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education. Diabetic Medicine 29. 709-715. 2012. Ramadan
http://dx.doi.org/10.1111/j.1464-5491.2011.03563.x
Ahrén B.
Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives. Diabetes & Metabolism 39. 195-201. 2013. GLP-1
http://www.sciencedirect.com/science/article/pii/S1262363613000438
Ahrén Bo, Johnson Susan L., Stewart Murray, Cirkel Deborah T., Yang Fred, Perry Caroline and Feinglos Mark N.
HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin. Diabetes Care 37. 2141-2148. 2014. Harmony 2
http://care.diabetesjournals.org/content/37/8/2141.abstract
Ahrén Bo, Leguizamo Dimas Aniceto, Miossec Patrick, Saubadu Stéphane and Aronson Ronnie
Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M). Diabetes Care 36. 2543-2550. 2013. GLP-1
http://care.diabetesjournals.org/content/36/9/2543.abstract
Alexander Charles M., Landsman Pamela B., Teutsch Steven M. and Haffner Steven M.
NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older. Diabetes 52. 1210-1214. 2003. NHANES III
http://diabetes.diabetesjournals.org/content/52/5/1210.abstract
Ali Mohammed K., Bullard Kai McKeever, Saaddine Jinan B., Cowie Catherine C., Imperatore Giuseppina and Gregg Edward W.
Achievement of Goals in U.S. Diabetes Care, 1999–2010. New England Journal of Medicine 368. 1613-1624. 2013. Care
http://www.nejm.org/doi/full/10.1056/NEJMsa1213829
Alssema M., Vistisen D., Heymans M., Nijpels G., Glümer C., Zimmet P., Shaw J., Eliasson M., Stehouwer C., Tabák A., Colagiuri S., Borch-Johnsen K. and Dekker J.
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia 54. 1004-1012. 2011. DETECT 2
http://dx.doi.org/10.1007/s00125-010-1990-7
Amori Renee E., Lau Joseph and Pittas Anastassios G.
Efficacy and Safety of Incretin Therapy in Type 2 Diabetes. JAMA: The Journal of the American Medical Association 298. 194-206. 2007. Meta-analysis
http://jama.ama-assn.org/content/298/2/194.abstract
Anderson Barbara J., Edelstein Sharon, Abramson Natalie Walders, Katz Lorraine E. Levitt, Yasuda Patrice M., Lavietes Sylvia J., Trief Paula M., Tollefsen Sherida E., McKay Siripoom Vudhipoom, Kringas Patricia, Casey Terri Lynn and Marcus Marsha D.
Depressive Symptoms and Quality of Life in Adolescents With Type 2 Diabetes. Diabetes Care 34. 2205-2207. 2011. TODAY Study
http://care.diabetesjournals.org/content/34/10/2205.abstract
Anderson Robert J., Bahn Gideon D., Moritz Thomas E., Kaufman Derrick, Abraira Carlos, Duckworth William and Group for the VADT Study
Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial. Diabetes Care 34. 34-38. 2011. VADT
http://care.diabetesjournals.org/content/34/1/34.abstract
Anderson Roger T., Narayan K.M. Venkat, Feeney Patricia, Goff David, Ali Mohammed K., Simmons Debra L., Sperl-Hillen Jo-Ann, Bigger Thomas, Cuddihy Robert, O'Conner Patrick J., Sood Ajay, Zhang Ping, Sullivan Mark D. and Investigators for the Action to Control Cardiovascular Risk in Diabetes
Effect of Intensive Glycemic Lowering on Health-Related Quality of Life in Type 2 Diabetes. Diabetes Care 34. 807-812. 2011. ACCORD
http://care.diabetesjournals.org/content/34/4/807.abstract
Andersson C., van Gaal L., Caterson I., Weeke P., James W., Couthino W., Finer N., Sharma A., Maggioni A. and Torp-Pedersen C.
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia 55. 2348-2355. 2012. Obesity
http://dx.doi.org/10.1007/s00125-012-2584-3
Arjona Ferreira Juan Camilo, Marre Michel, Barzilai Nir, Guo Hua, Golm Gregory T., Sisk Christine McCrary, Kaufman Keith D. and Goldstein Barry J.
Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency. Diabetes Care 36. 1067-1073. 2013. DPP4
http://care.diabetesjournals.org/content/36/5/1067.abstract
Armstrong David G., Bharara Manish, White Matthew, Lepow Brian, Bhatnagar Sugam, Fisher Timothy, Kimbriel Heather R., Walters Jodi, Goshima Kaoru R., Hughes John and Mills Joseph L.
The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot. Diabetes/Metabolism Research and Reviews 28. 514-518. 2012. Diabetic Foot
http://dx.doi.org/10.1002/dmrr.2299
Arnolds Sabine, Dellweg Sibylle, Clair Janina, Dain Marie-Paule, Nauck Michael A, Rave Klaus and Kapitza Christoph
Further improvement in postprandial glucose control when adding exenatide (EXE) or sitagliptin (SITA) to combination therapy with insulin glargine (GLAR) and metformin (MET) – a proof-of-concept study. Diabetes Care. 2010. GLP-1
http://care.diabetesjournals.org/content/early/2010/03/24/dc09-2191.abstract
Arnolds Sabine, Dellweg Sibylle, Clair Janina, Dain Marie-Paule, Nauck Michael A., Rave Klaus and Kapitza Christoph
Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin. Diabetes Care 33. 1509-1515. 2010. GLP-1
http://care.diabetesjournals.org/content/33/7/1509.abstract
Aronne Louis J., Wadden Thomas A., Peterson Craig, Winslow David, Odeh Sarah and Gadde Kishore M.
Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity 21. 2163-2171. 2013. Obesity
http://dx.doi.org/10.1002/oby.20584
Asche C. V., Bode B., Busk A. K. and Nair S. R.
The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 14. 47-57. 2012. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01487.x
Aspelund T., Þórisdóttir Ó, Ólafsdottir E., Gudmundsdottir A., Einarsdóttir A., Mehlsen J., Einarsson S., Pálsson Ó, Einarsson G., Bek T. and Stefánsson E.
Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia 54. 2525-2532. 2011. Retinopathy
http://dx.doi.org/10.1007/s00125-011-2257-7
Association American Diabetes
Standards of Medical Care in Diabetes—2014. Diabetes Care 37. S14-S80. 2014. Consensus
http://care.diabetesjournals.org/content/37/Supplement_1/S14.short
Assogba G. F. A., Couchoud C., Roudier C., Pornet C., Fosse S., Romon I., Druet C., Stengel B. and Fagot-Campagna A.
Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: The ENTRED surveys (2001 and 2007). Diabetes & Metabolism 38. 558-566. 2012. ENTRED
http://www.sciencedirect.com/science/article/pii/S126236361200122X
Astrup Arne, Rössner Stephan, Van Gaal Luc, Rissanen Aila, Niskanen Leo, Al Hakim Mazin, Madsen Jesper, Rasmussen Mads F. and Lean Michael E. J.
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. The Lancet 374. 1606-1616. 2009. GLP-1
http://www.sciencedirect.com/science/article/pii/S0140673609613751
Attard Samantha M., Herring Amy H., Howard Annie Green and Gordon-Larsen Penny
Longitudinal trajectories of BMI and cardiovascular disease risk: The national longitudinal study of adolescent health. Obesity 21. 2180-2188. 2013. Obesity
http://dx.doi.org/10.1002/oby.20569
Aung P. P., Strachan M. W. J., Frier B. M., Butcher I., Deary I. J., Price J. F. and on behalf of the Edinburgh Type 2 Diabetes Study Investigators
Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetic Medicine 29. 328-336. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1464-5491.2011.03505.x
Avanzini Fausto, Marelli Giuseppe, Donzelli Walter, Busi Giovanna, Carbone Stefania, Bellato Laura, Colombo Elena Lucia, Foschi Roberto, Riva Emma, Roncaglioni Maria Carla, De Martini Mario and Group on behalf of the Desio Diabetes Diagram Study
Transition From Intravenous to Subcutaneous Insulin. Diabetes Care 34. 1445-1450. 2011. DDDSG
http://care.diabetesjournals.org/content/34/7/1445.abstract
Azizi Michel and Menard Joel
Combined Blockade of the Renin-Angiotensin System With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists. Circulation 109. 2492-2499. 2004. ACE
Bacchi Elisabetta, Negri Carlo, Zanolin Maria Elisabetta, Milanese Chiara, Faccioli Niccolò, Trombetta Maddalena, Zoppini Giacomo, Cevese Antonio, Bonadonna Riccardo C., Schena Federico, Bonora Enzo, Lanza Massimo and Moghetti Paolo
Metabolic Effects of Aerobic Training and Resistance Training in Type 2 Diabetic Subjects. Diabetes Care 35. 676-682. 2012. Exercise
http://care.diabetesjournals.org/content/35/4/676.abstract
Bae Ji Cheol, Rhee Eun Jung, Lee Won Young, Park Se Eun, Park Cheol Young, Oh Ki Won, Park Sung Woo and Kim Sun Woo
Optimal range of HbA1c for the prediction of future diabetes: A 4-year longitudinal study. Diabetes research and clinical practice 93. 255-259. 2011. HbA1c
http://www.sciencedirect.com/science/article/pii/S0168822711002841
Bailey C. J., Iqbal N., T'Joen C. and List J. F.
Dapagliflozin monotherapy in drug-naïve patients with diabetes: a randomized-controlled trial of low-dose range. Diabetes, Obesity and Metabolism 14. 951-959. 2012. SGLT-2
http://dx.doi.org/10.1111/j.1463-1326.2012.01659.x
Baldwin David, Zander Jennifer, Munoz Christina, Raghu Preeya, DeLange-Hudec Susan, Lee Hong, Emanuele Mary Ann, Glossop Valerie, Smallwood Kimberly and Molitch Mark
A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency. Diabetes Care 35. 1970-1974. 2012. Nephropathy
http://care.diabetesjournals.org/content/35/10/1970.abstract
Bansal Shanti, Wackers Frans J.Th., Inzucchi Silvio E., Chyun Deborah A., Davey Janice A., Staib Lawrence H., Young Lawrence H. and Investigators for the DIAD Study
Five-Year Outcomes in High-Risk Participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study. Diabetes Care 34. 204-209. 2011. DIAD
http://care.diabetesjournals.org/content/34/1/204.abstract
Bao Jiansong, Gilbertson Heather R., Gray Robyn, Munns Diane, Howard Gabrielle, Petocz Peter, Colagiuri Stephen and Brand-Miller Jennie C.
Improving the Estimation of Mealtime Insulin Dose in Adults With Type 1 Diabetes. Diabetes Care 34. 2146-2151. 2011. NIDDA study
http://care.diabetesjournals.org/content/34/10/2146.abstract
Barakat A., Williams K. M., Prevost A. T., Kinmonth A. L., Wareham N. J., Griffin S. J. and Simmons R. K.
Changes in physical activity and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort. Diabetic Medicine 30. 233-238. 2013. ADDITION
http://dx.doi.org/10.1111/j.1464-5491.2012.03765.x
Barendse S., Singh H., Frier B. M. and Speight J.
The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review. Diabetic Medicine 29. 293-302. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1464-5491.2011.03416.x
Barnett A. H.
The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide. Diabetes, Obesity and Metabolism 14. 304-314. 2012. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2011.01523.x
Barnett Anthony H., Bain Stephen C., Bouter Paul, Karlberg Bengt, Madsbad Sten, Jervell Jak and Mustonen Jukka
Angiotensin-Receptor Blockade versus Converting Enzyme Inhibition in Type 2 Diabetes and Nephropathy. New England Journal of Medicine 351. 1952-1961. 2004. ACE
http://www.nejm.org/doi/full/10.1056/NEJMoa042274
Barnett Anthony H., Huisman Holger, Jones Russell, von Eynatten Maximilian, Patel Sanjay and Woerle Hans-Juergen
Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial. The Lancet 382. 1413-1423. 2013. DPP4
http://linkinghub.elsevier.com/retrieve/pii/S0140673613615007
Barton Franca B., Rickels Michael R., Alejandro Rodolfo, Hering Bernhard J. and al et
Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010. Diabetes Care 35. 1436-1445. 2012. Islet Cell Transplant
http://care.diabetesjournals.org/content/35/7/1436.abstract
Barzilay Joshua I., Howard Annie G., Evans Gregory W., Fleg Jerome L., Cohen Robert M., Booth Gillian L., Kimel Angela R., Pedley Carolyn F. and Cushman William C.
Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes. Diabetes Care 35. 1401-1405. 2012. ACCORD
http://care.diabetesjournals.org/content/35/7/1401.abstract
Battelino T., Conget I., Olsen B., Schütz-Fuhrmann I., Hommel E., Hoogma R., Schierloh U., Sulli N., Bolinder J. and Group the Switch Study
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55. 3155-3162. 2012. CSII
http://dx.doi.org/10.1007/s00125-012-2708-9
Battise Dawn
A New Basal Insulin Option: The BEGIN Trials in Patients With Type 2 Diabetes. Clinical Diabetes 31. 166-170. 2013. BEGIN
http://clinical.diabetesjournals.org/content/31/4/166.short
Bazzano L. A., Lee L. J., Shi L., Reynolds K., Jackson J. A. and Fonseca V.
Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetic Medicine 25. 924-932. 2008. Meta-analysis
http://dx.doi.org/10.1111/j.1464-5491.2008.02517.x
Beagley Jessica, Guariguata Leonor, Weil Clara and Motala Ayesha A.
Global estimates of undiagnosed diabetes in adults. Diabetes research and clinical practice 103. 150-160. 2014. Epidemiology
http://linkinghub.elsevier.com/retrieve/pii/S0168822713003847?showall=true
Beluchin E., Bäz L., Müller N., Lehmann T., Kloos C., Wolf G. and Müller U. A.
Frequency of self-adjustment of insulin dose and metabolic control in Type 2 diabetes –is there an association? Diabetic Medicine 30. e91-e94. 2013. Insulin
http://dx.doi.org/10.1111/dme.12071
Benhamou P. Y., Catargi B., Delenne B., Guerci B., Hanaire H., Jeandidier N., Leroy R., Meyer L., Penfornis A., Radermecker R. P., Renard E., Baillot-Rudoni S., Riveline J. P., Schaepelynck P., Sola-Gazagnes A., Sulmont V., Tubiana-Rufi N., Durain D. and Mantovani I.
Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: Consensus of experts from SFD, EVADIAC and SFE. Diabetes & Metabolism 38. S67-S83. 2012. Consensus
http://www.sciencedirect.com/science/article/pii/S1262363612715380
Bergenstal R. M., Li Y., Porter T. K. Booker, Weaver C. and Han J.
Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks. Diabetes, Obesity and Metabolism 15. 264-271. 2013. GLP-1
http://dx.doi.org/10.1111/dom.12026
Bergenstal Richard M., Tamborlane William V., Ahmann Andrew, Buse John B., Dailey George, Davis Stephen N., Joyce Carol, Perkins Bruce A., Welsh John B., Willi Steven M., Wood Michael A. and Group for the STAR 3 Study
Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study. Diabetes Care 34. 2403-2405. 2011. CSII
http://care.diabetesjournals.org/content/34/11/2403.abstract
Berhan Yonas, Waernbaum Ingeborg, Lind Torbjorn, Mollsten Anna, Dahlquist Gisela and Group* for the Swedish Childhood Diabetes Study
Thirty Years of Prospective Nationwide Incidence of Childhood Type 1 Diabetes. Diabetes 60. 577-581. 2011. Swedish Childhood Diabetes Study
http://diabetes.diabetesjournals.org/content/60/2/577.abstract
Berman Laura J., Weigensberg Marc J. and Spruijt-Metz Donna
Physical activity is related to insulin sensitivity in children and adolescents, independent of adiposity: a review of the literature. Diabetes/Metabolism Research and Reviews 28. 395-408. 2012. Exercise
http://dx.doi.org/10.1002/dmrr.2292
Best James D., Drury Paul L., Davis Timothy M.E., Taskinen Marja-Riitta, Kesäniemi Y. Antero, Scott Russell, Pardy Christopher, Voysey Merryn, Keech Anthony C., Intervention on behalf of the Fenofibrate and Investigators Event Lowering in Diabetes Study
Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes. Diabetes Care 35. 1165-1170. 2012. Review
http://care.diabetesjournals.org/content/35/5/1165.abstract
Best Jennie H., Hoogwerf Byron J., Herman William H., Pelletier Elise M., Smith Daniel B., Wenten Made and Hussein Mohamed A.
Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies. Diabetes Care 34. 90-95. 2011. GLP-1
http://care.diabetesjournals.org/content/34/1/90.abstract
Best Jennie H., Rubin Richard R., Peyrot Mark, Li Yan, Yan Ping, Malloy Jaret and Garrison Louis P.
Weight-Related Quality of Life, Health Utility, Psychological Well-Being, and Satisfaction With Exenatide Once Weekly Compared With Sitagliptin or Pioglitazone After 26 Weeks of Treatment. Diabetes Care 34. 314-319. 2011. GLP-1
http://care.diabetesjournals.org/content/34/2/314.abstract
Beynat J., Ben Mehidi A., Aubert J. P., Bron A. M., Massin P. and Creuzot-Garcher C.
RETIDIAB®: Assessment of a continuing medical education website for the improvement of diabetic retinopathy management. Diabetes & Metabolism 37. 118-123. 2011. RETIDIAB
http://www.sciencedirect.com/science/article/pii/S1262363610002363
Bhansali A., Walia R., Ravi Kumar P., Ravi Kiran M. and Shanmugasundar G.
Accuracy of glycated haemoglobin in screening for pre-diabetes in Asian Indians—a community survey: the Chandigarh Urban Diabetes Study (CUDS). Diabetic Medicine 29. 1385-1389. 2012. HbA1c
http://dx.doi.org/10.1111/j.1464-5491.2012.03634.x
Bhasin Shalender, Jasjua Guneet K., Pencina Michael, D’Agostino Ralph, Coviello Andrea D., Vasan Ramachandran S. and Travison Thomas G.
Sex Hormone–Binding Globulin, but Not Testosterone, Is Associated Prospectively and Independently With Incident Metabolic Syndrome in Men. Diabetes Care 34. 2464-2470. 2011. Metabolic Syndrome
http://care.diabetesjournals.org/content/34/11/2464.abstract
Bianchi Cristina, Miccoli Roberto, Bonadonna Riccardo C., Giorgino Francesco, Frontoni Simona, Faloia Emanuela, Marchesini Giulio, Dolci Maria A., Cavalot Franco, Cavallo Gisella M., Leonetti Frida, Del Prato Stefano and Investigators on behalf of the GENFIEV
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. Diabetes Care 35. 2607-2612. 2012. HbA1c
http://care.diabetesjournals.org/content/35/12/2607.abstract
Blacklock C. L., Hirst J. A., Taylor K. S., Stevens R. J., Roberts N. W. and Farmer A. J.
Evidence for a dose effect of renin–angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis. Diabetic Medicine 28. 1182-1187. 2011. Meta-analysis
http://dx.doi.org/10.1111/j.1464-5491.2011.03341.x
Blin P., Lassalle R., Dureau-Pournin C., Ambrosino B., Bernard M., Abouelfath A., Gin H., Le Jeunne C., Pariente A., Droz C. and Moore N.
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database. Diabetologia 55. 644-653. 2012. Insulin
http://dx.doi.org/10.1007/s00125-011-2429-5
Blonde L. and Russell-Jones D.
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies. Diabetes, Obesity and Metabolism 11. 26-34. 2009. LEAD 1-5
http://dx.doi.org/10.1111/j.1463-1326.2009.01075.x
Bode B. W., Buse J. B., Fisher M., Garg S. K., Marre M., Merker L., Renard E., Russell-Jones D. L., Hansen C. T., Rana A., Heller S. R. and Investigators Begin® Basal–Bolus Type 1 Trial
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal–Bolus Type 1): 2-year results of a randomized clinical trial. Diabetic Medicine 30. 1293-1297. 2013. Insulin
http://dx.doi.org/10.1111/dme.12243
Bolinder J., Ljunggren Ö, Johansson L., Wilding J., Langkilde A. M., Sjöström C. D., Sugg J. and Parikh S.
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes, Obesity and Metabolism 16. 159-169. 2014. SGLT2
http://dx.doi.org/10.1111/dom.12189
Bonds D., Craven T., Buse J., Crouse J., Cuddihy R., Elam M., Ginsberg H., Kirchner K., Marcovina S., Mychaleckyj J., O’Connor P. and Sperl-Hillen J. A.
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience. Diabetologia 55. 1641-1650. 2012. ACCORD
http://dx.doi.org/10.1007/s00125-012-2524-2
Bonds Denise E, Miller Michael E, Bergenstal Richard M, Buse John B, Byington Robert P, Cutler Jeff A, Dudl R James, Ismail-Beigi Faramarz, Kimel Angela R, Hoogwerf Byron, Horowitz Karen R, Savage Peter J, Seaquist Elizabeth R, Simmons Debra L, Sivitz William I, Speril-Hillen Joann M and Sweeney Mary Ellen
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. British Medical Journal 340. 2010. ACCORD
http://www.bmj.com/content/340/bmj.b4909.abstract
Bonora Enzo, Kiechl Stefan, Mayr Agnes, Zoppini Giacomo, Targher Giovanni, Bonadonna Riccardo C. and Willeit Johann
High-Normal HbA1c Is a Strong Predictor of Type 2 Diabetes in the General Population. Diabetes Care 34. 1038-1040. 2011. HbA1c
http://care.diabetesjournals.org/content/34/4/1038.abstract
Bosi E., Ellis G. C., Wilson C. A. and Fleck P. R.
Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study. Diabetes, Obesity and Metabolism 13. 1088-1096. 2011. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2011.01463.x
Bosi Emanuele, Scavini Marina, Ceriello Antonio, Cucinotta Domenico, Tiengo Antonio, Marino Raffaele, Bonizzoni Erminio, Giorgino Francesco and Group on behalf of the PRISMA Study
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA randomized trial. Diabetes Care 36. 2887-2894. 2013. PRISMA Study
http://care.diabetesjournals.org/content/36/10/2887.abstract
Bottazzo G., Bosi E., Cull C., Bonifacio E., Locatelli M., Zimmet P., Mackay I. and Holman R.
IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia 48. 703-708. 2005. UKPDS 71
http://dx.doi.org/10.1007/s00125-005-1691-9
Boulton Andrew J. M., Valensi Paul and Tesfaye Solomon
International Neuropathy Workshop of 2009: Introduction to the final reports. Diabetes/Metabolism Research and Reviews 27. 617-619. 2011. Consensus
http://dx.doi.org/10.1002/dmrr.1228
Braun Karl F., Otter Wolfgang, Sandor Stefanie M., Standl Eberhard and Schnell Oliver
All-cause in-hospital mortality and comorbidity in diabetic and non-diabetic patients with stroke. Diabetes research and clinical practice 98. 164-168. 2012. CVA
http://linkinghub.elsevier.com/retrieve/pii/S0168822712001507?showall=true
Bray G. A., Smith S. R., Banerji M. A., Tripathy D., Clement S. C., Buchanan T. A., Henry R. R., Kitabchi A. E., Mudaliar S., Musi N., Ratner R. E., Schwenke D. C., Stentz F. B., Reaven P. D. and DeFronzo R. A.
Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial. Diabetes, Obesity and Metabolism 15. 931-937. 2013. ACT NOW
http://dx.doi.org/10.1111/dom.12099
Brazeau A. S., Mircescu H., Desjardins K., Dubé M. C., Weisnagel S. J., Lavoie C. and Rabasa-Lhoret R.
The Barriers to Physical Activity in Type 1 Diabetes (BAPAD-1) scale: Predictive validity and reliability. Diabetes & Metabolism 38. 164-170. 2012. BAPAD-1
http://www.sciencedirect.com/science/article/pii/S1262363611002059
Brenner Barry M., Cooper Mark E., de Zeeuw Dick, Keane William F., Mitch William E., Parving Hans-Henrik, Remuzzi Giuseppe, Snapinn Steven M., Zhang Zhonxin and Shahinfar Shahnaz
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. New England Journal of Medicine 345. 861-869. 2001. ARB
http://www.nejm.org/doi/full/10.1056/NEJMoa011161
Bretzel Reinhard G., Nuber Ulrike, Landgraf Wolfgang, Owens David R., Bradley Clare and Linn Thomas
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. The Lancet 371. 1073-1084. 2008. APOLLO
http://www.sciencedirect.com/science/article/pii/S0140673608604857
Brod M., Wolden M., Christensen T. and Bushnell D. M.
A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes, Obesity and Metabolism 15. 546-557. 2013. Hypoglycaemia
http://dx.doi.org/10.1111/dom.12070
Bruce David G., Van Minnen Kylie, Davis Wendy A., Mudhar Jaspreet, Perret Michael, Subawickrama Dayani P., Venkitachalam Stephanie, Ravine David and Davis Timothy M.E.
Maternal Family History of Diabetes Is Associated With a Reduced Risk of Cardiovascular Disease in Women With Type 2 Diabetes. Diabetes Care 33. 1477-1483. 2010. Cardiovascular
http://care.diabetesjournals.org/content/33/7/1477.abstract
Buckley B. S., Harreiter J., Damm P., Corcoy R., Chico A., Simmons D., Vellinga A., Dunne F. and on behalf of the Dali Core Investigator Group
Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabetic Medicine 29. 844-854. 2012. Review
http://dx.doi.org/10.1111/j.1464-5491.2011.03541.x
Burant Charles F., Viswanathan Prabhakar, Marcinak John, Cao Charlie, Vakilynejad Majid, Xie Benhuai and Leifke Eckhard
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet 379. 1403-1411. 2012. TAK-875
http://linkinghub.elsevier.com/retrieve/pii/S0140673611618795
Buse John B., Nauck Michael, Forst Thomas, Sheu Wayne H. H., Shenouda Sylvia K., Heilmann Cory R., Hoogwerf Byron J., Gao Aijun, Boardman Marilyn K., Fineman Mark, Porter Lisa and Schernthaner Guntram
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study. The Lancet 381. 117-124. 2013. DURATION-6
http://linkinghub.elsevier.com/retrieve/pii/S0140673612612677
Buse John B., Rosenstock Julio, Sesti Giorgio, Schmidt Wolfgang E., Montanya Eduard, Brett Jason H., Zychma Marcin and Blonde Lawrence
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). The Lancet 374. 39-47. 2009. LEAD 6
http://www.sciencedirect.com/science/article/pii/S0140673609606590
Buse John B., Wolffenbuttel Bruce H.R., Herman William H., Hippler Stephen, Martin Sherry A., Jiang Honghua H., Shenouda Sylvia K. and Fahrbach Jessie L.
The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial. Diabetes Care 34. 249-255. 2011. DURABLE
Calanna Salvatore, Christensen Mikkel, Holst Jens J., Laferrère Blandine, Gluud Lise L., Vilsbøll Tina and Knop Filip K.
Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes: Systematic review and meta-analysis of clinical studies. Diabetes Care 36. 3346-3352. 2013. Meta-analysis
http://care.diabetesjournals.org/content/36/10/3346.abstract
Califf Robert M., Boolell Mitradev, Haffner Steven M., Bethel M. Angelyn, McMurray John, Duggal Anil and Holman Rury R.
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. American Heart Journal 156. 623-632. 2008. NAVIGATOR
http://www.sciencedirect.com/science/article/pii/S000287030800389X
Calle R., McCarthy M., Banerjee P., Zeggini E., Cull C., Thorne K., Wiltshire S., Terra S., Meyer D., Richmond J., Mancuso J., Milos P., Fryburg D. and Holman R.
Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76. Diabetologia 49. 2892-2899. 2006. UKPDS 76
http://dx.doi.org/10.1007/s00125-006-0436-8
Camafort M., Álvarez-Rodríguez L. R., Muñoz-Torrero J. F. S., Sahuquillo J. C., López-Jiménez L., Coll R., Monreal M. and the Frena Investigators
Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry. Diabetic Medicine 28. 73-80. 2011. FRENA
http://dx.doi.org/10.1111/j.1464-5491.2010.03153.x
Camargo E. G., Soares A. A., Detanico A. B., Weinert L. S., Veronese F. V., Gomes E. C. and Silveiro S. P.
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals. Diabetic Medicine 28. 90-95. 2011. CKDEPI
http://dx.doi.org/10.1111/j.1464-5491.2010.03161.x
Camastra Stefania, Muscelli Elza, Gastaldelli Amalia, Holst Jens J., Astiarraga Brenno, Baldi Simona, Nannipieri Monica, Ciociaro Demetrio, Anselmino Marco, Mari Andrea and Ferrannini Ele
Long-Term Effects of Bariatric Surgery on Meal Disposal and β-Cell Function in Diabetic and Nondiabetic Patients. Diabetes 62. 3709-3717. 2013. Bariatric
http://diabetes.diabetesjournals.org/content/62/11/3709.abstract
Cariou B.
Harnessing the incretin system beyond glucose control: Potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetes. Diabetes & Metabolism 38. 298-308. 2012. GLP-1
http://www.sciencedirect.com/science/article/pii/S126236361200078X
Carstensen B., Witte D. and Friis S.
Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia. 1-11. 2011. Cancer
http://dx.doi.org/10.1007/s00125-011-2381-4
Carter Aleesa A, Gomes Tara, Camacho Ximena, Juurlink David N, Shah Baiju R and Mamdani Muhammad M
Risk of incident diabetes among patients treated with statins: population based study. British Medical Journal 346. 2013. Statins
http://www.bmj.com/content/346/bmj.f2610
Caterson I. D., Finer N., Coutinho W., Van Gaal L. F., Maggioni A. P., Torp-Pedersen C., Sharma A. M., Legler U. F., Shepherd G. M., Rode R. A., Perdok R. J., Renz C. L., James W. P. T. and on behalf of the Scout Investigators
Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes, Obesity and Metabolism 14. 523-530. 2012. SCOUT Trial
http://dx.doi.org/10.1111/j.1463-1326.2011.01554.x
Cavagnolli G., Comerlato J., Comerlato C., Renz P. B., Gross J. L. and Camargo J. L.
HbA1c measurement for the diagnosis of diabetes: is it enough? Diabetic Medicine 28. 31-35. 2011. HbA1c
http://dx.doi.org/10.1111/j.1464-5491.2010.03159.x
Cavallerano Jerry D., Silva Paolo S., Tolson Ann M., Francis Taniya, Tolls Dorothy, Patel Bina, Eagan Sharon, Aiello Lloyd M. and Aiello Lloyd P.
Imager Evaluation of Diabetic Retinopathy at the Time of Imaging in a Telemedicine Program. Diabetes Care 35. 482-484. 2012. TELEMEDICINE
http://care.diabetesjournals.org/content/35/3/482.abstract
Cavalot Franco, Pagliarino Andrea, Valle Manuela, Di Martino Leonardo, Bonomo Katia, Massucco Paola, Anfossi Giovanni and Trovati Mariella
Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up. Diabetes Care 34. 2237-2243. 2011. San Luigi Gonzaga Diabetes Study
http://care.diabetesjournals.org/content/34/10/2237.abstract
Cebul Randall D., Love Thomas E., Jain Anil K. and Hebert Christopher J.
Electronic Health Records and Quality of Diabetes Care. New England Journal of Medicine 365. 825-833. 2011. EPR
http://www.nejm.org/doi/full/10.1056/NEJMsa1102519
Cederholm J., Eeg-Olofsson K., Eliasson B., Zethelius B., Gudbjörnsdottir S. and on behalf of the Swedish National Diabetes Register
A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR). Diabetic Medicine 28. 1213-1220. 2011. SNDR
http://dx.doi.org/10.1111/j.1464-5491.2011.03342.x
Cene Crystal Wiley and Pignone Michael
The Effect of Fruit and Vegetable Intake on the Incidence of Diabetes. Clinical Diabetes 29. 113-115. 2011. Diet
http://clinical.diabetesjournals.org/content/29/3/113.short
Chae Jey Sook, Kang Ryungwoo, Kwak Jung Hyun, Paik Jean Kyung, Kim Oh Yoen, Kim Minjoo, Park Ji Won, Jeon Justin Y. and Lee Jong Ho
Supervised Exercise Program, BMI, and Risk of Type 2 Diabetes in Subjects With Normal or Impaired Fasting Glucose. Diabetes Care 35. 1680-1685. 2012. Exercise
http://care.diabetesjournals.org/content/35/8/1680.abstract
Chakkera Harini A., Chang Yu-Hui, Ayub Asad, Gonwa Thomas A., Weil E. Jennifer and Knowler William C.
Validation of a Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation. Diabetes Care 36. 2881-2886. 2013. Risk Scores
http://care.diabetesjournals.org/content/36/10/2881.abstract
Chalk Daniel, Pitt Martin, Vaidya Bijay and Stein Ken
Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy? Diabetes Care 35. 1663-1668. 2012. Retinopathy
http://care.diabetesjournals.org/content/35/8/1663.abstract
Charbonnel B., Penfornis A., Varroud-Vial M., Kusnik-Joinville O. and Detournay B.
Insulin therapy for diabetes mellitus: Treatment regimens and associated costs. Diabetes & Metabolism 38. 156-163. 2012. Insulin
http://www.sciencedirect.com/science/article/pii/S1262363611002035
Charles Morten, Ejskjaer Niels, Witte Daniel R., Borch-Johnsen Knut, Lauritzen Torsten and Sandbaek Annelli
Prevalence of Neuropathy and Peripheral Arterial Disease and the Impact of Treatment in People With Screen-Detected Type 2 Diabetes. Diabetes Care 34. 2244-2249. 2011. Neuropathy: ADDITION-Denmark Study
http://care.diabetesjournals.org/content/34/10/2244.abstract
Charpentier Guillaume, Benhamou Pierre-Yves, Dardari Dured, Clergeot Annie, Franc Sylvia, Schaepelynck-Belicar Pauline, Catargi Bogdan, Melki Vincent, Chaillous Lucy, Farret Anne, Bosson Jean-Luc, Penfornis Alfred and Group on behalf of the TeleDiab Study
The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients. Diabetes Care 34. 533-539. 2011. TELEMEDICINE
http://care.diabetesjournals.org/content/34/3/533.abstract
Chatterjee R., Colangelo L., Yeh H., Anderson C., Daviglus M., Liu K. and Brancati F.
Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetologia 55. 1295-1303. 2012. CARDIA study
http://dx.doi.org/10.1007/s00125-012-2487-3
Chatterjee Ranee, Narayan K.M. Venkat, Lipscomb Joseph, Jackson Sandra L., Long Qi, Zhu Ming and Phillips Lawrence S.
Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk. Diabetes Care 36. 1981-1987. 2013. Prediabetes
http://care.diabetesjournals.org/content/36/7/1981.abstract
Chen Ailing, Huang Zhimin, Wan Xuesi, Deng Wanping, Wu Jiyan, Li Licheng, Cai Qiuling, Xiao Haipeng and Li Yanbing
Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment. Diabetes Care 35. 474-481. 2012. CSII
http://care.diabetesjournals.org/content/35/3/474.abstract
Cheng Peiyao, Neugaard Britta, Foulis Philip and Conlin Paul R.
Hemoglobin A1c as a Predictor of Incident Diabetes. Diabetes Care 34. 610-615. 2011. HbA1c
http://care.diabetesjournals.org/content/34/3/610.abstract
Chilelli NinoCristiano, Cosma Chiara, Ragazzi Eugenio, Burlina Silvia, Zaninotto Martina, Plebani Mario and Lapolla Annunziata
Screening with HbA1c identifies only one in two individuals with diagnosis of prediabetes at oral glucose tolerance test: findings in a real-world Caucasian population. Acta Diabetologica 51. 875-882. 2014. HbA1c
http://dx.doi.org/10.1007/s00592-014-0639-2
Chilton M., Dunkley A., Carter P., Davies M. J., Khunti K. and Gray L. J.
The effect of antiobesity drugs on waist circumference: a mixed treatment comparison. Diabetes, Obesity and Metabolism 16. 237-247. 2014. Obesity
http://dx.doi.org/10.1111/dom.12198
Chimen M., Kennedy A., Nirantharakumar K., Pang T., Andrews R. and Narendran P.
What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 55. 542-551. 2012. Review
http://dx.doi.org/10.1007/s00125-011-2403-2
Cho NamH, Kim TaeHyuk, Woo SeJoon, Park KyuHyung, Lim Soo, Cho YoungMin, Park KyongSoo, Jang HakC and Choi SungHee
Optimal HbA1c cutoff for detecting diabetic retinopathy. Acta Diabetologica 50. 837-842. 2013. Retinopathy
http://dx.doi.org/10.1007/s00592-013-0452-3
Chou H. S., Truitt K. E., Moberly J. B., Merante D., Choi Y., Mun Y. and Pfützner A.
A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 14. 1000-1009. 2012. PPAR
http://dx.doi.org/10.1111/j.1463-1326.2012.01631.x
Choudhary Pratik, Shin John, Wang Yongyin, Evans Mark L., Hammond Peter J., Kerr David, Shaw James A.M., Pickup John C. and Amiel Stephanie A.
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia. Diabetes Care 34. 2023-2025. 2011. CSII
http://care.diabetesjournals.org/content/34/9/2023.abstract
Christensen Robin, Kristensen Pernelle Kruse, Bartels Else Marie, Bliddal Henning and Astrup Arne
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. The Lancet 370. 1706-1713. 2007. Obesity
http://www.sciencedirect.com/science/article/pii/S0140673607617218
Chubb S. A. Paul, Van Minnen Kylie, Davis Wendy A., Bruce David G. and Davis Timothy M. E.
The relationship between self-monitoring of blood glucose results and glycated haemoglobin in type 2 diabetes: The Fremantle Diabetes Study. Diabetes research and clinical practice 94. 371-376. 2011. HbA1c
http://www.sciencedirect.com/science/article/pii/S0168822711004141
Chudyk Anna and Petrella Robert J.
Effects of Exercise on Cardiovascular Risk Factors in Type 2 Diabetes. Diabetes Care 34. 1228-1237. 2011. Exercise
http://care.diabetesjournals.org/content/34/5/1228.abstract
Clark Nathaniel G.
Postprandial Blood Glucose, Cardiovascular Events, and All-Cause Mortality: How Do We Use Postprandial Glucose in Clinical Practice? Clinical Diabetes 30. 67-69. 2012. Postprandial
http://clinical.diabetesjournals.org/content/30/2/67.short
Clarke P., Gray A., Adler A., Stevens R., Raikou M., Cull C., Stratton I. and Holman R.
Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51). Diabetologia 44. 298-304. 2001. UKPDS 51
http://dx.doi.org/10.1007/s001250051617
Clarke P., Gray A., Briggs A., Farmer A., Fenn P., Stevens R., Matthews D., Stratton I. and Holman R.
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 47. 1747-1759. 2004. UKPDS 68
http://dx.doi.org/10.1007/s00125-004-1527-z
Clarke P., Gray A., Briggs A., Stevens R., Matthews D. and Holman R.
Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia 48. 868-877. 2005. UKPDS 72
http://dx.doi.org/10.1007/s00125-005-1717-3
Clarke P., Gray A. and Holman R.
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making 22. 340. 2002. UKPDS 62
http://mdm.sagepub.com/content/22/4/340.short
Clarke P., Gray A., Legood R., Briggs A. and Holman R.
The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Medicine 20. 442-450. 2003. UKPDS 65
http://dx.doi.org/10.1046/j.1464-5491.2003.00972.x
Clarke Philip M., Simon Judit, Cull Carole A. and Holman Rury R.
Assessing the Impact of Visual Acuity on Quality of Life in Individuals With Type 2 Diabetes Using the Short Form-36. Diabetes Care 29. 1506-1511. 2006. QoL
http://care.diabetesjournals.org/content/29/7/1506.abstract
Cohen Ricardo V., Pinheiro Jose C., Schiavon Carlos A., Salles João E., Wajchenberg Bernardo L. and Cummings David E.
Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 35. 1420-1428. 2012. Bariatric
http://care.diabetesjournals.org/content/35/7/1420.abstract
Colagiuri S.
Optimal management of type 2 diabetes: the evidence. Diabetes, Obesity and Metabolism 14. 3-8. 2012. Review
http://dx.doi.org/10.1111/j.1463-1326.2011.01506.x
Colagiuri Stephen
Glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus—Practical implications. Diabetes research and clinical practice 93. 312-313. 2011. HbA1c
http://linkinghub.elsevier.com/retrieve/pii/S0168822711003470?showall=true
Colagiuri Stephen, Cull Carole A. and Holman Rury R.
Are Lower Fasting Plasma Glucose Levels at Diagnosis of Type 2 Diabetes Associated With Improved Outcomes? UKPDS 61. Diabetes Care 25. 1410-1417. 2002. UKPDS 61
http://care.diabetesjournals.org/content/25/8/1410.abstract
Colagiuri Stephen, Lee Crystal M.Y., Wong Tien Y., Balkau Beverley, Shaw Jonathan E., Borch-Johnsen Knut and Group the DETECT-2 Collaboration Writing
Glycemic Thresholds for Diabetes-Specific Retinopathy. Diabetes Care 34. 145-150. 2011. DETECT 2
http://care.diabetesjournals.org/content/34/1/145.abstract
Colayco Danielle C., Niu Fang, McCombs Jeffrey S. and Cheetham T. Craig
A1C and Cardiovascular Outcomes in Type 2 Diabetes. Diabetes Care 34. 77-83. 2011. HbA1c
http://care.diabetesjournals.org/content/34/1/77.abstract
Colhoun Helen M., Betteridge D. John, Durrington Paul N., Hitman Graham A., W Neil H. Andrew, Livingstone Shona J., Thomason Margaret J., Mackness Michael I., Charlton-Menys Valentine and Fuller John H.
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. The Lancet 364. 685-696. 2004. CARDS
http://www.sciencedirect.com/science/article/pii/S0140673604168955
Collins G. S. and Altman D. G.
External validation of QDSCORE® for predicting the 10-year risk of developing Type 2 diabetes. Diabetic Medicine 28. 599-607. 2011. QDSCORE
http://dx.doi.org/10.1111/j.1464-5491.2011.03237.x
Colmers I. N., Bowker S. L. and Johnson J. A.
Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis. Diabetes & Metabolism 38. 475-484. 2012. Meta-analysis
http://www.sciencedirect.com/science/article/pii/S1262363612001231
Colmers I. N., Bowker S. L., Tjosvold L. A. and Johnson J. A.
Insulin use and cancer risk in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies. Diabetes & Metabolism 38. 485-506. 2012. Meta-analysis
http://www.sciencedirect.com/science/article/pii/S1262363612001589
Connelly J., Kirk A., Masthoff J. and MacRury S.
The use of technology to promote physical activity in Type 2 diabetes management: a systematic review. Diabetic Medicine 30. 1420-1432. 2013. Meta-analysis
http://dx.doi.org/10.1111/dme.12289
Conroy R.M., Pyorala K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., De Bacquer D., Ducimetière P., Jousilahti P., Keil U., Njølstad I., Oganov R.G., Thomsen T., Tunstall-Pedoe H., Tverdal A., Wedel H., Whincup P., Wilhelmsen L. and Graham I.M.
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 24. 987-1003. 2003. SCORE
http://eurheartj.oxfordjournals.org/content/24/11/987.abstract
Conway Baqiyyah N., May Michael E., Signorello Lisa B. and Blot William J.
Mortality Experience of a Low-Income Population With Young-Onset Diabetes. Diabetes Care 35. 542-548. 2012. MODY
http://care.diabetesjournals.org/content/35/3/542.abstract
Cooke Debbie, O’Hara Mary Clare, Beinart Naomi, Heller Simon, La Marca Roberto, Byrne Molly, Mansell Peter, Dinneen Sean F., Clark Marie, Bond Rod, Speight Jane and Group for the U.K. NIHR DAFNE Study
Linguistic and Psychometric Validation of the Diabetes-Specific Quality-of-Life Scale in U.K. English for Adults With Type 1 Diabetes. Diabetes Care 36. 1117-1125. 2013. QoL
http://care.diabetesjournals.org/content/36/5/1117.abstract
Cordua S., Secher A. L., Ringholm L., Damm P. and Mathiesen E. R.
Real-time continuous glucose monitoring during labour and delivery in women with Type 1 diabetes — observations from a randomized controlled trial. Diabetic Medicine 30. 1374-1381. 2013. CGM
http://dx.doi.org/10.1111/dme.12246
Cosson E., Chiheb S., Cussac-Pillegand C., Banu I., Hamo-Tchatchouang E., Nguyen M. T., Aout M., Charnaux N. and Valensi P.
Haemoglobin glycation may partly explain the discordance between HbA1c measurement and oral glucose tolerance test to diagnose dysglycaemia in overweight/obese subjects. Diabetes & Metabolism 39. 118-125. 2013. HbA1c
http://www.sciencedirect.com/science/article/pii/S1262363612001632
Crasto W., Jarvis J., Khunti K., Skinner T. C., Gray L. J., Brela J., Troughton J., Daly H., Lawrence I. G., McNally P. G., Carey M. E. and Davies M. J.
Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: The Microalbuminuria Education and Medication Optimisation (MEMO) study. Diabetes research and clinical practice 93. 328-336. 2011. MEMO Study
http://linkinghub.elsevier.com/retrieve/pii/S016882271100235X?showall=true
Cull C. A., Neil H. A. W. and Holman R. R.
Changing aspirin use in patients with Type 2 diabetes in the UKPDS. Diabetic Medicine 21. 1368-1371. 2004. UKPDS
http://dx.doi.org/10.1111/j.1464-5491.2004.01328.x
Cull Carole A., Jensen Christine C., Retnakaran Ravi and Holman Rury R.
Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus. UKPDS 78. Circulation 116. 2119-2126. 2007. UKPDS 78
http://circ.ahajournals.org/content/116/19/2119.abstract
Cullmann M., Hilding A. and Östenson C. G.
Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population. Diabetic Medicine 29. 441-452. 2012. Alcohol
http://dx.doi.org/10.1111/j.1464-5491.2011.03450.x
Cundy T.
Proposed new diagnostic criteria for gestational diabetes – a pause for thought? Diabetic Medicine 29. 176-180. 2012. Gestational
http://dx.doi.org/10.1111/j.1464-5491.2011.03407.x
Cyganek Katarzyna, Hebda-Szydlo Alicja, Skupien Jan, Janas Izabela, Walczyk Joanna, Lipowska Anna, Borys Sebastian and Malecki Maciej T.
Postpregnancy Glycemic Control and Weight Changes in Type 1 Diabetic Women. Diabetes Care 36. 1083-1087. 2013. Gestational
d’Emden MichaelC, Jenkins AliciaJ, Li Liping, Zannino Diana, Mann KristyP, Best JamesD, Stuckey BronwynG A., Park Kris, Saltevo Juha and Keech AnthonyC
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 57. 2296-2303. 2014. Cardiovascular
http://dx.doi.org/10.1007/s00125-014-3344-3
Dale J. R., Williams S. M. and Bowyer V.
What is the effect of peer support on diabetes outcomes in adults? A systematic review. Diabetic Medicine 29. 1361-1377. 2012. Review
http://dx.doi.org/10.1111/j.1464-5491.2012.03749.x
Damm Julie Agner, Ásbjörnsdóttir Björg, Callesen Nicoline Foged, Mathiesen Jonathan M., Ringholm Lene, Pedersen Berit Woetmann and Mathiesen Elisabeth R.
Diabetic Nephropathy and Microalbuminuria in Pregnant Women With Type 1 and Type 2 Diabetes: Prevalence, antihypertensive strategy, and pregnancy outcome. Diabetes Care 36. 3489-3494. 2013. Pregnancy
http://care.diabetesjournals.org/content/36/11/3489.abstract
Dauber Andrew, Corcia Liat, Safer Jason, Agus Michael S.D., Einis Sara and Steil Garry M.
Closed-Loop Insulin Therapy Improves Glycemic Control in Children Aged <7 Years: A randomized controlled trial. Diabetes Care 36. 222-227. 2013. CSII
http://care.diabetesjournals.org/content/36/2/222.abstract
Davies M. J., Chubb B. D., Smith I. C. and Valentine W. J.
Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus. Diabetic Medicine 29. 313-320. 2012. GLP-1
http://dx.doi.org/10.1111/j.1464-5491.2011.03429.x
Davies M., Pratley R., Hammer M., Thomsen A. B. and Cuddihy R.
Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin. Diabetic Medicine 28. 333-337. 2011. GLP-1
http://dx.doi.org/10.1111/j.1464-5491.2010.03074.x
Davies Melanie, Heller Simon, Sreenan Seamus, Sapin Hélène, Adetunji Omolara, Tahbaz Arash and Vora Jiten
Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas. Diabetes Care 36. 1368-1376. 2013. GLP-1
http://care.diabetesjournals.org/content/36/5/1368.abstract
Davis T. M. E., Coleman R. L., Holman R. R. and Group Ukpds
Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83). Diabetic Medicine 31. 200-207. 2014. UKPDS 83
http://dx.doi.org/10.1111/dme.12353
Davis T., Ting R., Best J., Donoghoe M., Drury P., Sullivan D., Jenkins A., O’Connell R., Whiting M., Glasziou P., Simes R., Kesäniemi Y., Gebski V., Scott R. and Keech A.
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia 54. 280-290. 2011. FIELD
http://dx.doi.org/10.1007/s00125-010-1951-1
Davis T., Wright A., Mehta Z., Cull C., Stratton I., Bottazzo G., Bosi E., Mackay I. and Holman R.
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia 48. 695-702. 2005. UKPDS 70
http://dx.doi.org/10.1007/s00125-005-1690-x
Davis T.M.E., Millns H., Stratton I.M., Holman R.R. and Turner R.C.
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Archives of internal medicine 159. 1097. 1999. UKPDS 29
http://cat.inist.fr/?aModele=afficheN&cpsidt=1784877
Davis Timothy ME, Stratton Irene M, Fox Charles J, Holman Rury R, Turner Robert C and Group U.K. Prospective Diabetes Study
U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM. Diabetes Care 20. 1435-1441. 1997. UKPDS 22
http://care.diabetesjournals.org/content/20/9/1435.abstract
Davis TM, Cull C.A. and Holman R.R.
Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: UK Prospective Diabetes Study (UKPDS 55). Diabetes Care 24. 1167. 2001. UKPDS 55
http://www.ncbi.nlm.nih.gov/pubmed/11423497
Davis W. A., Bruce D. G. and Davis T. M. E.
Economic impact of moderate weight loss in patients with Type 2 diabetes: The Fremantle Diabetes Study. Diabetic Medicine 28. 1131-1135. 2011. FDS
http://dx.doi.org/10.1111/j.1464-5491.2011.03314.x
Day Caroline and Bailey Clifford J
The hypocaloric diet in type 2 diabetes - déjà vu. The British Journal of Diabetes & Vascular Disease 12. 48-51. 2012. Diet
http://dvd.sagepub.com/cgi/content/abstract/12/1/48
DCCT
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine 329. 977-986. 1993. DCCT
http://www.nejm.org/doi/full/10.1056/NEJM199309303291401
De Cosmo Salvatore, Copetti Massimiliano, Lamacchia Olga, Fontana Andrea, Massa Michela, Morini Eleonora, Pacilli Antonio, Fariello Stefania, Palena Antonio, Rauseo Anna, Viti Rafaella, Di Paola Rosa, Menzaghi Claudia, Cignarelli Mauro, Pellegrini Fabio and Trischitta Vincenzo
Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care 36. 2830-2835. 2013. Mortality
http://care.diabetesjournals.org/content/36/9/2830.abstract
de Lusignan S., Sadek N., Mulnier H., Tahir A., Russell-Jones D. and Khunti K.
Miscoding, misclassification and misdiagnosis of diabetes in primary care. Diabetic Medicine 29. 181-189. 2012. Epidemiology
http://dx.doi.org/10.1111/j.1464-5491.2011.03419.x
De Marco Marina, de Simone Giovanni, Roman Mary J., Chinali Marcello, Lee Elisa T., Calhoun Darren, Howard Barbara V. and Devereux Richard B.
Cardiac Geometry and Function in Diabetic or Prediabetic Adolescents and Young Adults. Diabetes Care 34. 2300-2305. 2011. Strong Heart Study
http://care.diabetesjournals.org/content/34/10/2300.abstract
de Mello Vanessa D.F., Lindström Jaana, Eriksson Johan, Ilanne-Parikka Pirjo, Keinänen-Kiukaanniemi Sirkka, Sundvall Jouko, Laakso Markku, Tuomilehto Jaakko and Uusitupa Matti
Insulin Secretion and Its Determinants in the Progression of Impaired Glucose Tolerance to Type 2 Diabetes in Impaired Glucose-Tolerant Individuals. Diabetes Care 35. 211-217. 2012. Insulin
http://care.diabetesjournals.org/content/35/2/211.abstract
de Mulder M., Umans V. A., Stam F., Cornel J. H., Oemrawsingh R. M. and Boersma E.
Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial. Diabetic Medicine 28. 1168-1175. 2011. BIOMArCS 2 glucose trial
http://dx.doi.org/10.1111/j.1464-5491.2011.03307.x
de Wit HelenaM, Vervoort GeraldM M., Jansen HenryJ, de Grauw WimJ C., de Galan BastiaanE and Tack CeesJ
Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT). Diabetologia 57. 1812-1819. 2014. ELEGANT Study
http://dx.doi.org/10.1007/s00125-014-3302-0
Deacon C. F., Mannucci E. and Ahrén B.
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes—a review and meta analysis. Diabetes, Obesity and Metabolism 14. 762-767. 2012. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2012.01603.x
DeFronzo Ralph A., Tripathy Devjit, Schwenke Dawn C., Banerji MaryAnn, Bray George A., Buchanan Thomas A., Clement Stephen C., Gastaldelli Amalia, Henry Robert R., Kitabchi Abbas E., Mudaliar Sunder, Ratner Robert E., Stentz Frankie B., Musi Nicolas, Reaven Peter D. and Study for the ACT NOW
Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic Correlates. Diabetes 62. 3920-3926. 2013. ACT NOW
http://diabetes.diabetesjournals.org/content/62/11/3920.abstract
Dellasega Cheryl, Añel-Tiangco Raquel M. and Gabbay Robert A.
How patients with type 2 diabetes mellitus respond to motivational interviewing. Diabetes research and clinical practice 95. 37-41. 2012. Review
http://www.sciencedirect.com/science/article/pii/S0168822711004542
Desai M., Cull C., Horton V., Christie M., Bonifacio E., Lampasona V., Bingley P., Levy J., Mackay I., Zimmet P., Holman R. and Clark A.
GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia 50. 2052-2060. 2007. UKPDS 77
http://dx.doi.org/10.1007/s00125-007-0745-6
Detournay B., Simon D., Guillausseau P. J., Joly D., Verges B., Attali C., Clement O., Briand Y. and Delaitre O.
Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes. Diabetes & Metabolism 38. 102-112. 2012. Nephropathy
http://www.sciencedirect.com/science/article/pii/S1262363611002254
Devineni D., Morrow L., Hompesch M., Skee D., Vandebosch A., Murphy J., Ways K. and Schwartz S.
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin. Diabetes, Obesity and Metabolism 14. 539-545. 2012. SGLT-2
http://dx.doi.org/10.1111/j.1463-1326.2012.01558.x
DeVries J. Hans, Bain Stephen C., Rodbard Helena W., Seufert Jochen, D’Alessio David, Thomsen Anne B., Zychma Marcin, Rosenstock Julio and Group on behalf of the Liraglutide-Detemir Study
Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets. Diabetes Care 35. 1446-1454. 2012. Liraglutide-Detemir Study
http://care.diabetesjournals.org/content/35/7/1446.abstract
Dhatariya K., Levy N., Kilvert A., Watson B., Cousins D., Flanagan D., Hilton L., Jairam C., Leyden K., Lipp A., Lobo D., Sinclair-Hammersley M., Rayman G. and for the Joint British Diabetes Societies
NHS Diabetes guideline for the perioperative management of the adult patient with diabetes*. Diabetic Medicine 29. 420-433. 2012. Consensus
http://dx.doi.org/10.1111/j.1464-5491.2012.03582.x
Diamant Michaela, Nauck Michael A., Shaginian Rimma, Malone James K., Cleall Simon, Reaney Matthew, de Vries Danielle, Hoogwerf Byron J., MacConell Leigh and Wolffenbuttel Bruce H.R.
Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes. Diabetes Care 37. 2763-2773. 2014. GLP-1
http://care.diabetesjournals.org/content/37/10/2763.abstract
Diamant Michaela, Van Gaal Luc, Stranks Stephen, Guerci Bruno, MacConell Leigh, Haber Harry, Scism-Bacon Jamie and Trautmann Michael
Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks. Diabetes Care 35. 683-689. 2012. GLP-1
http://care.diabetesjournals.org/content/35/4/683.abstract
Ding Ming, Bhupathiraju Shilpa N., Chen Mu, van Dam Rob M. and Hu Frank B.
Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-analysis. Diabetes Care 37. 569-586. 2014. Metaanalysis
http://care.diabetesjournals.org/content/37/2/569.abstract
Dirksen C., Jørgensen N., Bojsen-Møller K., Jacobsen S., Hansen D., Worm D., Holst J. and Madsbad S.
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 55. 1890-1901. 2012. Bariatric
http://dx.doi.org/10.1007/s00125-012-2556-7
Dixon J. B., Hur K. Y., Lee W. J., Kim M. J., Chong K., Chen S. C., E. Straznicky N. and Zimmet P.
Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes. Diabetic Medicine 30. e127-e134. 2013. Bariatric
http://dx.doi.org/10.1111/dme.12107
Dixon John B., Chuang Lee-Ming, Chong Keong, Chen Shu-Chun, Lambert Gavin W., Straznicky Nora E., Lambert Elisabeth A. and Lee Wei-Jei
Predicting the Glycemic Response to Gastric Bypass Surgery in Patients With Type 2 Diabetes. Diabetes Care 36. 20-26. 2013. Bariatric
http://care.diabetesjournals.org/content/36/1/20.abstract
Dluhy Robert G. and McMahon Graham T.
Intensive Glycemic Control in the ACCORD and ADVANCE Trials. New England Journal of Medicine 358. 2630-2633. 2008. ACCORD
http://www.nejm.org/doi/full/10.1056/NEJMe0804182
Dobbins R. L., O’Connor-Semmes R., Kapur A., Kapitza C., Golor G., Mikoshiba I., Tao W. and Hussey E. K.
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients. Diabetes, Obesity and Metabolism 14. 15-22. 2012. SGLT-2
http://dx.doi.org/10.1111/j.1463-1326.2011.01462.x
Dobbins R. L., Shearn S. P., Byerly R. L., Gao F. F., Mahar K. M., Napolitano A., Nachbaur G. J. and Le Monnier de Gouville A. C.
GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 15. 1013-1021. 2013. G-Protein
http://dx.doi.org/10.1111/dom.12132
Doerr R., Hoffmann U., Otter W., Heinemann L., Hunger-Battefeld W., Kulzer B., Klinge A., Lodwig V., Amann-Zalan I., Sturm D., Tschoepe D., Spitzer S., Stumpf J., Lohmann T. and Schnell O.
Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia 54. 2923-2930. 2011. Silent Diabetes Study
http://dx.doi.org/10.1007/s00125-011-2253-y
Doi Y., Ninomiya T., Hata J., Hirakawa Y., Mukai N., Iwase M. and Kiyohara Y.
Two risk score models for predicting incident Type 2 diabetes in Japan. Diabetic Medicine 29. 107-114. 2012. Predicting Diabetes
http://dx.doi.org/10.1111/j.1464-5491.2011.03376.x
Donnelly Joseph E., Goetz Jeannine, Gibson Cheryl, Sullivan Debra K., Lee Robert, Smith Bryan K., Lambourne Kate, Mayo Matthew S., Hunt Suzanne, Lee Jae Hoon, Honas Jeffrey J. and Washburn Richard A.
Equivalent weight loss for weight management programs delivered by phone and clinic. Obesity 21. 1951-1959. 2013. Obesity
http://dx.doi.org/10.1002/oby.20334
Dormandy John A., Charbonnel Bernard, Eckland David J. A., Erdmann Erland, Massi-Benedetti Massimo, Moules Ian K., Skene Allan M., Tan Meng H., Lefèbvre Pierre J., Murray Gordon D., Standl Eberhard, Wilcox Robert G., Wilhelmsen Lars, Betteridge John, Birkeland Kåre, Golay Alain, Heine Robert J., Korányi László, Laakso Markku, Moká Marián, Norkus Antanas, Pirags Valdis, Podar Toomas, Scheen André, Scherbaum Werner, Schernthaner Guntram, Schmitz Ole, krha Jan, Smith Ulf and Tato Jan
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. The Lancet 366. 1279-1289. 2005. PROactive
http://linkinghub.elsevier.com/retrieve/pii/S0140673605675289
Doucet J., Le Floch J. P., Bauduceau B. and Verny C.
GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion. Diabetes & Metabolism 38. 523-530. 2012. GERODIAB
http://www.sciencedirect.com/science/article/pii/S1262363612001243
Doulton Timothy W.R., He Feng J. and MacGregor Graham A.
Systematic Review of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blockade in Hypertension. Hypertension 45. 880-886. 2005. ACE
http://hyper.ahajournals.org/content/45/5/880.abstract
Downie Elizabeth, Craig Maria E., Hing Stephen, Cusumano Janine, Chan Albert K.F. and Donaghue Kim C.
Continued Reduction in the Prevalence of Retinopathy in Adolescents With Type 1 Diabetes. Diabetes Care 34. 2368-2373. 2011. Retinopathy
http://care.diabetesjournals.org/content/34/11/2368.abstract
Driskell Owen J., Holland David, Waldron Jenna L., Ford Clare, Scargill Jonathan J., Heald Adrian, Tran Martin, Hanna Fahmy W., Jones Peter W., Pemberton R. John and Fryer Anthony A.
Reduced Testing Frequency for Glycated Hemoglobin, HbA1c, Is Associated With Deteriorating Diabetes Control. Diabetes Care 37. 2731-2737. 2014. HbA1c
http://care.diabetesjournals.org/content/37/10/2731.abstract
Duckworth William, Abraira Carlos, Moritz Thomas, Reda Domenic, Emanuele Nicholas, Reaven Peter D., Zieve Franklin J., Marks Jennifer, Davis Stephen N., Hayward Rodney, Warren Stuart R., Goldman Steven, McCarren Madeline, Vitek Mary Ellen, Henderson William G. and Huang Grant D.
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. New England Journal of Medicine 360. 129-139. 2009. VETERANS
http://www.nejm.org/doi/full/10.1056/NEJMoa0808431
Duclos M., Oppert J. M., Verges B., Coliche V., Gautier J. F., Guezennec Y., Reach G. and Strauch G.
Physical activity and type 2 diabetes. Recommandations of the SFD (Francophone Diabetes Society) diabetes and physical activity working group. Diabetes & Metabolism 39. 205-216. 2013. Exercise
http://www.sciencedirect.com/science/article/pii/S1262363613000530
Dudley Christopher R. K., Keavney Bernard, Stratton Irene M., Turner Robert C. and Ratcliffe Peter J.
U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48. 1907-1911. 1995. UKPDS 15
http://dx.doi.org/10.1038/ki.1995.490
Due-Christensen M., Zoffmann V., Hommel E. and Lau M.
Can sharing experiences in groups reduce the burden of living with diabetes, regardless of glycaemic control? Diabetic Medicine 29. 251-256. 2012. Education
http://dx.doi.org/10.1111/j.1464-5491.2011.03521.x
Dumville J., Soares M., O’Meara S. and Cullum N.
Systematic review and mixed treatment comparison: dressings to heal diabetic foot ulcers. Diabetologia 55. 1902-1910. 2012. Meta-analysis
http://dx.doi.org/10.1007/s00125-012-2558-5
Dungan Kathleen M., Povedano Santiago Tofé, Forst Thomas, González José G. González, Atisso Charles, Sealls Whitney and Fahrbach Jessie L.
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial. The Lancet 384. 1349-1357. 2014. AWARD-6
http://linkinghub.elsevier.com/retrieve/pii/S0140673614609764
Dunkley A. J., Charles K., Gray L. J., Camosso-Stefinovic J., Davies M. J. and Khunti K.
Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis. Diabetes, Obesity and Metabolism 14. 616-625. 2012. Meta-analysis
http://dx.doi.org/10.1111/j.1463-1326.2012.01571.x
Dyck Peter J., Albers James W., Andersen Henning, Arezzo Joseph C., Biessels Geert-Jan, Bril Vera, Feldman Eva L., Litchy William J., O'Brien Peter C., Russell James W. and on behalf of The Toronto Expert Panel on Diabetic Neuropathy
Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes/Metabolism Research and Reviews 27. 620-628. 2011. Consensus
http://dx.doi.org/10.1002/dmrr.1226
Dyck Peter J., Clark Vicki M., Overland Carol J., Davies Jenny L., Pach John M., Dyck P. James B., Klein Christopher J., Rizza Robert A., Melton L. Joseph, Carter Rickey E., Klein Ronald and Litchy William J.
Impaired Glycemia and Diabetic Polyneuropathy. Diabetes Care 35. 584-591. 2012. Neuropathy
http://care.diabetesjournals.org/content/35/3/584.abstract
Dyson P. A., Hammersley M. S., Morris R. J., Holman R. R. and Turner R. C.
The fasting hyperglycaemia study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism 46. 50-55. 1997. FHS 2
Echouffo–Tcheugui J. B., Ali M. K., Roglic G., Hayward R. A. and Narayan K. M.
Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review. Diabetic Medicine 30. 1272-1292. 2013. Retinopathy
http://dx.doi.org/10.1111/dme.12274
Edelman S., Ng-Mak D. S., Fusco M., Ashton D., Okerson T., Liu Q., Jin J. and Dixon J. B.
Control of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) study. Diabetes, Obesity and Metabolism 16. 1009-1015. 2014. HERO Study
http://dx.doi.org/10.1111/dom.12313
Eeg-Olofsson Katarina, Cederholm Jan, Nilsson Peter M., Zethelius Bjorn, Svensson Ann-Marie, Gudbjornsdottir Soffia and Eliasson Bjorn
Glycemic Control and Cardiovascular Disease in 7,454 Patients With Type 1 Diabetes. Diabetes Care 33. 1640-1646. 2010. SNDR
http://care.diabetesjournals.org/content/33/7/1640.abstract
Eeley E. A., Stratton I. M., Hadden D. R., Turner R. C. and Holman R. R.
UKPDS 18: Estimated Dietary Intake in Type 2 Diabetic Patients Randomly Allocated to Diet, Sulphonylurea or Insulin Therapy. Diabetic Medicine 13. 656-662. 1996. UKPDS 18
http://dx.doi.org/10.1002/(SICI)1096-9136(199607)13:7<656::AID-DIA131>3.0.CO;2-5
Ekström N., Miftaraj M., Svensson A. M., Andersson Sundell K., Cederholm J., Zethelius B., Gudbjörnsdottir S. and Eliasson B.
Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register. Diabetes, Obesity and Metabolism 14. 717-726. 2012. SNDR
http://dx.doi.org/10.1111/j.1463-1326.2012.01591.x
Eliasson B., Möller-Goede D., Eeg-Olofsson K., Wilson C., Cederholm J., Fleck P., Diamant M., Taskinen M. R. and Smith U.
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. Diabetologia 55. 915-925. 2012. DPP4
http://dx.doi.org/10.1007/s00125-011-2447-3
Eliasson M., Jansson J. H., Lundblad D. and Näslund U.
The disparity between long-term survival in patients with and without diabetes following a first myocardial infarction did not change between 1989 and 2006: an analysis of 6,776 patients in the Northern Sweden MONICA Study. Diabetologia 54. 2538-2543. 2011. MONICA Study
http://dx.doi.org/10.1007/s00125-011-2247-9
Ellis S. L., Moser E. G., Snell-Bergeon J. K., Rodionova A. S., Hazenfield R. M. and Garg S. K.
Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial. Diabetic Medicine 28. 1176-1181. 2011. DPP4
http://dx.doi.org/10.1111/j.1464-5491.2011.03331.x
Erdmann E., Song E., Spanheimer R., van Troostenburg de Bruyn A. R. and Perez A.
Observational follow-up of the PROactive study: a 6-year update. Diabetes, Obesity and Metabolism 16. 63-74. 2014. PROactive study
http://dx.doi.org/10.1111/dom.12180
Esposito K., Chiodini P., Bellastella G., Maiorino M. I. and Giugliano D.
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes, Obesity and Metabolism 14. 228-233. 2012. HbA1c
http://dx.doi.org/10.1111/j.1463-1326.2011.01512.x
Eto T., Inoue S. and Kadowaki T.
Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial. Diabetes, Obesity and Metabolism 14. 1040-1046. 2012. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2012.01662.x
Evans J. M. M., Mackison D., Emslie-Smith A. and Lawton J.
Self-monitoring of blood glucose in Type 2 diabetes: cross-sectional analyses in 1993, 1999 and 2009. Diabetic Medicine 29. 792-795. 2012. Monitoring
http://dx.doi.org/10.1111/j.1464-5491.2011.03567.x
Evans M., Schumm-Draeger P. M., Vora J. and King A. B.
A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations. Diabetes, Obesity and Metabolism 13. 677-684. 2011. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01395.x
Evert Alison B., Boucher Jackie L., Cypress Marjorie, Dunbar Stephanie A., Franz Marion J., Mayer-Davis Elizabeth J., Neumiller Joshua J., Nwankwo Robin, Verdi Cassandra L., Urbanski Patti and Yancy William S.
Nutrition Therapy Recommendations for the Management of Adults With Diabetes. Diabetes Care 36. 3821-3842. 2013. Consensus
Faglia Ezio, Clerici Giacomo, Scatena Alessia, Caminiti Maurizio, Curci Vincenzo, Morabito Alberto, Prisco Vincenzo, Greco Rosaria and Edmonds Mike
Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: An observational study. Diabetes research and clinical practice 103. 292-297. 2014. Epidemiology
http://linkinghub.elsevier.com/retrieve/pii/S0168822714000217?showall=true
Fajans Stefan S. and Bell Graeme I.
MODY. Diabetes Care 34. 1878-1884. 2011. MODY
http://care.diabetesjournals.org/content/34/8/1878.short
Fall E., Roche B., Izaute M., Batisse M., Tauveron I. and Chakroun N.
A brief psychological intervention to improve adherence in type 2 diabetes. Diabetes & Metabolism 39. 432-438. 2013. Psychology
http://www.sciencedirect.com/science/article/pii/S1262363613000931
Farahani Pendar
A Perspective on Principles of Comparative Cost-Effectiveness Studies for Pharmacotherapy of Chronic Diseases. Clinical Diabetes 30. 54-60. 2012. Cost Effectiveness
http://clinical.diabetesjournals.org/content/30/2/54.abstract
Farkouh Michael E., Domanski Michael, Sleeper Lynn A., Siami Flora S., Dangas George, Mack Michael, Yang May, Cohen David J., Rosenberg Yves, Solomon Scott D., Desai Akshay S., Gersh Bernard J., Magnuson Elizabeth A., Lansky Alexandra, Boineau Robin, Weinberger Jesse, Ramanathan Krishnan, Sousa J. Eduardo, Rankin Jamie, Bhargava Balram, Buse John, Hueb Whady, Smith Craig R., Muratov Victoria, Bansilal Sameer, King Spencer, Bertrand Michel and Fuster Valentin
Strategies for Multivessel Revascularization in Patients with Diabetes. New England Journal of Medicine 367. 2375-2384. 2012. Vascular
http://www.nejm.org/doi/full/10.1056/NEJMoa1211585
Farmer A. J., Brockbank K. J., Keech M. L., England E. J. and Deakin C. D.
Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England. Diabetic Medicine 29. 1447-1450. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1464-5491.2012.03657.x
Farmer Andrew J, Perera Rafael, Ward Alison, Heneghan Carl, Oke Jason, Barnett Anthony H, Davidson Mayer B, Guerci Bruno, Coates Vivien, Schwedes Ulrich and O’Malley Simon
Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. British Medical Journal 344. 2012. Meta-analysis
Farrell K. and Holmes–Walker D. J.
Mobile phone support is associated with reduced ketoacidosis in young adults. Diabetic Medicine 28. 1001-1004. 2011. Communication
http://dx.doi.org/10.1111/j.1464-5491.2011.03302.x
Fegan P. G., Davis W. A., Kamber N., Sivakumar S., Beilby J. and Davis T. M. E.
Renin–angiotensin–aldosterone system blockade and urinary albumin excretion in community-based patients with Type 2 diabetes: The Fremantle Diabetes Study. Diabetic Medicine 28. 849-855. 2011. FDS
http://dx.doi.org/10.1111/j.1464-5491.2011.03230.x
Ferrannini Ele, Veltkamp Stephan A., Smulders Ronald A. and Kadokura Takeshi
Renal Glucose Handling: Impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes. Diabetes Care 36. 1260-1265. 2013. SGLT2
http://care.diabetesjournals.org/content/36/5/1260.abstract
Festa Andreas, D'Agostino Ralph, Jr., Howard George, Mykkanen Leena, Tracy Russell P. and Haffner Steven M.
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58. 1703-1710. 2000. IRAS
http://dx.doi.org/10.1046/j.1523-1755.2000.00331.x
Festa Andreas, D’Agostino Ralph, Howard George, Mykkanen Leena, Tracy Russell P. and Haffner Steven M.
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome : The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102. 42-47. 2000. IRAS
http://circ.ahajournals.org/content/102/1/42.abstract
Fhärm E., Cederholm J., Eliasson B., Gudbjörnsdottir S. and Rolandsson O.
Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003–2008. Diabetic Medicine 29. 198-206. 2012. SNDR
http://dx.doi.org/10.1111/j.1464-5491.2011.03425.x
Fineman M. S., Mace K. F., Diamant M., Darsow T., Cirincione B. B., Booker Porter T. K., Kinninger L. A. and Trautmann M. E.
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment. Diabetes, Obesity and Metabolism 14. 546-554. 2012. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2012.01561.x
Fisman E. Z., Tenenbaum A., Benderly M., Goldbourt U., Behar S. and Motro M.
Antihyperglycemic Treatment in Diabetics with Coronary Disease: Increased Metformin-Associated Mortality over a 5-Year Follow-Up. Cardiology 91. 195-202. 1999. OHGA
http://www.karger.com/DOI/10.1159/000006909
Fisman Enriqe Z., Tenenbaum Alexander, Adler Yehuda, Motro Michael, Boyko Valentina, Benderly Michal, Friedensohn Aharon, Kohanovski Mira, Rotzak Rene, Schneider Hanan and Behar Solomon
Oral antidiabetic treatment in patients with coronary disease: Time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up. Clinical Cardiology 24. 151-158. 2001. Cardiovascular
http://dx.doi.org/10.1002/clc.4960240210
Fonseca V., Gill J., Zhou R. and Leahy J.
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia. Diabetes, Obesity and Metabolism 13. 814-822. 2011. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01412.x
Forster AliceS, Forbes Angus, Dodhia Hiten, Connor Clare, Chemin Alain, Sivaprasad Sobha, Mann Samantha and Gulliford MartinC
Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study. Diabetologia 56. 2187-2193. 2013. Retinopathy
http://dx.doi.org/10.1007/s00125-013-2975-0
Foster P. D., Mamdani M. M., Juurlink D. N., Shah B. R., Paterson J. M. and Gomes T.
Trends in selection and timing of first-line pharmacotherapy in older patients with Type 2 diabetes diagnosed between 1994 and 2006. Diabetic Medicine 30. 1209-1213. 2013. OHGA
http://dx.doi.org/10.1111/dme.12214
Fouqueray Pascale, Pirags Valdis, Inzucchi Silvio E., Bailey Clifford J., Schernthaner Guntram, Diamant Michaela and Lebovitz Harold E.
The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy. Diabetes Care 36. 565-568. 2013. OHGA
http://care.diabetesjournals.org/content/36/3/565.abstract
Franc S., Daoudi A., Mounier S., Boucherie B., Dardari D., Laroye H., Neraud B., Requeda E., Canipel L. and Charpentier G.
Telemedicine and diabetes: Achievements and prospects. Diabetes & Metabolism 37. 463-476. 2011. Technology
http://www.sciencedirect.com/science/article/pii/S1262363611001273
Franciosi M., Lucisano G., Pellegrini F., Cantarello A., Consoli A., Cucco L., Ghidelli R., Sartore G., Sciangula L., Nicolucci A. and on behalf of the Roses Study Group
ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabetic Medicine 28. 789-796. 2011. ROSES
http://dx.doi.org/10.1111/j.1464-5491.2011.03268.x
Freemantle N., Evans M., Christensen T., Wolden M. L. and Bjorner J. B.
A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials. Diabetes, Obesity and Metabolism 15. 564-571. 2013. Meta-analysis
http://dx.doi.org/10.1111/dom.12086
Freemantle N., Meneghini L., Christensen T., Wolden M. L., Jendle J. and Ratner R.
Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials. Diabetic Medicine 30. 226-232. 2013. Insulin
http://dx.doi.org/10.1111/dme.12086
Fu A. Z., Qiu Y., Davies M. J., Radican L. and Engel S. S.
Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy. Diabetes, Obesity and Metabolism 13. 765-769. 2011. Treatment Intensification
Gaede Peter, Lund-Andersen Henrik, Parving Hans-Henrik and Pedersen Oluf
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes. New England Journal of Medicine 358. 580-591. 2008. STENO 2
http://www.nejm.org/doi/full/10.1056/NEJMoa0706245
Gagliardino J. J., Aschner P., Baik S. H., Chan J., Chantelot J. M., Ilkova H. and Ramachandran A.
Patients’ education, and its impact on care outcomes, resource consumption and working conditions: Data from the International Diabetes Management Practices Study (IDMPS). Diabetes & Metabolism 38. 128-134. 2012. IDMPS
http://www.sciencedirect.com/science/article/pii/S1262363611001625
Gagnon Claudia, Lu Zhong X., Magliano Dianna J., Dunstan David W., Shaw Jonathan E., Zimmet Paul Z., Sikaris Ken, Ebeling Peter R. and Daly Robin M.
Low Serum 25-Hydroxyvitamin D Is Associated with Increased Risk of the Development of the Metabolic Syndrome at Five Years: Results from a National, Population-Based Prospective Study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). Journal of Clinical Endocrinology & Metabolism 97. 1953-1961. 2012. AUSDIAB
http://jcem.endojournals.org/content/97/6/1953.abstract
Gallwitz Baptist, Bohmer Michael, Segiet Thomas, Molle Andrea, Milek Karsten, Becker Bernd, Helsberg Karin, Petto Helmut, Peters Natalie and Bachmann Oliver
Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes. Diabetes Care 34. 604-606. 2011. GLP-1
http://care.diabetesjournals.org/content/34/3/604.abstract
Gambineri Alessandra, Patton Laura, Altieri Paola, Pagotto Uberto, Pizzi Carmine, Manzoli Lamberto and Pasquali Renato
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes. Diabetes 61. 2369-2374. 2012. PCOS
http://diabetes.diabetesjournals.org/content/61/9/2369.abstract
Gao W., Dong J., Liu J., Li Y., Liu F., Yang L., Zhou X. and Liao L.
Efficacy and safety of initial combination of DPP-IV inhibitors and metformin versus metformin monotherapy in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes, Obesity and Metabolism 16. 179-185. 2014. Metaanalysis
http://dx.doi.org/10.1111/dom.12193
Garber Alan, Henry Robert, Ratner Robert, Garcia-Hernandez Pedro A., Rodriguez-Pattzi Hiromi, Olvera-Alvarez Israel, Hale Paula M., Zdravkovic Milan and Bode Bruce
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. The Lancet 373. 473-481. 2009. LEAD 3
http://www.sciencedirect.com/science/article/pii/S0140673608612465
Garber Alan J., King Allen B., Prato Stefano Del, Sreenan Seamus, Balci Mustafa K., Muñoz-Torres Manuel, Rosenstock Julio, Endahl Lars A., Francisco Ann Marie Ocampo and Hollander Priscilla
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. The Lancet 379. 1498-1507. 2012. Insulin
http://linkinghub.elsevier.com/retrieve/pii/S0140673612602050
Garg Rajesh, Hurwitz Shelley, Turchin Alexander and Trivedi Apoorva
Hypoglycemia, With or Without Insulin Therapy, Is Associated With Increased Mortality Among Hospitalized Patients. Diabetes Care 36. 1107-1110. 2013. Hypoglycaemia
http://care.diabetesjournals.org/content/36/5/1107.abstract
Garg Satish K., Voelmle Mary K., Beatson Christie R., Miller Hayley A., Crew Lauren B., Freson Brandon J. and Hazenfield Rachel M.
Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy. Diabetes Care 34. 574-579. 2011. CSII
http://care.diabetesjournals.org/content/34/3/574.abstract
Gastaldelli A., Balas B., Ratner R., Rosenstock J., Charbonnel B., Bolli G. B., Boldrin M. and Balena R.
A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment. Diabetes, Obesity and Metabolism 16. 170-178. 2014. GLP-1
http://dx.doi.org/10.1111/dom.12192
Gayoso-Diz Pilar, Otero-Gonzalez Alfonso, Rodriguez-Alvarez María Xosé, Gude Francisco, Cadarso-Suarez Carmen, García Fernando and De Francisco Angel
Insulin resistance index (HOMA-IR) levels in a general adult population: Curves percentile by gender and age. The EPIRCE study. Diabetes research and clinical practice 94. 146-155. 2011. EPIRCE Study
http://linkinghub.elsevier.com/retrieve/pii/S0168822711003652?showall=true
Genuth S. and Ismail-Beigi F.
Clinical Implications of the ACCORD Trial. Journal of Clinical Endocrinology & Metabolism 97. 41-48. 2012. ACCORD
http://jcem.endojournals.org/content/97/1/41.abstract
Gerrald K. R., Van Scoyoc E., Wines R. C., Runge T. and Jonas D. E.
Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes, Obesity and Metabolism 14. 481-492. 2012. Meta-analysis
http://dx.doi.org/10.1111/j.1463-1326.2011.01540.x
Gerstein HC, Yusuf S., Holman R., Bosch J. and Pogue J.
Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 47. 1519. 2004. DREAM
http://www.ncbi.nlm.nih.gov/pubmed/15322749
Gerstein Hertzel C., Ambrosius Walter T., Danis Ronald, Ismail-Beigi Faramarz, Cushman William, Calles Jorge, Banerji MaryAnn, Schubart Ulrich, Chew Emily Y. and Group for the ACCORD Study
Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial. Diabetes Care 36. 1266-1271. 2013. ACCORD
http://care.diabetesjournals.org/content/36/5/1266.abstract
Gianatti Emily J., Dupuis Philippe, Hoermann Rudolf, Strauss Boyd J., Wentworth John M., Zajac Jeffrey D. and Grossmann Mathis
Effect of Testosterone Treatment on Glucose Metabolism in Men With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 37. 2098-2107. 2014. Testosterone
http://care.diabetesjournals.org/content/37/8/2098.abstract
Giugliano Dario, Maiorino Maria Ida, Bellastella Giuseppe, Chiodini Paolo, Ceriello Antonio and Esposito Katherine
Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes. Diabetes Care 34. 510-517. 2011. HbA1c
http://care.diabetesjournals.org/content/34/2/510.abstract
Giunti Sara, Gruden Gabriella, Fornengo Paolo, Barutta Federica, Amione Cristina, Ghezzo Giuseppe, Cavallo-Perin Paolo and Bruno Graziella
Increased QT Interval Dispersion Predicts 15-Year Cardiovascular Mortality in Type 2 Diabetic Subjects. Diabetes Care 35. 581-583. 2012. Cardiovascular
http://care.diabetesjournals.org/content/35/3/581.abstract
Gloyn A. L., Hashim Y., Ashcroft S. J. H., Ashfield R., Wiltshire S. and Turner R. C.
Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabetic Medicine 18. 206-212. 2001. UKPDS 53
http://dx.doi.org/10.1046/j.1464-5491.2001.00449.x
Goatman K. A., Philip S., Fleming A. D., Harvey R. D., Swa K. K., Styles C., Black M., Sell G., Lee N., Sharp P. F. and Olson J. A.
External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening Programme. Diabetic Medicine 29. 776-783. 2012. Retinopathy
http://dx.doi.org/10.1111/j.1464-5491.2011.03504.x
Goff Jr David C., Gerstein Hertzel C., Ginsberg Henry N., Cushman William C., Margolis Karen L., Byington Robert P., Buse John B., Genuth Saul, Probstfield Jeffrey L. and Simons-Morton Denise G.
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. The American Journal of Cardiology 99. S4-S20. 2007. ACCORD
http://www.sciencedirect.com/science/article/pii/S0002914907004377
Goh J. E. L., Sadler L. and Rowan J.
Metformin for gestational diabetes in routine clinical practice. Diabetic Medicine 28. 1082-1087. 2011. Gestational
http://dx.doi.org/10.1111/j.1464-5491.2011.03361.x
Gonçalves A., Leal E., Paiva A., Teixeira Lemos E., Teixeira F., Ribeiro C. F., Reis F., Ambrósio A. F. and Fernandes R.
Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood–retinal barrier in a type 2 diabetes animal model. Diabetes, Obesity and Metabolism 14. 454-463. 2012. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2011.01548.x
Gong Q., Gregg E., Wang J., An Y., Zhang P., Yang W., Li H., Jiang Y., Shuai Y., Zhang B., Zhang J., Gerzoff R., Roglic G., Hu Y., Li G. and Bennett P.
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 54. 300-307. 2011. Da Qing
http://dx.doi.org/10.1007/s00125-010-1948-9
Gough Stephen C.L., Bhargava Anuj, Jain Rajeev, Mersebach Henriette, Rasmussen Søren and Bergenstal Richard M.
Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial. Diabetes Care 36. 2536-2542. 2013. Insulin
http://care.diabetesjournals.org/content/36/9/2536.abstract
Govan Lindsay, Wu Olivia, Briggs Andrew, Colhoun Helen M., Fischbacher Colin M., Leese Graham P., McKnight John A., Philip Sam, Sattar Naveed, Wild Sarah H., Lindsay Robert S. and Group on behalf of the Scottish Diabetes Research Network Epidemiology
Achieved Levels of HbA1c and Likelihood of Hospital Admission in People With Type 1 Diabetes in the Scottish Population. Diabetes Care 34. 1992-1997. 2011. SDRNEG
http://care.diabetesjournals.org/content/34/9/1992.abstract
Graefe-Mody U., Friedrich C., Port A., Ring A., Retlich S., Heise T., Halabi A. and Woerle H. J.
Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin*. Diabetes, Obesity and Metabolism 13. 939-946. 2011. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2011.01458.x
Gram Jeppe, Henriksen Jan Erik, Grodum Ellen, Juhl Henning, Hansen Tony Bill, Christiansen Christian, Yderstræde Knud, Gjessing Hans, Hansen Henrik M., Vestergaard Vibe, Hangaard Jørgen and Beck-Nielsen Henning
Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes. Diabetes Care 34. 27-33. 2011. Insulin
http://care.diabetesjournals.org/content/34/1/27.abstract
Grantham N. M., Magliano D. J., Tanamas S. K., Söderberg S., Schlaich M. P. and Shaw J. E.
Higher heart rate increases risk of diabetes among men: The Australian Diabetes Obesity and Lifestyle (AusDiab) Study. Diabetic Medicine 30. 421-427. 2013. AUSDIAB
http://dx.doi.org/10.1111/dme.12045
Gray A., Clarke P., Raikou M., Adler A., Stevens R., Neil A., Cull C., Stratton I., Holman R. and the Ukpds Group
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54). Diabetic Medicine 18. 438-444. 2001. UKPDS 54
http://dx.doi.org/10.1046/j.1464-5491.2001.00485.x
Gray A., Raikou M., McGuire A., Fenn P., Stevens R., Cull C., Stratton I., Adler A., Holman R. and Turner R.
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). British Medical Journal 320. 1373. 2000. UKPDS 41
http://www.bmj.com/content/320/7246/1373.full.pdf
Gray Alastair, Clarke Philip, Farmer Andrew and Holman Rury
Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63). British Medical Journal 325. 860. 2002. UKPDS 63
http://www.bmj.com/content/325/7369/860.1.abstract
Gray L., Davies M., Hiles S., Taub N., Webb D., Srinivasan B. and Khunti K.
Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 55. 959-966. 2012. EPR
http://dx.doi.org/10.1007/s00125-011-2432-x
Greenwood Darren C., Threapleton Diane E., Evans Charlotte E.L., Cleghorn Christine L., Nykjaer Camilla, Woodhead Charlotte and Burley Victoria J.
Glycemic Index, Glycemic Load, Carbohydrates, and Type 2 Diabetes: Systematic review and dose–response meta-analysis of prospective studies. Diabetes Care 36. 4166-4171. 2013. Meta-analysis
http://care.diabetesjournals.org/content/36/12/4166.abstract
Grempler R., Thomas L., Eckhardt M., Himmelsbach F., Sauer A., Sharp D. E., Bakker R. A., Mark M., Klein T. and Eickelmann P.
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors. Diabetes, Obesity and Metabolism 14. 83-90. 2012. SGLT-2
http://dx.doi.org/10.1111/j.1463-1326.2011.01517.x
Group Heart Protection Study Collaborative
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. The Lancet 361. 2005-2016. 2003. HPS
http://linkinghub.elsevier.com/retrieve/pii/S0140673603136367
Group Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study
Hemoglobin A1c and Mean Glucose in Patients With Type 1 Diabetes. Diabetes Care 34. 540-544. 2011. HbA1c
http://care.diabetesjournals.org/content/34/3/540.abstract
Group The Action to Control Cardiovascular Risk in Diabetes Study
Effects of Intensive Glucose Lowering in Type 2 Diabetes. New England Journal of Medicine 358. 2545-2559. 2008. ACCORD
http://www.nejm.org/doi/full/10.1056/NEJMoa0802743
Group The ADVANCE Collaborative
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine 358. 2560-2572. 2008. ADVANCE
http://www.nejm.org/doi/full/10.1056/NEJMoa0802987
Group The DECODE study
Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. The Lancet 354. 617-621. 1999. DECODE
http://linkinghub.elsevier.com/retrieve/pii/S0140673698121311
Group The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. New England Journal of Medicine 353. 2643-2653. 2005. DCCT/EDIC
http://www.nejm.org/doi/full/10.1056/NEJMoa052187
Group The Diabetes Prevention Program Research
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention. Diabetes Care 35. 723-730. 2012. Cost Effectiveness
http://care.diabetesjournals.org/content/35/4/723.abstract
Group The Diabetes Prevention Program Research
Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care 35. 731-737. 2012. DPPOS
http://care.diabetesjournals.org/content/35/4/731.abstract
Group The NAVIGATOR Study
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine 362. 1477-1490. 2010. NAVIGATOR
http://www.nejm.org/doi/full/10.1056/NEJMoa1001121
Group The NAVIGATOR Study
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine 362. 1463-1476. 2010. NAVIGATOR
http://www.nejm.org/doi/full/10.1056/NEJMoa1001122
Group TODAY Study
Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes: The TODAY experience. Diabetes Care 36. 1765-1771. 2013. TODAY
http://care.diabetesjournals.org/content/36/6/1765.abstract
Group TODAY Study
Treatment Effects on Measures of Body Composition in the TODAY Clinical Trial. Diabetes Care 36. 1742-1748. 2013. TODAY
http://care.diabetesjournals.org/content/36/6/1742.abstract
Group TODAY Study
Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial. Diabetes Care 36. 1772-1774. 2013. TODAY
http://care.diabetesjournals.org/content/36/6/1772.abstract
Group TODAY Study
Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes: The TODAY clinical trial. Diabetes Care 36. 1735-1741. 2013. TODAY
http://care.diabetesjournals.org/content/36/6/1735.abstract
Group TODAY Study
Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY. Diabetes Care 36. 1749-1757. 2013. TODAY
http://care.diabetesjournals.org/content/36/6/1749.abstract
Group TODAY Study
Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes: The TODAY clinical trial. Diabetes Care 36. 1758-1764. 2013. TODAY
http://care.diabetesjournals.org/content/36/6/1758.abstract
Group U. K. Prospective Diabetes Study
UK Prospective Diabetes Study XII: Differences Between Asian, Afro-Caribbean and White Caucasian Type 2 Diabetic Patients at Diagnosis of Diabetes. Diabetic Medicine 11. 670-677. 1994. UKPDS 12
http://dx.doi.org/10.1111/j.1464-5491.1994.tb00331.x
Group U. K. Prospective Diabetes Study
UK Prospective Diabetes Study (UKPDS) XI: Biochemical Risk Factors in Type 2 Diabetic Patients at Diagnosis Compared with Age-matched Normal Subjects. Diabetic Medicine 11. 534-544. 1994. UKPDS 11
http://dx.doi.org/10.1111/j.1464-5491.1994.tb02032.x
Group U.K. Prospective Diabetes Study
U.K. Prospective Diabetes Study 27: Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 20. 1683-1687. 1997. UKPDS 27
http://care.diabetesjournals.org/content/20/11/1683.abstract
Group U.K. Prospective Diabetes Study
Ethnicity and Cardiovascular Disease: The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (U.K. Prospective Diabetes Study 32). Diabetes Care 21. 1271-1277. 1998. UKPDS 32
http://care.diabetesjournals.org/content/21/8/1271.abstract
Group U.K. Prospective Diabetes Study
UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 Diabetes. Diabetes Care 21. 87-92. 1998. UKPDS 28
http://care.diabetesjournals.org/content/21/1/87.abstract
Group U.K.P.D.S.
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. British Medical Journal 317. 720-726. 1998. UKPDS 40
http://www.jstor.org/pss/25180362
Group UK Prospective Diabetes Study
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 352. 837-853. 1998. UKPDS 33
http://linkinghub.elsevier.com/retrieve/pii/S0140673698070196
Group UK Prospective Diabetes Study (UKPDS)
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet 352. 854-865. 1998. UKPDS 34
http://linkinghub.elsevier.com/retrieve/pii/S0140673698070378
Group UKPDS
United Kingdom Prospective diabetes study 7. Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. Metab Clin Exp 39. 905-912. 1990. UKPDS 7
Group UKPDS
UK prospective diabetes study (UKPDS) VIII. Study design, progress and performance. Diabetologia 34. 877-890. 1991. UKPDS 8
http://dx.doi.org/10.1007/BF00400195
Group UKPDS
UK prospective diabetes study (UKPDS) IX: Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of Type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy. Diabetologia 36. 835-842. 1993. UKPDS 9
http://dx.doi.org/10.1007/BF00400359
Group UKPDS
UK Prospective Diabetes Study (UKPDS) X. Urinary albumin excretion over 3 years in diet-treated Type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 36. 1021-1029. 1993. UKPDS 10
http://dx.doi.org/10.1007/BF02374494
Group UKPDS
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 44. 1249-1258. 1995. UKPDS 16
http://diabetes.diabetesjournals.org/content/44/11/1249.abstract
Group UKPDS
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 317. 703-713. 1998. UKPDS 38
http://www.bmj.com/content/317/7160/703.abstract
Group UKPDS
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. British Medical Journal 317. 713-720. 1998. UKPDS 39
http://www.bmj.com/content/317/7160/713.abstract
Group UKPDS
A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy. UKPDS 24. Annals of Internal Medicine 128. 165-175. 1998. UKPDS 24
Group UKPDS
UKPDS 31: Hepatocyte nuclear factor-1alpha (the MODY3 gene) mutations in late onset Type II diabetic patients in the United Kingdom. Diabetologia 42. 120-121. 1999. UKPDS 31
http://dx.doi.org/10.1007/s001250051127
Group UKPDS
Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care 22. 1125-1136. 1999. UKPDS 37
http://care.diabetesjournals.org/content/22/7/1125.abstract
Group UKPDS Study
U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study. Diabetes 34. 793-798. 1985. UKPDS 2
http://diabetes.diabetesjournals.org/content/34/8/793.abstract
Gruden Gabriella, Barutta Federica, Chaturvedi Nish, Schalkwijk Casper, Stehouwer Coen D., Witte Daniel R., Fuller John H., Cavallo Perin Paolo and Bruno Graziella
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes. Diabetes Care 35. 1598-1604. 2012. EURODIAB
http://care.diabetesjournals.org/content/35/7/1598.abstract
Grunberger G., Chang A., Garcia Soria G., Botros F. T., Bsharat R. and Milicevic Z.
Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study. Diabetic Medicine 29. 1260-1267. 2012. GLP-1
http://dx.doi.org/10.1111/j.1464-5491.2012.03745.x
Guariguata L., Linnenkamp U., Beagley J., Whiting D. R. and Cho N. H.
Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes research and clinical practice 103. 176-185. 2014. Epidemiology
http://linkinghub.elsevier.com/retrieve/pii/S0168822713003860?showall=true
Guariguata L., Whiting D. R., Hambleton I., Beagley J., Linnenkamp U. and Shaw J. E.
Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice 103. 137-149. 2014. Epidemiology
http://linkinghub.elsevier.com/retrieve/pii/S0168822713003859?showall=true
Guariguata Leonor, Whiting David, Weil Clara and Unwin Nigel
The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes research and clinical practice 94. 322-332. 2011. Epidemiology
http://www.sciencedirect.com/science/article/pii/S0168822711006036
Gudbjörnsdottir S., Eliasson B., Eeg-Olofsson K., Zethelius B., Cederholm J. and Register on behalf of the National Diabetes
Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register. Diabetologia 54. 2544-2551. 2011. SNDR
http://dx.doi.org/10.1007/s00125-011-2218-1
Guerci B., Monnier L., Serusclat P., Petit C., Valensi P., Huet D., Raccah D., Colette C., Quéré S. and Dejager S.
Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: Results from the randomized Optima study. Diabetes & Metabolism 38. 359-366. 2012. OPTIMA Study
http://www.sciencedirect.com/science/article/pii/S1262363612001152
Guldberg T. L., Vedsted P., Kristensen J. K. and Lauritzen T.
Improved quality of Type 2 diabetes care following electronic feedback of treatment status to general practitioners: a cluster randomized controlled trial. Diabetic Medicine 28. 325-332. 2011. Communication
http://dx.doi.org/10.1111/j.1464-5491.2010.03178.x
Gulli Giovanni, Frasson Stefania, Borzì Vito, Fontanella Andrea, Grandi Marco, Marengo Claudio, Nicolucci Antonio, Pastorelli Ruggero, Solerte Bruno, Gatti Adriano, Raimondo FrancescoCristiano, Bonizzoni Erminio, Gussoni Gualberto, Mazzone Antonino and Ceriello Antonio
Effectiveness of an educational intervention on the management of type 2 diabetic patients hospitalized in Internal Medicine: results from the FADOI-DIAMOND study. Acta Diabetologica 51. 765-770. 2014. FADOI-DIAMOND Study
http://dx.doi.org/10.1007/s00592-014-0585-z
Gunn D. and Mansell P.
Glycaemic control and weight 7 years after Dose Adjustment For Normal Eating (DAFNE) structured education in Type 1 diabetes. Diabetic Medicine 29. 807-812. 2012. DAFNE
http://dx.doi.org/10.1111/j.1464-5491.2011.03525.x
Gunnlaugsdottir E., Halldorsdottir S., Klein R., Eiriksdottir G., Klein B., Benediktsson R., Harris T., Launer L., Aspelund T., Gudnason V., Cotch M. and Jonasson F.
Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility—Reykjavik Study (AGES-R). Diabetologia. 1-10. 2011. Retinopathy
http://dx.doi.org/10.1007/s00125-011-2395-y
Gunnlaugsdottir E., Halldorsdottir S., Klein R., Eiriksdottir G., Klein B., Benediktsson R., Harris T., Launer L., Aspelund T., Gudnason V., Cotch M. and Jonasson F.
Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility—Reykjavik Study (AGES-R). Diabetologia 55. 671-680. 2012. AGES-R
http://dx.doi.org/10.1007/s00125-011-2395-y
Gupta A. K., Prieto-Merino D., Dahlöf B., Sever P. S., Poulter N. R. and on behalf of the Ascot Investigators
Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach. Diabetic Medicine 28. 941-947. 2011. ASCOT
http://dx.doi.org/10.1111/j.1464-5491.2011.03330.x
Gupta Ajay K., Dahlof Bjorn, Sever Peter S., Poulter Neil R. and investigators for the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm
Metabolic Syndrome, Independent of Its Components, Is a Risk Factor for Stroke and Death But Not for Coronary Heart Disease Among Hypertensive Patients in the ASCOT-BPLA. Diabetes Care 33. 1647-1651. 2010. ASCOT
http://care.diabetesjournals.org/content/33/7/1647.abstract
Guyton John R., Fazio Sergio, Adewale Adeniyi J., Jensen Erin, Tomassini Joanne E., Shah Arvind and Tershakovec Andrew M.
Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial. Diabetes Care 35. 857-860. 2012. Niacin
http://care.diabetesjournals.org/content/35/4/857.abstract
Guzder R. N., Gatling W., Mullee M. A., Mehta R. L. and Byrne C. D.
Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Diabetic Medicine 22. 554-562. 2005. UKPDS
Haak T., Meinicke T., Jones R., Weber S., Eynatten M. von and Woerle H. J.
Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled study. Diabetes, Obesity and Metabolism 14. 565-574. 2012. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2012.01590.x
Hajos T. R. S., Pouwer F., de Grooth R., Holleman F., Twisk J. W. R., Diamant M. and Snoek F. J.
Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care. Diabetic Medicine 28. 1096-1102. 2011. QoL
http://dx.doi.org/10.1111/j.1464-5491.2011.03329.x
Halimi J. M.
The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. Diabetes & Metabolism 38. 291-297. 2012. Nephropathy
http://www.sciencedirect.com/science/article/pii/S1262363612000742
Halimi S., Aubert J. P., Fontbonne A., Guillausseau P. J., Nachit F., Bouée S. and Detournay B.
A real-life study of the use, effectiveness and tolerability of rosiglitazone in France: The AVANCE study. Diabetes & Metabolism 38. 343-351. 2012. AVANCE Study
http://www.sciencedirect.com/science/article/pii/S1262363612000481
Hall G. C., McMahon A. D., Dain M. P. and Home P. D.
A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes. Diabetes research and clinical practice 94. 442-448. 2011. Insulin
http://www.sciencedirect.com/science/article/pii/S0168822711004918
Hall G. C., McMahon A. D., Dain M. P., Wang E. and Home P. D.
Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK. Diabetic Medicine 30. 681-686. 2013. GLP-1
http://dx.doi.org/10.1111/dme.12137
Hall H. N., Chinn D. J., Sinclair A. and Styles C. J.
Epidemiology of blindness attributable to diabetes in Scotland: change over 20 years in a defined population. Diabetic Medicine 30. 1349-1354. 2013. Retinopathy
http://dx.doi.org/10.1111/dme.12223
Hamet P.
What matters in ADVANCE and ADVANCE-ON. Diabetes, Obesity and Metabolism 14. 20-29. 2012. ADVANCE-ON
http://dx.doi.org/10.1111/j.1463-1326.2011.01509.x
Hammersley M. S., Meyer L. C., Morris R. J., Manley S. E., Turner R. C. and Holman R. R.
The fasting hyperglycaemia study: I. Subject identification and recruitment for a non--insulin-dependent diabetes prevention trial. Metabolism 46. 44-49. 1997. FHS 1
http://www.sciencedirect.com/science/article/pii/S0026049597903176
Hanley Anthony J.G., Wagenknecht Lynne E., Norris Jill M., Bergman Richard, Anderson Andrea, Chen Y. Ida, Lorenzo Carlos and Haffner Steven M.
Adiponectin and the Incidence of Type 2 Diabetes in Hispanics and African Americans. Diabetes Care 34. 2231-2236. 2011. IRAS
http://care.diabetesjournals.org/content/34/10/2231.abstract
Hansen A. L. S., Wijndaele K., Owen N., Magliano D. J., Thorp A. A., Shaw J. E. and Dunstan D. W.
Adverse associations of increases in television viewing time with 5-year changes in glucose homoeostasis markers: the AusDiab study. Diabetic Medicine 29. 918-925. 2012. AUSDIAB
http://dx.doi.org/10.1111/j.1464-5491.2012.03656.x
Hansen Anne-Louise S., Carstensen Bendix, Helge Jørn W., Johansen Nanna B., Gram Bibi, Christiansen Jens S., Brage Søren, Lauritzen Torsten, Jørgensen Marit E., Aadahl Mette, Witte Daniel R. and Committee ADDITION-Denmark Steering
Combined Heart Rate– and Accelerometer-Assessed Physical Activity Energy Expenditure and Associations With Glucose Homeostasis Markers in a Population at High Risk of Developing Diabetes: The ADDITION-PRO study. Diabetes Care 36. 3062-3069. 2013. ADDITION-PRO study
http://care.diabetesjournals.org/content/36/10/3062.abstract
Hansen B., Kurtzhals P., Jensen A., Dejgaard A. and Russell-Jones D.
Insulin X10 revisited: a super-mitogenic insulin analogue. Diabetologia 54. 2226-2231. 2011. Insulin
http://dx.doi.org/10.1007/s00125-011-2203-8
Hansen M., Jensen M. and Carstensen B.
Causes of death among diabetic patients in Denmark. Diabetologia. 1-9. 2011. Mortality
http://dx.doi.org/10.1007/s00125-011-2383-2
Hansson Lennart, Lindholm Lars H., Niskanen Leo, Lanke Jan, Hedner Thomas, Niklason Anders, Luomanmäki Kimmo, Dahlöf Björn, de Faire Ulf, Mörlin Claes, Karlberg Bengt E., Wester P. O. and Björck Jan-Erik
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. The Lancet 353. 611-616. 1999. CAPPP
http://www.sciencedirect.com/science/article/pii/S0140673698050120
Häring Hans-Ulrich, Merker Ludwig, Seewaldt-Becker Elke, Weimer Marc, Meinicke Thomas, Woerle Hans J., Broedl Uli C. and Investigators on behalf of the EMPA-REG METSU Trial
Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes: A 24-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 36. 3396-3404. 2013. SGLT2
http://care.diabetesjournals.org/content/36/11/3396.abstract
Harris Nwanyanwu Kristen, Talwar Nidhi, Gardner Thomas W., Wrobel James S., Herman William H. and Stein Joshua D.
Predicting Development of Proliferative Diabetic Retinopathy. Diabetes Care 36. 1562-1568. 2013. Retinopathy
http://care.diabetesjournals.org/content/36/6/1562.abstract
Harris Stewart B., Yale Jean-François, Berard Lori, Stewart John, Abbaszadeh Babak, Webster-Bogaert Susan and Gerstein Hertzel C.
Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study: A Randomized Noninferiority Trial. Diabetes Care 37. 604-610. 2014. Insulin
http://care.diabetesjournals.org/content/37/3/604.abstract
Hartling L., Dryden D. M., Guthrie A., Muise M., Vandermeer B. and Donovan L.
Diagnostic thresholds for gestational diabetes and their impact on pregnancy outcomes: a systematic review. Diabetic Medicine 31. 319-331. 2014. Metaanalysis
http://dx.doi.org/10.1111/dme.12357
Hasdai David, Granger Christopher B., Srivatsa S. Sanjay, Criger Douglas A., Ellis Stephen G., Califf Robert M., Topol Eric J. and Holmes Jr David R.
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy. Journal of the American College of Cardiology 35. 1502-1512. 2000. GUSTO-IIb angioplasty
http://www.sciencedirect.com/science/article/pii/S073510970000591X
Hassinen Maija, Lakka Timo A., Hakola Leena, Savonen Kai, Komulainen Pirjo, Litmanen Hannu, Kiviniemi Vesa, Kouki Reija, Heikkilá Harri and Rauramaa Rainer
Cardiorespiratory Fitness and Metabolic Syndrome in Older Men and Women. Diabetes Care 33. 1655-1657. 2010. Exercise
http://care.diabetesjournals.org/content/33/7/1655.abstract
Hawa Mohammed I., Kolb Hubert, Schloot Nanette, Beyan Huriya, Paschou Stavroula A., Buzzetti Raffaella, Mauricio Didac, De Leiva Alberto, Yderstraede Knud, Beck-Neilsen Henning, Tuomilehto Jaakko, Sarti Cinzia, Thivolet Charles, Hadden David, Hunter Steven, Schernthaner Guntram, Scherbaum Werner A., Williams Rhys, Brophy Sinead, Pozzilli Paolo, Leslie Richard David and consortium on behalf of the Action LADA
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care 36. 908-913. 2013. Action LADA 7
http://care.diabetesjournals.org/content/36/4/908.abstract
Hayes A. J., Leal J., Kelman C. W. and Clarke P. M.
Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia. Diabetic Medicine 28. 428-435. 2011. AUSTRALIA
http://dx.doi.org/10.1111/j.1464-5491.2010.03189.x
Hayes L., Hawthorne G. and Unwin N.
Undiagnosed diabetes in the over-60s: performance of the Association of Public Health Observatories (APHO) Diabetes Prevalence Model in a general practice. Diabetic Medicine 29. 115-120. 2012. APHO
http://dx.doi.org/10.1111/j.1464-5491.2011.03389.x
He F., Xia X., Wu X. F., Yu X. Q. and Huang F. X.
Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetologia 56. 457-466. 2013. Metaanalysis
http://dx.doi.org/10.1007/s00125-012-2796-6
Healy Sara J., Black Dawn, Harris Cara, Lorenz Andrew and Dungan Kathleen M.
Inpatient Diabetes Education Is Associated With Less Frequent Hospital Readmission Among Patients With Poor Glycemic Control. Diabetes Care 36. 2960-2967. 2013. Inpatient
http://care.diabetesjournals.org/content/36/10/2960.abstract
Heart Protection Study Collaborative Group
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20?536 high-risk individuals: a randomised controlled trial. The Lancet 378. 2013-2020. 2011. HPS
http://linkinghub.elsevier.com/retrieve/pii/S0140673611611252
Heianza Yoriko, Arase Yasuji, Fujihara Kazuya, Hsieh Shiun Dong, Saito Kazumi, Tsuji Hiroshi, Kodama Satoru, Yahagi Naoya, Shimano Hitoshi, Yamada Nobuhiro, Hara Shigeko and Sone Hirohito
Longitudinal Trajectories of HbA1c and Fasting Plasma Glucose Levels During the Development of Type 2 Diabetes. Diabetes Care 35. 1050-1052. 2012. HbA1c
http://care.diabetesjournals.org/content/35/5/1050.abstract
Heine Robert J., Van Gaal Luc F., Johns Don, Mihm Michael J., Widel Mario H., Brodows Robert G. and Group* for the GWAA Study
Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes. Annals of Internal Medicine 143. 559-569. 2005. GLP-1
http://www.annals.org/content/143/8/559.abstract
Heise T., Hermanski L., Nosek L., Feldman A., Rasmussen S. and Haahr H.
Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes. Diabetes, Obesity and Metabolism 14. 859-864. 2012. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2012.01627.x
Heise T., Nosek L., Bøttcher S. G., Hastrup H. and Haahr H.
Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes. Diabetes, Obesity and Metabolism 14. 944-950. 2012. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2012.01638.x
Helgeson V. S., Reynolds K. A., Snyder P. R., Palladino D. K., Becker D. J., Siminerio L. and Escobar O.
Characterizing the transition from paediatric to adult care among emerging adults with Type 1 diabetes. Diabetic Medicine 30. 610-615. 2013. Transitional
http://dx.doi.org/10.1111/dme.12067
Hellemons M. E., Kerschbaum J., Bakker S. J. L., Neuwirt H., Mayer B., Mayer G., de Zeeuw D., Lambers Heerspink H. J. and Rudnicki M.
Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review. Diabetic Medicine 29. 567-577. 2012. Review
http://dx.doi.org/10.1111/j.1464-5491.2011.03437.x
Heller Simon, Buse John, Fisher Miles, Garg Satish, Marre Michel, Merker Ludwig, Renard Eric, Russell-Jones David, Philotheou Areti, Francisco Ann Marie Ocampo, Pei Huiling and Bode Bruce
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. The Lancet 379. 1489-1497. 2012. Insulin
http://linkinghub.elsevier.com/retrieve/pii/S0140673612602049
Hemmingsen Bianca, Christensen Louise Lundby, Wetterslev Jørn, Vaag Allan, Gluud Christian, Lund Søren S and Almdal Thomas
Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses. British Medical Journal 344. 2012. Meta-analysis
Hemmingsen Bianca, Lund Søren S, Gluud Christian, Vaag Allan, Almdal Thomas, Hemmingsen Christina and Wetterslev Jørn
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. British Medical Journal 343. 2011. Meta-analysis
http://www.bmj.com/content/343/bmj.d6898
Heng L. Z., Comyn O., Peto T., Tadros C., Ng E., Sivaprasad S. and Hykin P. G.
Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabetic Medicine 30. 640-650. 2013. Retinopathy
http://dx.doi.org/10.1111/dme.12089
Henry R. R., Aroda V. R., Mudaliar S., Garvey W. T., Chou H. S. and Jones M. R.
Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 14. 40-46. 2012. Colesevelam
http://dx.doi.org/10.1111/j.1463-1326.2011.01486.x
Henry Robert R., Rosenstock Julio, Logan Douglas K., Alessi Thomas R., Luskey Kenneth and Baron Michelle A.
Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes. Diabetes Care 36. 2559-2565. 2013. GLP-1
http://care.diabetesjournals.org/content/36/9/2559.abstract
Herlitz Johan, Malmberg Klas, Karlson BjÖRn W., RydÉN Lars and Hjalmarson ÅKe
Mortality and Morbidity During a Five-year Follow-up of Diabetics with Myocardial Infarction. Acta Medica Scandinavica 224. 31-38. 1988. MI
http://dx.doi.org/10.1111/j.0954-6820.1988.tb16735.x
Hermanides J., Nørgaard K., Bruttomesso D., Mathieu C., Frid A., Dayan C. M., Diem P., Fermon C., Wentholt I. M. E., Hoekstra J. B. L. and DeVries J. H.
Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabetic Medicine 28. 1158-1167. 2011. CSII
http://dx.doi.org/10.1111/j.1464-5491.2011.03256.x
Hermanns Norbert, Kulzer Bernhard, Ehrmann Dominic, Bergis-Jurgan Nikola and Haak Thomas
The effect of a diabetes education programme (PRIMAS) for people with type 1 diabetes: Results of a randomized trial. Diabetes research and clinical practice 102. 149-157. 2013. PRISMAS
http://linkinghub.elsevier.com/retrieve/pii/S0168822713003513?showall=true
Hermans Michel P., Ahn Sylvie A., Mahadeb Yovan P. and Rousseau Michel F.
Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance. Diabetes/Metabolism Research and Reviews 29. 227-234. 2013. Cardiovascular
http://dx.doi.org/10.1002/dmrr.2387
Hermans Michel P., Elisaf Moses, Michel Georges, Muls Erik, Nobels Frank, Vandenberghe Hans, Brotons Carlos and Committee for the OPTIMISE International Steering
Benchmarking Is Associated With Improved Quality of Care in Type 2 Diabetes: The OPTIMISE randomized, controlled trial. Diabetes Care 36. 3388-3395. 2013. OPTIMISE
http://care.diabetesjournals.org/content/36/11/3388.abstract
Hex N., Bartlett C., Wright D., Taylor M. and Varley D.
Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Medicine 29. 855-862. 2012. Health Economics
http://dx.doi.org/10.1111/j.1464-5491.2012.03698.x
Hirakawa Yoichiro, Arima Hisatomi, Zoungas Sophia, Ninomiya Toshiharu, Cooper Mark, Hamet Pavel, Mancia Giuseppe, Poulter Neil, Harrap Stephen, Woodward Mark and Chalmers John
Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial. Diabetes Care 37. 2359-2365. 2014. ADVANCE Trial
http://care.diabetesjournals.org/content/37/8/2359.abstract
Hirst J. A., Farmer A. J., Dyar A., Lung T. W. C. and Stevens R. J.
Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis. Diabetologia 56. 973-984. 2013. Meta-analysis
http://dx.doi.org/10.1007/s00125-013-2856-6
Hirst Jennifer A., Farmer Andrew J., Ali Raghib, Roberts Nia W. and Stevens Richard J.
Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control. Diabetes Care 35. 446-454. 2012. OHGA
http://care.diabetesjournals.org/content/35/2/446.abstract
Hochberg G., Pucheu S., Kleinebreil L., Halimi S. and Fructuoso-Voisin C.
WHO-5, a tool focusing on psychological needs in patients with diabetes: The French contribution to the DAWN study. Diabetes & Metabolism 38. 515-522. 2012. DAWN
http://www.sciencedirect.com/science/article/pii/S1262363612001188
Hoffmann F. and Andersohn F.
Immortal time bias and survival in patients who self-monitor blood glucose in the Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes (ROSSO). Diabetologia 54. 308-311. 2011. ROSSO
http://dx.doi.org/10.1007/s00125-010-1909-3
Holdaas Hallvard, Fellström Bengt, Jardine Alan G., Holme Ingar, Nyberg Gudrun, Fauchald Per, Grönhagen-Riska Carola, Madsen Søren, Neumayer Hans-Hellmut, Cole Edward, Maes Bart, Ambuhl Patrice, Olsson Anders G., Hartmann Anders, Solbu Dag O. and Pedersen Terje R.
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. The Lancet 361. 2024-2031. 2003. Statins
http://linkinghub.elsevier.com/retrieve/pii/S0140673603136380
Holfort S., Nørgaard K., Jackson G., Hommel E., Madsbad S., Munch I., Klemp K., Sander B. and Larsen M.
Retinal function in relation to improved glycaemic control in type 1 diabetes. Diabetologia 54. 1853-1861. 2011. RETINAL
http://dx.doi.org/10.1007/s00125-011-2149-x
Hollander Priscilla, Gupta Alok K., Plodkowski Raymond, Greenway Frank, Bays Harold, Burns Colleen, Klassen Preston, Fujioka Ken and Group for the COR-Diabetes Study
Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes. Diabetes Care 36. 4022-4029. 2013. Obesity
http://care.diabetesjournals.org/content/36/12/4022.abstract
Hollander Priscilla, Lasko Ben, Barnett Anthony H., Bengus Monica, Kanitra Linda, Pi-Sunyer F. Xavier and Balena Raffaella
Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T-emerge 7 study). Obesity 21. 238-247. 2013. GLP-1
http://dx.doi.org/10.1002/oby.20042
Holman N., Forouhi N. G., Goyder E. and Wild S. H.
The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010–2030. Diabetic Medicine 28. 575-582. 2011. APHO
http://dx.doi.org/10.1111/j.1464-5491.2010.03216.x
Holman N., Hillson R. and Young R. J.
Excess mortality during hospital stays among patients with recorded diabetes compared with those without diabetes. Diabetic Medicine 30. 1393-1402. 2013. Inpatient
http://dx.doi.org/10.1111/dme.12282
Holman N., Young R. and Jeffcoate W.
Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia 55. 1919-1925. 2012. Diabetic Foot
http://dx.doi.org/10.1007/s00125-012-2468-6
Holman R R, Cull C A and Turner R C
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 22. 960-964. 1999. UKPDS 44
http://care.diabetesjournals.org/content/22/6/960.abstract
Holman R., Paul S., Farmer A., Tucker L., Stratton I. and Neil H.
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial. Diabetologia 52. 50-59. 2009. AFFORD
http://dx.doi.org/10.1007/s00125-008-1179-5
Holman RR, Cull CA, Fox C. and Turner RC
United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. British Medical Journal 310. 83–88. 1995. UKPDS 13
http://www.bmj.com/content/310/6972/83.full
Holman Rury R., Paul Sanjoy K., Bethel M. Angelyn, Matthews David R. and Neil H. Andrew W.
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. UKPDS 80. New England Journal of Medicine 359. 1577-1589. 2008. UKPDS 80
http://www.nejm.org/doi/full/10.1056/NEJMoa0806470
Holman Rury R., Paul Sanjoy K., Bethel M. Angelyn, Neil H. Andrew W. and Matthews David R.
Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes. UKPDS 81. New England Journal of Medicine 359. 1565-1576. 2008. UKPDS 81
http://www.nejm.org/doi/full/10.1056/NEJMoa0806359
Holman Rury R., Thorne Kerensa I., Farmer Andrew J., Davies Melanie J., Keenan Joanne F., Paul Sanjoy and Levy Jonathan C.
Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes. New England Journal of Medicine 357. 1716-1730. 2007. Insulin
http://www.nejm.org/doi/full/10.1056/NEJMoa075392
Holmes Valerie A., Young Ian S., Patterson Christopher C., Pearson Donald W.M., Walker James D., Maresh Michael J.A., McCance David R., Diabetes for the and Group Pre-eclampsia Intervention Trial Study
Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial. Diabetes Care 34. 1683-1688. 2011. Pre-Eclampsia Intervention trial
http://care.diabetesjournals.org/content/34/8/1683.abstract
Holstein Andreas, Patzer Olaf M., Machalke Kathrin, Holstein Judith D., Stumvoll Michael and Kovacs Peter
Substantial Increase in Incidence of Severe Hypoglycemia Between 1997–2000 and 2007–2010. Diabetes Care 35. 972-975. 2012. Hypoglycaemia
http://care.diabetesjournals.org/content/35/5/972.abstract
Home P. D., Meneghini L., Wendisch U., Ratner R. E., Johansen T., Christensen T. E., Jendle J., Roberts A. P. and Birkeland K. I.
Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes. Diabetic Medicine 29. 716-720. 2012. Insulin
http://dx.doi.org/10.1111/j.1464-5491.2011.03547.x
Home Philip, Naggar Nabil El, Khamseh Mohammed, Gonzalez-Galvez Guillermo, Shen Chunduo, Chakkarwar Praful and Wenying Yang
An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study. Diabetes research and clinical practice 94. 352-363. 2011. The A1chieve study
http://www.sciencedirect.com/science/article/pii/S0168822711005638
Hommel E., Olsen B., Battelino T., Conget I., Schütz-Fuhrmann I., Hoogma R., Schierloh U., Sulli N., Gough H., Castañeda J., de Portu S. and Bolinder J.
Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetologica 51. 845-851. 2014. SWITCH Study
http://dx.doi.org/10.1007/s00592-014-0598-7
Hopkins David, Lawrence Ian, Mansell Peter, Thompson Gillian, Amiel Stephanie, Campbell Michael and Heller Simon
Improved Biomedical and Psychological Outcomes 1 Year After Structured Education in Flexible Insulin Therapy for People With Type 1 Diabetes. Diabetes Care 35. 1638-1642. 2012. DAFNE
http://care.diabetesjournals.org/content/35/8/1638.abstract
Horton V., Stratton I., Bottazzo G. F., Shattock M., Mackay I., Zimmet P., Manley S., Holman R. and Turner R.
Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). Diabetologia 42. 608-616. 1999. UKPDS 43
http://dx.doi.org/10.1007/s001250051202
Hovorka Roman, Kumareswaran Kavita, Harris Julie, Allen Janet M, Elleri Daniela, Xing Dongyuan, Kollman Craig, Nodale Marianna, Murphy Helen R, Dunger David B, Amiel Stephanie A, Heller Simon R, Wilinska Malgorzata E and Evans Mark L
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. British Medical Journal 342. 2011. CSII
http://www.bmj.com/content/342/bmj.d1855.abstract
Hsu C., Chang H., Huang M., Hwang S., Yang Y., Lee Y., Shin S. and Tai T.
HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study. Diabetologia 55. 3163-3172. 2012. HbA1c
http://dx.doi.org/10.1007/s00125-012-2700-4
Hsu Chih-Cheng, Chang Hsing-Yi, Huang Meng-Chuan, Hwang Shang-Jyh, Yang Yi-Ching, Tai Tong-Yuan, Yang Hung-Jen, Chang Chwen-Tzuei, Chang Chih-Jen, Li Yu-Sheng, Shin Shyi-Jang and Kuo Ken N.
Association Between Insulin Resistance and Development of Microalbuminuria in Type 2 Diabetes. Diabetes Care 34. 982-987. 2011. ACR
http://care.diabetesjournals.org/content/34/4/982.abstract
Hsu Pai-Feng, Sung Shih-Hsien, Cheng Hao-Min, Yeh Jong-Shiuan, Liu Wen-Ling, Chan Wan-Leong, Chen Chen-Huan, Chou Pesus and Chuang Shao-Yuan
Association of Clinical Symptomatic Hypoglycemia With Cardiovascular Events and Total Mortality in Type 2 Diabetes: A nationwide population-based study. Diabetes Care 36. 894-900. 2013. Hypoglycaemia
http://care.diabetesjournals.org/content/36/4/894.abstract
Hu Gang, Jousilahti Pekka, Barengo Noël C., Qiao Qing, Lakka Timo A. and Tuomilehto Jaakko
Physical Activity, Cardiovascular Risk Factors, and Mortality Among Finnish Adults With Diabetes. Diabetes Care 28. 799-805. 2005. FINNISH
http://care.diabetesjournals.org/content/28/4/799.abstract
Huang Elbert S., Liu Jennifer Y., Moffet Howard H., John Priya M. and Karter Andrew J.
Glycemic Control, Complications, and Death in Older Diabetic Patients. Diabetes Care 34. 1329-1336. 2011. Elderly
http://care.diabetesjournals.org/content/34/6/1329.abstract
Hussein Wiam I., Hasan Khadija and Jaradat Ahmed A.
Effectiveness of mobile phone short message service on diabetes mellitus management; the SMS-DM study. Diabetes research and clinical practice 94. e24-e26. 2011. SMS-DM study
http://linkinghub.elsevier.com/retrieve/pii/S0168822711004013?showall=true
Hypertension in Diabetes Study Group
Hypertension in Diabetes Study III. Prospective Study of Therapy of Hypertension in Type 2 Diabetic Patients: Efficacy of ACE Inhibition and β-Blockade. Diabetic Medicine 11. 773-782. 1994. HDS 3
Idris I., Pillai A., Fernando D. J., Thomson G. and Tate H.
Responders to insulin therapy at 18 months in adults with newly diagnosed diabetes: which insulin regimen? Diabetic Medicine 30. e95-e100. 2013. Insulin
http://dx.doi.org/10.1111/dme.12096
Ilanne-Parikka Pirjo, Laaksonen David E., Eriksson Johan G., Lakka Timo A., Lindstr Jaanaom, Peltonen Markku, Aunola Sirkka, Keinánen-Kiukaanniemi Sirkka, Uusitupa Matti and Tuomilehto Jaakko
Leisure-Time Physical Activity and the Metabolic Syndrome in the Finnish Diabetes Prevention Study. Diabetes Care 33. 1610-1617. 2010. FDPS
http://care.diabetesjournals.org/content/33/7/1610.abstract
Imperatore Giuseppina, Boyle James P., Thompson Theodore J., Case Doug, Dabelea Dana, Hamman Richard F., Lawrence Jean M., Liese Angela D., Liu Lenna L., Mayer-Davis Elizabeth J., Rodriguez Beatriz L., Standiford Debra and Group for the SEARCH for Diabetes in Youth Study
Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2050: Dynamic modeling of incidence, mortality, and population growth. Diabetes Care 35. 2515-2520. 2012. Epidemiology
http://care.diabetesjournals.org/content/35/12/2515.abstract
Inagaki N., Kondo K., Yoshinari T., Maruyama N., Susuta Y. and Kuki H.
Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study. Diabetes, Obesity and Metabolism 15. 1136-1145. 2013. SGLT2
http://dx.doi.org/10.1111/dom.12149
Investigator The DREAM Trial
Effect of Ramipril on the Incidence of Diabetes. New England Journal of Medicine 355. 1551-1562. 2006. DREAM
http://www.nejm.org/doi/full/10.1056/NEJMoa065061
Investigators Heart Outcomes Prevention Evaluation (HOPE) Study
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. The Lancet 355. 253-259. 2000. HOPE/MICRO-HOPE
http://www.sciencedirect.com/science/article/pii/S0140673699123237
Investigators The DREAM Trial
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. The Lancet 368. 1096-1105. 2006. DREAM
http://linkinghub.elsevier.com/retrieve/pii/S0140673606694208
Investigators The DREAM Trial
Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal. Diabetes Care 34. 1265-1269. 2011. DREAM
http://care.diabetesjournals.org/content/34/6/1265.abstract
Investigators The Heart Outcomes Prevention Evaluation Study
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients. New England Journal of Medicine 342. 145-153. 2000. HOPE
http://www.nejm.org/doi/full/10.1056/NEJM200001203420301
Investigators The ORIGIN Trial
Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 36. 2915-2922. 2013. ORIGIN Study
http://care.diabetesjournals.org/content/36/10/2915.abstract
Investigators The Tide Trial
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia 55. 36-45. 2012. TIDE Trial
http://dx.doi.org/10.1007/s00125-011-2357-4
Inzucchi S., Bergenstal R., Buse J., Diamant M., Ferrannini E., Nauck M., Peters A., Tsapas A., Wender R. and Matthews D.
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55. 1577-1596. 2012. Consensus
http://dx.doi.org/10.1007/s00125-012-2534-0
Ismail-Beigi Faramarz, Craven Timothy, Banerji Mary Ann, Basile Jan, Calles Jorge, Cohen Robert M., Cuddihy Robert, Cushman William C., Genuth Saul, Grimm Jr Richard H., Hamilton Bruce P., Hoogwerf Byron, Karl Diane, Katz Lois, Krikorian Armand, O'Connor Patrick, Pop-Busui Rodica, Schubart Ulrich, Simmons Debra, Taylor Harris, Thomas Abraham, Weiss Daniel and Hramiak Irene
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. The Lancet 376. 419-430. 2010. ACCORD
Jabbour Serge A., Hardy Elise, Sugg Jennifer, Parikh, Shamik and Group for the Study 10
Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Diabetes Care 37. 740-750. 2014. SGLT2
http://care.diabetesjournals.org/content/37/3/740.abstract
Jacobsen Peter, Andersen Steen, Jensen Berit R. and Parving Hans-Henrik
Additive Effect of ACE Inhibition and Angiotensin II Receptor Blockade in Type I Diabetic Patients with Diabetic Nephropathy. Journal of the American Society of Nephrology 14. 992-999. 2003. ACE
http://jasn.asnjournals.org/content/14/4/992.abstract
Jacobsen Peter, Andersen Steen, Rossing Kasper, Hansen Birgitte V. and Parving Hans-Henrik
Dual blockade of the renin angiotensin system in type 1 patients with diabetic nephropathy. Nephrology Dialysis Transplantation 17. 1019-1024. 2002. ACE
http://ndt.oxfordjournals.org/content/17/6/1019.abstract
Jacobsen Peter, Andersen Steen, Rossing Kasper, Jensen Berit R. and Parving Hans-Henrik
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. Kidney Int 63. 1874-1880. 2003. ACE
http://dx.doi.org/10.1046/j.1523-1755.2003.00940.x
Jacobson Alan M., Braffett Barbara H., Cleary Patricia A., Gubitosi-Klug Rose A., Larkin Mary E. and Group the DCCT/EDIC Research
The Long-Term Effects of Type 1 Diabetes Treatment and Complications on Health-Related Quality of Life: A 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort. Diabetes Care 36. 3131-3138. 2013. DCCT/EDIC
http://care.diabetesjournals.org/content/36/10/3131.abstract
Jakubowicz Daniela, Barnea Maayan, Wainstein Julio and Froy Oren
High Caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity 21. 2504-2512. 2013. Obesity
http://dx.doi.org/10.1002/oby.20460
James Stefan K., Lindahl Bertil, Timmer Jorik R., Ottervanger Jan Paul, Siegbahn Agneta, Stridsberg Mats, Armstrong Paul, Califf Robert, Wallentin Lars and Simoons Maarten L.
Usefulness of Biomarkers for Predicting Long-Term Mortality in Patients With Diabetes Mellitus and Non-ST-Elevation Acute Coronary Syndromes (A GUSTO IV Substudy). The American Journal of Cardiology 97. 167-172. 2006. GUSTO IV
http://www.sciencedirect.com/science/article/pii/S0002914905017959
Janssen M. F., Lubetkin E. I., Sekhobo J. P. and Pickard A. S.
The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabetic Medicine 28. 395-413. 2011. QoL
http://dx.doi.org/10.1111/j.1464-5491.2010.03136.x
Jansson S. P. O., Andersson D. K. G. and Svärdsudd K.
Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes. Diabetic Medicine 30. 349-357. 2013. Cardiovascular
http://dx.doi.org/10.1111/dme.12106
Jasuja Guneet Kaur, Travison Thomas G., Davda Maithili, Rose Adam J., Zhang Anqi, Kushnir Mark M., Rockwood Alan L., Meikle Wayne, Coviello Andrea D., D’Agostino Ralph, Vasan Ramachandran S. and Bhasin Shalender
Circulating Estrone Levels Are Associated Prospectively With Diabetes Risk in Men of the Framingham Heart Study. Diabetes Care 36. 2591-2596. 2013. Framingham Heart Study
http://care.diabetesjournals.org/content/36/9/2591.abstract
Jeffery R., Iserman E., Haynes R. B. and the Cdss Systematic Review Team
Can computerized clinical decision support systems improve diabetes management? A systematic review and meta-analysis. Diabetic Medicine 30. 739-745. 2013. Meta-analysis
http://dx.doi.org/10.1111/dme.12087
Jelsing J., Vrang N., Hansen G., Raun K., Tang-Christensen M. and Bjerre Knudsen L.
Liraglutide: short-lived effect on gastric emptying—long lasting effects on body weight. Diabetes, Obesity and Metabolism 14. 531-538. 2012. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2012.01557.x
Jenkins N., Hallowell N., Farmer A. J., Holman R. R. and Lawton J.
Participants’ experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study. Diabetic Medicine 28. 543-548. 2011. 4-T
http://dx.doi.org/10.1111/j.1464-5491.2010.03200.x
John W. G. and on behalf of the U. K. Department of Health Advisory Committee on Diabetes
Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011. Diabetic Medicine 29. 1350-1357. 2012. Consensus
http://dx.doi.org/10.1111/j.1464-5491.2012.03762.x
Johnson J. and Bowker S.
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia 54. 25-31. 2011. Meta-analysis
http://dx.doi.org/10.1007/s00125-010-1933-3
Johnson StephanieR, Cooper MatthewN, Jones TimothyW and Davis ElizabethA
Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control study. Diabetologia 56. 2392-2400. 2013. CSII
http://dx.doi.org/10.1007/s00125-013-3007-9
Jones Colin D., Greenwood Richard H., Misra Aseema and Bachmann Max O.
Incidence and Progression of Diabetic Retinopathy During 17 Years of a Population-Based Screening Program in England. Diabetes Care 35. 592-596. 2012. Retinopathy
http://care.diabetesjournals.org/content/35/3/592.abstract
Jørgensen MaritE, Almdal ThomasP and Carstensen Bendix
Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia 56. 2401-2404. 2013. Mortality
Kabadi Shaum M., Lee Brian K. and Liu Longjian
Joint Effects of Obesity and Vitamin D Insufficiency on Insulin Resistance and Type 2 Diabetes. Diabetes Care 35. 2048-2054. 2012. Obesity
http://care.diabetesjournals.org/content/35/10/2048.abstract
Kahn Steven E., Haffner Steven M., Heise Mark A., Herman William H., Holman Rury R., Jones Nigel P., Kravitz Barbara G., Lachin John M., O'Neill M. Colleen, Zinman Bernard and Viberti Giancarlo
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. New England Journal of Medicine 355. 2427-2443. 2006. ADOPT
http://www.nejm.org/doi/full/10.1056/NEJMoa066224
Kahn Steven E., Haffner Steven M., Viberti Giancarlo, Herman William H., Lachin John M., Kravitz Barbara G., Yu Dahong, Paul Gitanjali, Holman Rury R., Zinman Bernard and Group for A Diabetes Outcome Progression Trial Study
Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain. Diabetes Care 33. 177-183. 2010. ADOPT
http://care.diabetesjournals.org/content/33/1/177.abstract
Kahn Steven E., Lachin John M., Zinman Bernard, Haffner Steven M., Aftring R. Paul, Paul Gitanjali, Kravitz Barbara G., Herman William H., Viberti Giancarlo, Holman Rury R. and Group and the ADOPT Study
Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT. Diabetes 60. 1552-1560. 2011. ADOPT
http://diabetes.diabetesjournals.org/content/60/5/1552.abstract
Kaku K., Inoue S., Matsuoka O., Kiyosue A., Azuma H., Hayashi N., Tokudome T., Langkilde A. M. and Parikh S.
Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial. Diabetes, Obesity and Metabolism 15. 432-440. 2013. SGLT2
http://dx.doi.org/10.1111/dom.12047
Kalter-Leibovici Ofra, Freedman Laurence S., Olmer Liraz, Liebermann Nicky, Heymann Anthony, Tal Orna, Lerner-Geva Liat, Melamed Nir and Hod Moshe
Screening and Diagnosis of Gestational Diabetes Mellitus. Diabetes Care 35. 1894-1896. 2012. IADPSG
http://care.diabetesjournals.org/content/35/9/1894.abstract
Kannel WB and McGee DL
Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59. 8-13. 1979. FRAMINGHAM
http://circ.ahajournals.org/content/59/1/8.abstract
Kannel William B.
Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study. American Heart Journal 110. 1100-1107. 1985. FRAMINGHAM
http://www.sciencedirect.com/science/article/pii/0002870385902248
Kannel William B., D'Agostino Ralph B., Wilson Peter W. F., Belanger Albert J. and Gagnon David R.
Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. American Heart Journal 120. 672-676. 1990. FRAMINGHAM
http://www.sciencedirect.com/science/article/pii/000287039090026T
Kannel William B., Hjortland Marthana and Castelli William P.
Role of diabetes in congestive heart failure: The Framingham study. The American Journal of Cardiology 34. 29-34. 1974. FRAMINGHAM
http://www.sciencedirect.com/science/article/pii/0002914974900897
Karagiannis Thomas, Paschos Paschalis, Paletas Konstantinos, Matthews David R and Tsapas Apostolos
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. British Medical Journal 344. 2012. Meta-analysis
Karlson B. W., Herlitz J. and Hjalmarson Å
Prognosis of Acute Myocardial Infarction in Diabetic and Non-diabetic Patients. Diabetic Medicine 10. 449-454. 1993. MI
http://dx.doi.org/10.1111/j.1464-5491.1993.tb00097.x
Karunakara S., Hammersley M. S., Morris R. J., Turner R. C. and Holman R. R.
The fasting hyperglycaemia study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose. Metabolism 46. 56-60. 1997. FHS III
http://www.sciencedirect.com/science/article/pii/S002604959790319X
Kato M., Noda M., Suga H., Nakamura T., Matsumoto M., Kanazawa Y. and for the Omiya M. A. Cohort Study Group
Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study. Diabetic Medicine 29. 905-910. 2012. HbA1c
http://dx.doi.org/10.1111/j.1464-5491.2012.03572.x
Katula Jeffrey A., Vitolins Mara Z., Rosenberger Erica L., Blackwell Caroline S., Morgan Timothy M., Lawlor Michael S. and Goff David C.
One-Year Results of a Community-Based Translation of the Diabetes Prevention Program. Diabetes Care 34. 1451-1457. 2011. Diabetes Prevention Program
http://care.diabetesjournals.org/content/34/7/1451.abstract
Kawasaki R., Tanaka S., Yamamoto T., Sone H., Ohashi Y., Akanuma Y., Yamada N., Yamashita H. and Group on behalf of the Japan Diabetes Complications Study
Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 54. 2288-2294. 2011. JDCS
http://dx.doi.org/10.1007/s00125-011-2199-0
Keavney B., Dudley C., Stratton I., Holman R., Matthews D., Ratcliffe P. and Turner R.
UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 38. 948-952. 1995. UKPDS 14
http://dx.doi.org/10.1007/BF00400584
Keen A. J. A., Duncan E., McKillop-Smith A., Evans N. D. and Gold A. E.
Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits? Diabetic Medicine 29. 670-676. 2012. DAFNE
http://dx.doi.org/10.1111/j.1464-5491.2011.03479.x
Kempler P., Amarenco G., Freeman R., Frontoni S., Horowitz M., Stevens M., Low P., Pop-Busui R., Tahrani A. A., Tesfaye S., Várkonyi T., Ziegler D., Valensi P. and on behalf of The Toronto Consensus Panel on Diabetic Neuropathy
Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes. Diabetes/Metabolism Research and Reviews 27. 665-677. 2011. Consensus
http://dx.doi.org/10.1002/dmrr.1223
Kendall David M., Riddle Matthew C., Rosenstock Julio, Zhuang Dongliang, Kim Dennis D., Fineman Mark S. and Baron Alain D.
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea. Diabetes Care 28. 1083-1091. 2005. GLP-1
http://care.diabetesjournals.org/content/28/5/1083.abstract
Khunti K., Damci T., Meneghini L., Pan C. Y., Yale J. F. and on behalf of the Solve Study Group
Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Diabetes, Obesity and Metabolism 14. 654-661. 2012. SOLVE
http://dx.doi.org/10.1111/j.1463-1326.2012.01602.x
Khunti Kamlesh, Gray Laura J, Skinner Timothy, Carey Marian E, Realf Kathryn, Dallosso Helen, Fisher Harriet, Campbell Michael, Heller Simon and Davies Melanie J
Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. British Medical Journal 344. 2012. DESMOND
http://www.bmj.com/content/344/bmj.e2333
Khunti Kamlesh, Wolden Michael L., Thorsted Brian Larsen, Andersen Marc and Davies Melanie J.
Clinical Inertia in People With Type 2 Diabetes: A retrospective cohort study of more than 80,000 people. Diabetes Care 36. 3411-3417. 2013. OHGA
http://care.diabetesjournals.org/content/36/11/3411.abstract
Kielgast Urd, Holst Jens J. and Madsbad Sten
Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function. Diabetes 60. 1599-1607. 2011. GLP-1
http://diabetes.diabetesjournals.org/content/60/5/1599.abstract
Kilpatrick E. S., Rigby A. S., Atkin S. L. and Frier B. M.
Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database. Diabetic Medicine 29. 1195-1198. 2012. DCCT
http://dx.doi.org/10.1111/j.1464-5491.2012.03612.x
Kim Catherine, Cleary Patricia A., Cowie Catherine C., Braffett Barbara H., Dunn Rodney L., Larkin Mary E., Gatcomb Patricia M., Wessells Hunter B., Nathan David M., Sarma Aruna V. and Group for the DCCT/EDIC Research
Effect of Glycemic Treatment and Microvascular Complications on Menopause in Women With Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort. Diabetes Care 37. 701-708. 2014. DCCT
http://care.diabetesjournals.org/content/37/3/701.abstract
Kim Sun H., Abbasi Fahim, Lamendola Cindy, Liu Alice, Ariel Danit, Schaaf Patricia, Grove Kaylene, Tomasso Vanessa, Ochoa Hector, Liu Yeheng V., Chen Yii-Der Ida and Reaven Gerald
Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes. Diabetes Care 36. 3276-3282. 2013. GLP-1
http://care.diabetesjournals.org/content/36/10/3276.abstract
Kim Y. G., Hahn S., Oh T. J., Kwak S. H., Park K. S. and Cho Y. M.
Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis. Diabetologia 56. 696-708. 2013. DPP4
http://dx.doi.org/10.1007/s00125-012-2827-3
King Paromita, Peacock Ian and Donnelly Richard
The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. British Journal of Clinical Pharmacology 48. 643-648. 1999. UKPDS
http://dx.doi.org/10.1046/j.1365-2125.1999.00092.x
Kiran Tara, Victor J. Charles, Kopp Alexander, Shah Baiju R. and Glazier Richard H.
The Relationship Between Financial Incentives and Quality of Diabetes Care in Ontario, Canada. Diabetes Care 35. 1038-1046. 2012. Review
http://care.diabetesjournals.org/content/35/5/1038.abstract
Klein Ronald, Klein Barbara E. K., Moss Scot E., Davis Matthew D. and DeMets David L.
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and Risk of Diabetic Retinopathy When Age at Diagnosis Is Less Than 30 Years. Arch Ophthalmol 102. 520-526. 1984. Wisconsin Epidemiologic Study of Diabetic Retinopathy
http://archopht.ama-assn.org/cgi/content/abstract/102/4/520
Klein Samuel, Sheard Nancy F., Pi-Sunyer Xavier, Daly Anne, Wylie-Rosett Judith, Kulkarni Karmeen and Clark Nathaniel G.
Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies. Diabetes Care 27. 2067-2073. 2004. Obesity
http://care.diabetesjournals.org/content/27/8/2067.short
Knopp Robert H., D'Emden Michael, Smilde Johan G. and Pocock Stuart J.
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes. Diabetes Care 29. 1478-1485. 2006. Statins
http://care.diabetesjournals.org/content/29/7/1478.abstract
Kodama Keiichi, Tojjar Damon, Yamada Satoru, Toda Kyoko, Patel Chirag J. and Butte Atul J.
Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response: A systematic review and meta-analysis. Diabetes Care 36. 1789-1796. 2013. Meta-analysis
http://care.diabetesjournals.org/content/36/6/1789.abstract
Koehler Gerd, Heller Simon, Korsatko Stefan, Roepstorff Carsten, Rasmussen Søren, Haahr Hanne and Pieber ThomasR
Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study. Diabetologia 57. 40-49. 2014. Insulin
http://dx.doi.org/10.1007/s00125-013-3056-0
Kohner E. M., Stratton I. M., Aldington S. J., Holman R. R. and Matthews D. R.
Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabetic Medicine 18. 178-184. 2001. UKPDS 52
http://dx.doi.org/10.1046/j.1464-5491.2001.00458.x
Kohner E. M., Stratton I. M., Aldington S. J., Turner R. C. and Matthews D. R.
Microaneurysms in the development of diabetic retinopathy (UKPDS 42). Diabetologia 42. 1107-1112. 1999. UKPDS 42
http://dx.doi.org/10.1007/s001250051278
Kohner Eva M., Aldington Stephen J., Stratton Irene M., Manley Susan E., Holman Rury R., Matthews David R., Turner Robert C. and for the United Kingdom Prospective Diabetes Study
United Kingdom Prospective Diabetes Study, 30: Diabetic Retinopathy at Diagnosis of Non-Insulin-Dependent Diabetes Mellitus and Associated Risk Factors. Arch Ophthalmol 116. 297-303. 1998. UKPDS 30
http://archopht.ama-assn.org/cgi/content/abstract/116/3/297
Koivisto V., Cleall S., Pontiroli A. E. and Giugliano D.
Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial. Diabetes, Obesity and Metabolism 13. 1149-1157. 2011. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01484.x
Kong A. P. S., Yamasaki A., Ozaki R., Saito H., Asami T., Ohwada S., Ko G. T. C., Wong C. K., Leung G. T. C., Lee K. F., Yeung C. Y. and Chan J. C. N.
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose–lipid control in type 2 diabetes. Diabetes, Obesity and Metabolism 13. 806-813. 2011. OHGA
http://dx.doi.org/10.1111/j.1463-1326.2011.01411.x
Konstantopoulos Nicky, Molero Juan C., McGee Sean L., Spolding Briana, Connor Tim, de Vries Melissa, Wanyonyi Stephen, Fahey Richard, Morrison Shona, Swinton Courtney, Jones Sharon, Cooper Adrian, Garcia-Guerra Lucia, Foletta Victoria C., Krippner Guy, Andrikopoulos Sofianos and Walder Ken R.
Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo. Diabetes 61. 2146-2154. 2012. Methizolamide
http://diabetes.diabetesjournals.org/content/61/8/2146.abstract
Kothari V., Stevens R.J., Adler A.I., Stratton I.M., Manley S.E., Neil H.A. and Holman R.R.
UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33. 1776. 2002. UKPDS 60
http://stroke.ahajournals.org/content/33/7/1776.abstract
Kovacs C. S., Seshiah V., Swallow R., Jones R., Rattunde H., Woerle H. J., Broedl U. C. and on behalf of the Empa- R. E. G. Pio™ trial investigators
Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial. Diabetes, Obesity and Metabolism 16. 147-158. 2014. DPP4
http://dx.doi.org/10.1111/dom.12188
Kovatchev Boris P., Renard Eric, Cobelli Claudio, Zisser Howard C., Keith-Hynes Patrick, Anderson Stacey M., Brown Sue A., Chernavvsky Daniel R., Breton Marc D., Farret Anne, Pelletier Marie-Josée, Place Jérôme, Bruttomesso Daniela, Del Favero Simone, Visentin Roberto, Filippi Alessio, Scotton Rachele, Avogaro Angelo and Doyle Francis J.
Feasibility of Outpatient Fully Integrated Closed-Loop Control: First studies of wearable artificial pancreas. Diabetes Care 36. 1851-1858. 2013. Artifical Pancreas
http://care.diabetesjournals.org/content/36/7/1851.abstract
Kowall B., Rathmann W. and Landgraf R.
Is HbA1c a valid and feasible tool for the diagnosis of diabetes? Diabetes research and clinical practice 93. 314-316. 2011. HbA1c
http://linkinghub.elsevier.com/retrieve/pii/S0168822711003469?showall=true
Kramer C. K. and Retnakaran R.
Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial. Diabetic Medicine 30. 1333-1341. 2013. DCCT
http://dx.doi.org/10.1111/dme.12296
Kramer Caroline K., Rodrigues Ticiana C., Canani Luis H., Gross Jorge L. and Azevedo Mirela J.
Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes. Diabetes Care 34. 1238-1244. 2011. Retinopathy
http://care.diabetesjournals.org/content/34/5/1238.abstract
Krebs J., Elley C., Parry-Strong A., Lunt H., Drury P., Bell D., Robinson E., Moyes S. and Mann J.
The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia 55. 905-914. 2012. DEWL Trial
http://dx.doi.org/10.1007/s00125-012-2461-0
Kristensen P. L., Hansen L. S., Jespersen M. J., Pedersen-Bjergaard U., Beck-Nielsen H., Christiansen J. S., Nørgaard K., Perrild H., Parving H. H., Thorsteinsson B. and Tarnow L.
Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes research and clinical practice 96. 17-23. 2012. Hypoglycaemia
http://www.sciencedirect.com/science/article/pii/S0168822711006097
Kuntz Susan, Johnson Eric L., Blehm Julie and Hosford Charles C.
Use of A1C for Screening and Diagnosis of Type 2 Diabetes in Three Rural Health Care Systems. Clinical Diabetes 30. 61-66. 2012. HbA1c
http://clinical.diabetesjournals.org/content/30/2/61.short
Kunutsor Setor K., Apekey Tanefa A., Walley John and Kain Kirti
Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence. Diabetes/Metabolism Research and Reviews 29. 308-318. 2013. Meta-analysis
http://dx.doi.org/10.1002/dmrr.2394
Kuusisto J, Mykanen L, Pyorala K and Laakso M
NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43. 960-967. 1994. Cardiovascular
http://diabetes.diabetesjournals.org/content/43/8/960.abstract
Kwak SooHeon, Choi SungHee, Kim Kyunga, Jung HyeSeung, Cho YoungMin, Lim Soo, Cho NamH, Kim SeongYeon, Park KyongSoo and Jang HakC
Prediction of type 2 diabetes in women with a history of gestational diabetes using a genetic risk score. Diabetologia 56. 2556-2563. 2013. Risk Scores
Lachin John M., Viberti Giancarlo, Zinman Bernard, Haffner Steven M., Aftring R. Paul, Paul Gitanjali, Kravitz Barbara G., Herman William H., Holman Rury R., Kahn Steven E. and Group the ADOPT Study
Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy. Clinical Journal of the American Society of Nephrology 6. 1032-1040. 2011. ADOPT
http://cjasn.asnjournals.org/content/6/5/1032.abstract
Larsen R., Mann N., Maclean E. and Shaw J.
The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial. Diabetologia 54. 731-740. 2011. Diet
http://dx.doi.org/10.1007/s00125-010-2027-y
Laurenzi Andrea, Bolla Andrea M., Panigoni Gabriella, Doria Valentina, Uccellatore AnnaChiara, Peretti Elena, Saibene Alessandro, Galimberti Gabriella, Bosi Emanuele and Scavini Marina
Effects of Carbohydrate Counting on Glucose Control and Quality of Life Over 24 Weeks in Adult Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion. Diabetes Care 34. 823-827. 2011. CSII
http://care.diabetesjournals.org/content/34/4/823.abstract
Lauritzen T., Sandbaek A., Skriver M. and Borch-Johnsen K.
HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark Diabetologia 54. 1318-1326. 2011. ADDITION
http://dx.doi.org/10.1007/s00125-011-2077-9
Lázaro-Martínez José Luis, Aragón-Sánchez Javier and García-Morales Esther
Antibiotics Versus Conservative Surgery for Treating Diabetic Foot Osteomyelitis: A Randomized Comparative Trial. Diabetes Care 37. 789-795. 2014. Osteomyelitis
http://care.diabetesjournals.org/content/37/3/789.abstract
Leal Jose, Hayes Alison J., Gray Alastair M., Holman Rury R. and Clarke Philip M.
Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data. Diabetes Care 36. 1541-1546. 2013. UKPDS
http://care.diabetesjournals.org/content/36/6/1541.abstract
LeCaire Tamara J., Klein Barbara E.K., Howard Kerri P., Lee Kristine E. and Klein Ronald
Risk for End-Stage Renal Disease Over 25 Years in the Population-Based WESDR Cohort. Diabetes Care 37. 381-388. 2014. WESDR
http://care.diabetesjournals.org/content/37/2/381.abstract
Lee C. Christine, Haffner Steven M., Wagenknecht Lynne E., Lorenzo Carlos, Norris Jill M., Bergman Richard N., Stefanovski Darko, Anderson Andrea M., Rotter Jerome I., Goodarzi Mark O. and Hanley Anthony J.
Insulin Clearance and the Incidence of Type 2 Diabetes in Hispanics and African Americans: The IRAS Family Study. Diabetes Care 36. 901-907. 2013. IRAS
http://care.diabetesjournals.org/content/36/4/901.abstract
Lee Ji Won R., Brancati Frederick L. and Yeh Hsin-Chieh
Trends in the Prevalence of Type 2 Diabetes in Asians Versus Whites. Diabetes Care 34. 353-357. 2011. Epidemiology
http://care.diabetesjournals.org/content/34/2/353.abstract
Lewis Edmund J., Hunsicker Lawrence G., Bain Raymond P. and Rohde Richard D
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy. New England Journal of Medicine 329. 1456-1462. 1993. ACE
http://www.nejm.org/doi/full/10.1056/NEJM199311113292004
Lewis Edmund J., Hunsicker Lawrence G., Clarke William R., Berl Tomas, Pohl Marc A., Lewis Julia B., Ritz Eberhard, Atkins Robert C., Rohde Richard and Raz Itamar
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes. New England Journal of Medicine 345. 851-860. 2001. ARB
http://www.nejm.org/doi/full/10.1056/NEJMoa011303
Liakos A., Karagiannis T., Athanasiadou E., Sarigianni M., Mainou M., Papatheodorou K., Bekiari E. and Tsapas A.
Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis. Diabetes, Obesity and Metabolism 16. 984-993. 2014. Meta-analysis
http://dx.doi.org/10.1111/dom.12307
Liang X., Wang Q., Yang X., Cao J., Chen J., Mo X., Huang J., Wang L. and Gu D.
Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabetic Medicine 28. 455-463. 2011. Meta-analysis
http://dx.doi.org/10.1111/j.1464-5491.2010.03180.x
Liao S., Mei J., Song W., Liu Y., Tan Y. D., Chi S., Li P., Chen X. and Deng S.
The impact of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) fasting glucose diagnostic criterion on the prevalence and outcomes of gestational diabetes mellitus in Han Chinese women. Diabetic Medicine 31. 341-351. 2014. IADPSG
http://dx.doi.org/10.1111/dme.12349
Lim E., Hollingsworth K., Aribisala B., Chen M., Mathers J. and Taylor R.
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54. 2506-2514. 2011. Diet
http://dx.doi.org/10.1007/s00125-011-2204-7
Lind M., Olsson M., Rosengren A., Svensson A. M., Bounias I. and Gudbjörnsdottir S.
The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetologia 55. 2946-2953. 2012. SNDR
http://dx.doi.org/10.1007/s00125-012-2681-3
Lindholm Lars H., Ibsen Hans, Dahlöf Björn, Devereux Richard B., Beevers Gareth, de Faire Ulf, Fyhrquist Frej, Julius Stevo, Kjeldsen Sverre E., Kristiansson Krister, Lederballe-Pedersen Ole, Nieminen Markku S., Omvik Per, Oparil Suzanne, Wedel Hans, Aurup Peter, Edelman Jonathan and Snapinn Steven
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet 359. 1004-1010. 2002. LIFE
http://www.sciencedirect.com/science/article/pii/S014067360208090X
Lingvay Ildiko, Guth Eve, Islam Arsalla and Livingston Edward
Rapid Improvement in Diabetes After Gastric Bypass Surgery: Is it the diet or surgery? Diabetes Care 36. 2741-2747. 2013. Bariatric
http://care.diabetesjournals.org/content/36/9/2741.abstract
Linnebjerg H., Kothare P. A., Skrivanek Z., de la Peña A., Atkins M., Ernest C. S. and Trautmann M. E.
Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes. Diabetic Medicine 23. 240-245. 2006. GLP-1
http://dx.doi.org/10.1111/j.1464-5491.2006.01800.x
Linnenkamp U., Guariguata L., Beagley J., Whiting D. R. and Cho N. H.
The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy. Diabetes research and clinical practice 103. 186-196. 2014. Epidemiology
http://linkinghub.elsevier.com/retrieve/pii/S0168822713003872?showall=true
Lipska Kasia J., Warton E. Margaret, Huang Elbert S., Moffet Howard H., Inzucchi Silvio E., Krumholz Harlan M. and Karter Andrew J.
HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes: The Diabetes and Aging Study. Diabetes Care 36. 3535-3542. 2013. The Diabetes and Aging Study
http://care.diabetesjournals.org/content/36/11/3535.abstract
Lipsky Benjamin A., Weigelt John A., Sun Xiaowu, Johannes Richard S., Derby Karen G. and Tabak Ying P.
Developing and Validating a Risk Score for Lower-Extremity Amputation in Patients Hospitalized for a Diabetic Foot Infection. Diabetes Care 34. 1695-1700. 2011. Risk Scores
http://care.diabetesjournals.org/content/34/8/1695.abstract
Lister Sam
The politics of NHS reconfiguration. British Medical Journal 343. 2011. NHS Politics
http://www.bmj.com/content/343/bmj.d5311.short
Little Stuart A., Leelarathna Lalantha, Walkinshaw Emma, Tan Horng Kai, Chapple Olivia, Lubina-Solomon Alexandra, Chadwick Thomas J., Barendse Shalleen, Stocken Deborah D., Brennand Catherine, Marshall Sally M., Wood Ruth, Speight Jane, Kerr David, Flanagan Daniel, Heller Simon R., Evans Mark L. and Shaw James A.M.
Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 × 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS). Diabetes Care 37. 2114-2122. 2014. Hypoglycaemia
http://care.diabetesjournals.org/content/37/8/2114.abstract
Liu Jiwen, Lee TaeWeon and DeFronzo Ralph A.
Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans? Diabetes 61. 2199-2204. 2012. SGLT2
http://diabetes.diabetesjournals.org/content/61/9/2199.abstract
Logue Jennifer, Walker Jeremy J., Leese Graham, Lindsay Robert, McKnight John, Morris Andrew, Philip Sam, Wild Sarah, Sattar Naveed and Group on behalf of the Scottish Diabetes Research Network Epidemiology
Association Between BMI Measured Within a Year After Diagnosis of Type 2 Diabetes and Mortality. Diabetes Care 36. 887-893. 2013. Obesity
http://care.diabetesjournals.org/content/36/4/887.abstract
Lorenzo Carlos, Wagenknecht Lynne E., Karter Andrew J., Hanley Anthony J.G., Rewers Marian J. and Haffner Steven M.
Cross-Sectional and Longitudinal Changes of Glucose Effectiveness in Relation to Glucose Tolerance. Diabetes Care 34. 1959-1964. 2011. Glucose Tolerance
http://care.diabetesjournals.org/content/34/9/1959.abstract
Lowe Lynn P., Metzger Boyd E., Dyer Alan R., Lowe Julia, McCance David R., Lappin Terence R.J., Trimble Elisabeth R., Coustan Donald R., Hadden David R., Hod Moshe, Oats Jeremy J.N., Persson Bengt and Group for the HAPO Study Cooperative Research
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35. 574-580. 2012. HAPO Study
http://care.diabetesjournals.org/content/35/3/574.abstract
Luippold G., Klein T., Mark M. and Grempler R.
Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus. Diabetes, Obesity and Metabolism 14. 601-607. 2012. SGLT2
http://dx.doi.org/10.1111/j.1463-1326.2012.01569.x
Lukashevich V., Schweizer A., Shao Q., Groop P. H. and Kothny W.
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial. Diabetes, Obesity and Metabolism 13. 947-954. 2011. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2011.01467.x
Luzio S. D., Dunseath G. J., Atkinson M. D. and Owens D. R.
A comparison of the pharmacodynamic profiles of insulin detemir and insulin glargine: A single dose clamp study in people with type 2 diabetes. Diabetes & Metabolism 39. 537-542. 2013. Insulin
MacDonald Michael R., Petrie Mark C., Home Philip D., Komajda Michel, Jones Nigel P., Beck-Nielsen Henning, Gomis Ramon, Hanefeld Markolf, Pocock Stuart J., Curtis Paula S. and McMurray John J.V.
Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes. Diabetes Care 34. 1394-1396. 2011. MI
http://care.diabetesjournals.org/content/34/6/1394.abstract
Mack C. M., Smith P. A., Athanacio J. R., Xu K., Wilson J. K., Reynolds J. M., Jodka C. M., Lu M. G. W. and Parkes D. G.
Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide. Diabetes, Obesity and Metabolism 13. 1105-1113. 2011. Davalintide
http://dx.doi.org/10.1111/j.1463-1326.2011.01465.x
Mader J. K., Neubauer K. M., Schaupp L., Augustin T., Beck P., Spat S., Höll B., Treiber G. M., Fruhwald F. M., Pieber T. R. and Plank J.
Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal–bolus insulin therapy in hospitalized type 2 diabetes patients. Diabetes, Obesity and Metabolism 16. 137-146. 2014. Insulin
http://dx.doi.org/10.1111/dom.12186
Magliano Dianna J, Davis Wendy A, Shaw Jonathan E, Bruce David G and Davis Timothy M E
Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study. European Journal of Endocrinology 167. 589-599. 2012. Fremantle Study
http://www.eje-online.org/content/167/4/589.abstract
Mak Mbbs Koon-Hou, Moliterno M. D. Facc David J., Granger M. D. Facc Christopher B., Miller M. S. Dave P., White M. B. DSc Facc Harvey D., Wilcox M. D. Facc Robert G., Califf M. D. Facc Robert M. and Topol M. D. Facc Eric J.
Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction. Journal of the American College of Cardiology 30. 171-179. 1997. GUSTO
http://www.sciencedirect.com/science/article/pii/S0735109797001186
Mäkelä Jyrki K., Schmüser Christine, Askonen Kari and Saukkonen Tero
Starting or switching to biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes: A multicenter, observational, primary care study conducted in Finland. Diabetes research and clinical practice 95. 10-18. 2012. Insulin
http://www.sciencedirect.com/science/article/pii/S0168822711003044
Mäkimattila S., Nikkilä K. and Yki-Järvinen H.
Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia 42. 406-412. 1999. Insulin
http://dx.doi.org/10.1007/s001250051172
Makrilakis K., Liatis S., Grammatikou S., Perrea D., Stathi C., Tsiligros P. and Katsilambros N.
Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes & Metabolism 37. 144-151. 2011. FINDRISC
http://www.sciencedirect.com/science/article/pii/S1262363610002326
Malandrino N., Wu W., Taveira T., Whitlatch H. and Smith R.
Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia 55. 226-235. 2012. Red Blood Cells
http://dx.doi.org/10.1007/s00125-011-2331-1
Malmberg K., Ryden L., Hamstent A., Herlitz J., Waldenstram A. and Wedel H.
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. European Heart Journal 17. 1337-1344. 1996. DIGAMI
http://eurheartj.oxfordjournals.org/content/17/9/1337.abstract
Malmberg Klas, Norhammar Anna, Wedel Hans and Ryden Lars
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study. Circulation 99. 2626-2632. 1999. DIGAMI
http://circ.ahajournals.org/content/99/20/2626.abstract
Malmberg Klas, Rydén Lars, Efendic Suad, Herlitz Johan, Nicol Peter, Waldenstrom Anders, Wedel Hans and Welin Lennart
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. Journal of the American College of Cardiology 26. 57-65. 1995. DIGAMI
http://www.sciencedirect.com/science/article/pii/073510979500126K
Manley S.
Haemoglobin A1c–a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clinical chemistry and laboratory medicine 41. 1182-1190. 2003. UKPDS
http://www.reference-global.com/doi/abs/10.1515/CCLM.2003.182
Manley S. E., Stratton I. M., Cull C. A., Frighi V., Eeley E. A., Matthews D. R., Holman R. R., Turner R. C. and Neil H. A. W.
Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). Diabetic Medicine 17. 518-523. 2000. UKPDS 45
http://dx.doi.org/10.1046/j.1464-5491.2000.00320.x
Manley SM, Meyer LC, Neil HAW, Ross IS, Turner RC and Holman RR
Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. UKPDS 6. Diabetes Res 13. 1-11. 1990. UKPDS 6
Maple-Brown L. J., Ye C. and Retnakaran R.
Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial. Diabetic Medicine 30. 95-99. 2013. DCCT
http://dx.doi.org/10.1111/dme.12004
Marcovecchio M. Loredana, Dalton R. Neil, Chiarelli Francesco and Dunger David B.
A1C Variability as an Independent Risk Factor for Microalbuminuria in Young People With Type 1 Diabetes. Diabetes Care 34. 1011-1013. 2011. HbA1c
http://care.diabetesjournals.org/content/34/4/1011.abstract
Marre M., Shaw J., Brändle M., Bebakar W. M. W., Kamaruddin N. A., Strand J., Zdravkovic M., Le Thi T. D., Colagiuri S. and on behalf of the Lead- S. U. study group
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabetic Medicine 26. 268-278. 2009. LEAD 1
http://dx.doi.org/10.1111/j.1464-5491.2009.02666.x
Marre Michel and Penfornis Alfred
GLP-1 receptor agonists today. Diabetes research and clinical practice 93. 317-327. 2011. GLP-1
http://linkinghub.elsevier.com/retrieve/pii/S0168822711000052?showall=true
Martín-Merino Elisa, Fortuny Joan, Rivero Elena and García-Rodríguez Luis Alberto
Validation of Diabetic Retinopathy and Maculopathy Diagnoses Recorded in a U.K. Primary Care Database. Diabetes Care 35. 762-767. 2012. Retinopathy
http://care.diabetesjournals.org/content/35/4/762.abstract
Matsuba Ikuro, Saito Kazumi, Takai Masahiko, Hirao Koichi and Sone Hirohito
Fasting Insulin Levels and Metabolic Risk Factors in Type 2 Diabetic Patients at the First Visit in Japan. Diabetes Care 35. 1853-1857. 2012. JDDM
http://care.diabetesjournals.org/content/35/9/1853.abstract
Matthews DR, Cull CA, Stratton IM, Holman RR and Turner RC
UKPDS 26: sulphonylurea failure in non insulin dependent diabetic patients over six years. Diabetic Medicine 15. 297-303. 1998. UKPDS 26
http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291096-9136%28199804%2915:4%3C297::AID-DIA572%3E3.0.CO;2-W/abstract
Matthews DR, Stratton IM, Aldington SJ, Holman RR and Kohner EM
Risks of Progression of Retinopathy and Vision Loss Related to Tight Blood Pressure Control in Type 2 Diabetes Mellitus: UKPDS 69. Arch Ophthalmol 122. 1631-1640. 2004. UKPDS 69
http://archopht.ama-assn.org/cgi/content/abstract/122/11/1631
McAuley Paul A., Artero Enrique G., Sui Xuemei, Lavie Carl J., Almeida M. Joao and Blair Steven N.
Fitness, Fatness, and Survival in Adults With Prediabetes. Diabetes Care 37. 529-536. 2014. IGR
http://care.diabetesjournals.org/content/37/2/529.abstract
McEwen Laura N., Karter Andrew J., Curb J. David, Marrero David G., Crosson Jesse C. and Herman William H.
Temporal Trends in Recording of Diabetes on Death Certificates. Diabetes Care 34. 1529-1533. 2011. Epidemiology
http://care.diabetesjournals.org/content/34/7/1529.abstract
McEwen Laura N., Kim Catherine, Ettner Susan L., Herman William H., Karter Andrew J., Beckles Gloria L. and Brown Arleen F.
Competing Demands for Time and Self-Care Behaviors, Processes of Care, and Intermediate Outcomes Among People With Diabetes. Diabetes Care 34. 1180-1182. 2011. Social
http://care.diabetesjournals.org/content/34/5/1180.abstract
McGill Janet B., Sloan Lance, Newman Jennifer, Patel Sanjay, Sauce Christophe, von Eynatten Maximilian and Woerle Hans-Juergen
Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study. Diabetes Care 36. 237-244. 2013. DPP4
http://care.diabetesjournals.org/content/36/2/237.abstract
McGuire D.K, Emanuelsson H, Granger C.B, Magnus Ohman E, Moliterno D.J, White H.D, Ardissino D, Box J.W, Califf R.M and Topol E.J
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study. European Heart Journal 21. 1750-1758. 2000. GUSTO-IIb
http://eurheartj.oxfordjournals.org/content/21/21/1750.abstract
McNaughton Candace D., Self Wesley H. and Slovis Corey
Diabetes in the Emergency Department: Acute Care of Diabetes Patients. Clinical Diabetes 29. 51-59. 2011. Acute Diabetes Care
http://clinical.diabetesjournals.org/content/29/2/51.abstract
Mellbin L., Malmberg K., Norhammar A., Wedel H. and Rydén L.
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study. Diabetologia 54. 1308-1317. 2011. DIGAMI 2
http://dx.doi.org/10.1007/s00125-011-2084-x
Mellbin Linda G., Bjerre Mette, Thiel Steffen and Hansen Troels K.
Complement Activation and Prognosis in Patients With Type 2 Diabetes and Myocardial Infarction. Diabetes Care 35. 911-917. 2012. MI
http://care.diabetesjournals.org/content/35/4/911.abstract
Mendez Carlos E., Mok Ki-Tae, Ata Ashar, Tanenberg Robert J., Calles-Escandon Jorge and Umpierrez Guillermo E.
Increased Glycemic Variability Is Independently Associated With Length of Stay and Mortality in Noncritically Ill Hospitalized Patients. Diabetes Care 36. 4091-4097. 2013. Inpatient
http://care.diabetesjournals.org/content/36/12/4091.abstract
Meneghini Luigi, Atkin Stephen L., Gough Stephen C.L., Raz Itamar, Blonde Lawrence, Shestakova Marina, Bain Stephen, Johansen Thue, Begtrup Kamilla, Birkeland Kåre I. and Investigators on behalf of the NN- Trial
The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes. Diabetes Care 36. 858-864. 2013. Insulin
http://care.diabetesjournals.org/content/36/4/858.abstract
Menge Björn A., Grüber Lena, Jørgensen Signe M., Deacon Carolyn F., Schmidt Wolfgang E., Veldhuis Johannes D., Holst Jens J. and Meier Juris J.
Loss of Inverse Relationship Between Pulsatile Insulin and Glucagon Secretion in Patients With Type 2 Diabetes. Diabetes 60. 2160-2168. 2011. Pulsatile Insulin
http://diabetes.diabetesjournals.org/content/60/8/2160.abstract
Miao Y., Dobre D., Lambers Heerspink H., Brenner B., Cooper M., Parving H. H., Shahinfar S., Grobbee D. and de Zeeuw D.
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia 54. 44-50. 2011. RENAAL
http://dx.doi.org/10.1007/s00125-010-1922-6
Midthjell K., Lee C. M. Y., Langhammer A., Krokstad S., Holmen T. L., Hveem K., Colagiuri S. and Holmen J.
Trends in overweight and obesity over 22 years in a large adult population: the HUNT Study, Norway. Clinical Obesity 3. 12-20. 2013. Obesity
http://dx.doi.org/10.1111/cob.12009
Mogensen Carl Erik, Neldam Steen, Tikkanen Ilkka, Oren Shmuel, Viskoper Reuven, Watts Richard W and Cooper Mark E
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. British Medical Journal 321. 1440-1444. 2000. CALM
http://www.bmj.com/content/321/7274/1440.abstract
Molitch Mark E., Steffes Michael, Sun Wanjie, Rutledge Brandy, Cleary Patricia, de Boer Ian H., Zinman Bernard, Lachin John, Interventions for the Epidemiology of Diabetes and Group Complications Study
Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 33. 1536-1543. 2010. DCCT
http://care.diabetesjournals.org/content/33/7/1536.abstract
Monami M., Ahrén B., Dicembrini I. and Mannucci E.
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes, Obesity and Metabolism 15. 112-120. 2013. DPP4
http://dx.doi.org/10.1111/dom.12000
Monami M., Dicembrini I. and Mannucci E.
Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials. Diabetes, Obesity and Metabolism 16. 48-56. 2014. Meta-analysis
http://dx.doi.org/10.1111/dom.12176
Monami M., Dicembrini I., Nardini C., Fiordelli I. and Mannucci E.
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes, Obesity and Metabolism 16. 38-47. 2014. Meta-analysis
http://dx.doi.org/10.1111/dom.12175
Monami M., Genovese S. and Mannucci E.
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials. Diabetes, Obesity and Metabolism 15. 938-953. 2013. Meta-analysis
http://dx.doi.org/10.1111/dom.12116
Monnier Louis, Colette Claude, Dunseath Gareth J. and Owens David R.
The Loss of Postprandial Glycemic Control Precedes Stepwise Deterioration of Fasting With Worsening Diabetes. Diabetes Care 30. 263-269. 2007. Postprandial
http://care.diabetesjournals.org/content/30/2/263.abstract
Montanya Eduard and Sesti Giorgio
A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus. Clinical Therapeutics 31. 2472-2488. 2009. GLP-1
http://www.sciencedirect.com/science/article/pii/S0149291809004342
Monteiro-Soares M., Boyko E. J., Ribeiro J., Ribeiro I. and Dinis-Ribeiro M.
Predictive factors for diabetic foot ulceration: a systematic review. Diabetes/Metabolism Research and Reviews 28. 574-600. 2012. Diabetic Foot
http://dx.doi.org/10.1002/dmrr.2319
Monti L. D., Setola E., Lucotti P. C. G., Marrocco-Trischitta M. M., Comola M., Galluccio E., Poggi A., Mammì S., Catapano A. L., Comi G., Chiesa R., Bosi E. and Piatti P. M.
Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial. Diabetes, Obesity and Metabolism 14. 893-900. 2012. Arginine
http://dx.doi.org/10.1111/j.1463-1326.2012.01615.x
Morden Nancy E., Liu Stephen K., Smith Jeremy, Mackenzie Todd A., Skinner Jonathan and Korc Murray
Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer. Diabetes Care 34. 1965-1971. 2011. Insulin
http://care.diabetesjournals.org/content/34/9/1965.abstract
Moretto Thomas J., Milton Denái R., Ridge Terry D., MacConell Leigh A., Okerson Ted, Wolka Anne M. and Brodows Robert G.
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug--naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study. Clinical Therapeutics 30. 1448-1460. 2008. GLP-1
http://www.sciencedirect.com/science/article/pii/S0149291808002725
Moss Scot E., Klein Ronald, Klein Barbara E. K. and Meuer Stacy M.
The Association of Glycemia and Cause-Specific Mortality in a Diabetic Population. Arch Intern Med 154. 2473-2479. 1994. Epidemiology
http://archinte.ama-assn.org/cgi/content/abstract/154/21/2473
Moxey P. W., Gogalniceanu P., Hinchliffe R. J., Loftus I. M., Jones K. J., Thompson M. M. and Holt P. J.
Lower extremity amputations — a review of global variability in incidence. Diabetic Medicine 28. 1144-1153. 2011. Meta-analysis
http://dx.doi.org/10.1111/j.1464-5491.2011.03279.x
Mukai N., Doi Y., Ninomiya T., Hata J., Hirakawa Y., Fukuhara M., Iwase M. and Kiyohara Y.
Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study. Diabetic Medicine 29. 99-106. 2012. Predicting Diabetes
http://dx.doi.org/10.1111/j.1464-5491.2011.03378.x
Multi-centre Study
UK Prospective Diabetes Study V. Characteristics of Newly presenting Type 2 Diabetic Patients: Estimated Insulin Sensitivity and Islet B-cell Function. Diabetic Medicine 5. 444-448. 1988. UKPDS 5
http://dx.doi.org/10.1111/j.1464-5491.1988.tb01025.x
Multi-centre Study
UK Prospective Diabetes Study. IV. Characteristics of Newly presenting Type 2 Diabetic Patients: Male Preponderance and Obesity at Different Ages. Diabetic Medicine 5. 154-159. 1988. UKPDS 4
http://dx.doi.org/10.1111/j.1464-5491.1988.tb00963.x
Murad Mohammad Hassan, Coburn John A., Coto-Yglesias Fernando, Dzyubak Svitlana, Hazem Ahmad, Lane Melanie A., Prokop Larry J. and Montori Victor M.
Glycemic Control in Non-Critically Ill Hospitalized Patients: A Systematic Review and Meta-Analysis. Journal of Clinical Endocrinology & Metabolism 97. 49-58. 2012. Meta-analysis
http://jcem.endojournals.org/content/97/1/49.abstract
Musacchio N., Lovagnini Scher A., Giancaterini A., Pessina L., Salis G., Schivalocchi F., Nicolucci A., Pellegrini F. and Rossi M. C. E.
Impact of a chronic care model based on patient empowerment on the management of Type 2 diabetes: effects of the SINERGIA programme. Diabetic Medicine 28. 724-730. 2011. SINERGIA
http://dx.doi.org/10.1111/j.1464-5491.2011.03253.x
Musso G., Cassader M., Rosina F. and Gambino R.
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55. 885-904. 2012. Meta-analysis
http://dx.doi.org/10.1007/s00125-011-2446-4
Mychaleckyj Josyf C., Craven Timothy, Nayak Uma, Buse John, Crouse John R., Elam Marshall, Kirchner Kent, Lorber Daniel, Marcovina Santica, Sivitz William, Sperl-Hillen JoAnn, Bonds Denise E. and Ginsberg Henry N.
Reversibility of Fenofibrate Therapy–Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants. Diabetes Care 35. 1008-1014. 2012. ACCORD
http://care.diabetesjournals.org/content/35/5/1008.abstract
Mykkanen Leena, Zaccaro Daniel J., O'Leary Daniel H., Howard George, Robbins David C. and Haffner Steven M.
Microalbuminuria and Carotid Artery Intima-Media Thickness in Nondiabetic and NIDDM Subjects : The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 28. 1710-1716. 1997. IRAS
http://stroke.ahajournals.org/content/28/9/1710.abstract
Mynarski W., Psurek A., Borek Z., Rozpara M., Grabara M. and Strojek K.
Declared and real physical activity in patients with type 2 diabetes mellitus as assessed by the International Physical Activity Questionnaire and Caltrac accelerometer monitor: A potential tool for physical activity assessment in patients with type 2 diabetes mellitus. Diabetes research and clinical practice 98. 46-50. 2012. Exercise
Nackers Lisa M., Middleton Kathryn R., Dubyak Pamela J., Daniels Michael J., Anton Stephen D. and Perri Michael G.
Effects of prescribing 1,000 versus 1,500 kilocalories per day in the behavioral treatment of obesity: A randomized trial. Obesity 21. 2481-2487. 2013. Obesity
http://dx.doi.org/10.1002/oby.20439
Nakao Yoko M., Teramukai Satoshi, Tanaka Sachiko, Yasuno Shinji, Fujimoto Akira, Kasahara Masato, Ueshima Kenji, Nakao Kazuhiro, Hinotsu Shiro, Nakao Kazuwa and Kawakami Koji
Effects of renin–angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes research and clinical practice 96. 68-75. 2012. Meta-analysis
http://www.sciencedirect.com/science/article/pii/S0168822711006656
Nasr CE, Hoogwerf BJ, Faiman C. and Reddy SS
United Kingdom Prospective Diabetes Study (UKPDS). Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus. Cleveland Clinic journal of medicine 66. 247. 1999. UKPDS
http://www.ncbi.nlm.nih.gov/pubmed/10199061/
Nathan David M., Buse John B., Davidson Mayer B., Heine Robert J., Holman Rury R., Sherwin Robert and Zinman Bernard
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Diabetes Care 29. 1963-1972. 2006. Consensus
http://care.diabetesjournals.org/content/29/8/1963.short
Nathan David M., McGee Paula, Steffes Michael W., Lachin John M. and Group the DCCT/EDIC Research
Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study. Diabetes 63. 282-290. 2014. DCCT/EDIC
http://diabetes.diabetesjournals.org/content/63/1/282.abstract
Nathanson D., Ullman B., Löfström U., Hedman A., Frick M., Sjöholm Å and Nyström T.
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety. Diabetologia 55. 926-935. 2012. GLP-1
http://dx.doi.org/10.1007/s00125-011-2440-x
Nauck M., Frid A., Hermansen K., Thomsen A. B., During M., Shah N., Tankova T., Mitha I. and Matthews D. R.
Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study. Diabetes, Obesity and Metabolism 15. 204-212. 2013. GLP-1
http://dx.doi.org/10.1111/dom.12012
Nauck M., Horton E., Andjelkovic M., Ampudia-Blasco F. J., Parusel C. T., Boldrin M., Balena R. and for the T. emerge Study Group
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial. Diabetic Medicine 30. 109-113. 2013. GLP-1
http://dx.doi.org/10.1111/dme.12003
Nauck Michael A.
A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks. Diabetes Care 36. 2126-2132. 2013. GLP-1
http://care.diabetesjournals.org/content/36/7/2126.abstract
Nauck Michael A., Del Prato Stefano, Meier Juris J., Durán-García Santiago, Rohwedder Katja, Elze Martina and Parikh Shamik J.
Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin. Diabetes Care 34. 2015-2022. 2011. SGLT2
http://care.diabetesjournals.org/content/34/9/2015.abstract
Nauck Michael, Frid Anders, Hermansen Kjeld, Shah Nalini S., Tankova Tsvetalina, Mitha Ismail H., Zdravkovic Milan, During Maria and Matthews David R.
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes. Diabetes Care 32. 84-90. 2009. GLP-1
http://care.diabetesjournals.org/content/32/1/84.abstract
Nauck Michael, Weinstock Ruth S., Umpierrez Guillermo E., Guerci Bruno, Skrivanek Zachary and Milicevic Zvonko
Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 37. 2149-2158. 2014. AWARD-5
http://care.diabetesjournals.org/content/37/8/2149.abstract
Nauta Sjoerd T., Deckers Jaap W., Akkerhuis K. Martijn and van Domburg Ron T.
Short- and Long-Term Mortality After Myocardial Infarction in Patients With and Without Diabetes. Diabetes Care 35. 2043-2047. 2012. Cardiovascular
http://care.diabetesjournals.org/content/35/10/2043.abstract
Neil H. A. W., Ceglarek U., Thiery J., Paul S., Farmer A. and Holman R. R.
Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: A randomised placebo controlled factorial trial. Atherosclerosis 213. 512-517. 2010. OMEGA
http://www.sciencedirect.com/science/article/pii/S0021915010007410
Nes Andréa A. G., van Dulmen Sandra, Eide Erlend, Finset Arnstein, Kristjánsdóttir Ólöf Birna, Steen Ida Synnøve and Eide Hilde
The development and feasibility of a web-based intervention with diaries and situational feedback via smartphone to support self-management in patients with diabetes type 2. Diabetes research and clinical practice 97. 385-393. 2012. Technology
http://linkinghub.elsevier.com/retrieve/pii/S0168822712001532?showall=true
Neumann A., Weill A., Ricordeau P., Fagot J., Alla F. and Allemand H.
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia 55. 1953-1962. 2012. Cancer
http://dx.doi.org/10.1007/s00125-012-2538-9
Newsom Sean A., Everett Allison C., Hinko Alexander and Horowitz Jeffrey F.
A Single Session of Low-Intensity Exercise Is Sufficient to Enhance Insulin Sensitivity Into the Next Day in Obese Adults. Diabetes Care 36. 2516-2522. 2013. Exercise
http://care.diabetesjournals.org/content/36/9/2516.abstract
NICECG10
Type 2 diabetes: Foot care. DoH. 2004. NICECG10
http://www.nice.org.uk/nicemedia/live/10934/29242/29242.pdf
NICECG15
Type 1 diabetes in adults: Part 1. DoH. 2004. NICECG15
http://www.nice.org.uk/nicemedia/live/10944/29393/29393.pdf
NICECG15
Type 1 diabetes: diagnosis and management of type 1diabetes in childrenand young people. DoH. 2004. NICECG15
http://www.nice.org.uk/nicemedia/live/10944/29394/29394.pdf
NICECG15
Type 1 diabetes in adults: Part 2. DoH. 2008. NICECG15
http://www.nice.org.uk/nicemedia/live/10944/29396/29396.pdf
NICECG62
Antenatal care. DoH. 2008. NICECG62
http://www.nice.org.uk/nicemedia/live/11947/40145/40145.pdf
NICECG63
Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. DoH. 2008. NICECG63
http://www.nice.org.uk/nicemedia/live/11946/41320/41320.pdf
NICECG66
Type 2 diabetes. DoH. 2008. NICECG66
http://www.nice.org.uk/nicemedia/live/11983/40803/40803.pdf
NICECG87
Type 2 diabetes: newer agents DoH. 2009. NICECG87
http://www.nice.org.uk/nicemedia/live/12165/44318/44318.pdf
NICECG114
Anaemia management in chronic kidney disease. DoH. 2011. NICECG114
http://www.nice.org.uk/nicemedia/live/13329/52851/52851.pdf
NICECG119
Diabetic foot problems: Inpatient management of diabetic foot problems DoH. 2011. NICECG119
http://www.nice.org.uk/nicemedia/live/13416/53556/53556.pdf
NICECGTA53
Guidance on the use oflong-acting insulin analoguesfor thetreatment ofdiabetes – insulin glargine. DoH. 2002. NICECGTA53
http://guidance.nice.org.uk/TA53/Guidance/pdf/English
NICECGTA60
Guidance on the use of patient-education models for diabetes. DoH. 2003. NICECGTA60
http://www.nice.org.uk/nicemedia/live/11496/32610/32610.pdf
NICECGTA151
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus DoH. 2003. NICECGTA151
http://www.nice.org.uk/nicemedia/live/12014/41300/41300.pdf
NICETA203
Liraglutide for treatment of Diabetes Type 2. DoH. 2010. NICETA203
http://www.nice.org.uk/nicemedia/live/13248/51259/51259.pdf
Nichols Gregory A., Kimes Teresa M., Harp Joyce B., Kou Tzuyung Doug and Brodovicz Kimberly G.
Glycemic Response and Attainment of A1C Goals Following Newly Initiated Insulin Therapy for Type 2 Diabetes. Diabetes Care 35. 495-497. 2012. HbA1c
http://care.diabetesjournals.org/content/35/3/495.abstract
Nichols Gregory A., Vupputuri Suma and Lau Helen
Medical Care Costs Associated With Progression of Diabetic Nephropathy. Diabetes Care 34. 2374-2378. 2011. Nephropathy
http://care.diabetesjournals.org/content/34/11/2374.abstract
Nicolucci A., Balducci S., Cardelli P., Cavallo S., Fallucca S., Bazuro A., Simonelli P., Iacobini C., Zanuso S., Pugliese G. and Investigators for the Italian Diabetes Exercise Study
Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES). Diabetologia 55. 579-588. 2012. IDES
http://dx.doi.org/10.1007/s00125-011-2425-9
Nirantharakumar K., Chen Y. F., Marshall T., Webber J. and Coleman J. J.
Clinical decision support systems in the care of inpatients with diabetes in non-critical care setting: systematic review. Diabetic Medicine 29. 698-708. 2012. Review
http://dx.doi.org/10.1111/j.1464-5491.2011.03540.x
Nissen Steven E., Nicholls Stephen J., Wolski Kathy, Nesto Richard, Kupfer Stuart, Perez Alfonso, Jure Horacio, De Larochellière Robert, Staniloae Cezar S., Mavromatis Kreton, Saw Jacqueline, Hu Bo, Lincoff A. Michael and Tuzcu E. Murat
Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes. The Journal of the American Medical Association 299. 1561-1573. 2008. OHGA
http://jama.ama-assn.org/content/299/13/1561.abstract
Niswender K., Pi-Sunyer X., Buse J., Jensen K. H., Toft A. D., Russell-Jones D. and Zinman B.
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme. Diabetes, Obesity and Metabolism 15. 42-54. 2013. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2012.01673.x
Niswender K., Piletic M., Andersen H., Conradsen Hiort L. and Hollander P.
Weight change upon once-daily initiation of insulin detemir with or without dietary intervention in overweight or obese insulin-naïve individuals with type 2 diabetes: results from the DIET trial. Diabetes, Obesity and Metabolism 16. 186-192. 2014. Insulin
http://dx.doi.org/10.1111/dom.12218
Nyazee Humaa A., Finney Kristina M., Sarikonda Molly, Towler Dwight A., Johnson Jeffrey E. and Babcock Hilary M.
Diabetic foot osteomyelitis: Bone markers and treatment outcomes. Diabetes research and clinical practice 97. 411-417. 2012. Diabetic Foot
O'Connor Patrick J., Bodkin Noni L., Fradkin Judith, Glasgow Russell E., Greenfield Sheldon, Gregg Edward, Kerr Eve A., Pawlson L. Gregory, Selby Joseph V., Sutherland John E., Taylor Michael L. and Wysham Carol H.
Consensus Report: Diabetes Performance Measures: Current Status and Future Directions. Clinical Diabetes 29. 102-112. 2011. Consensus
http://clinical.diabetesjournals.org/content/29/3/102.short
O’Connor Patrick J., Narayan K.M. Venkat, Anderson Roger, Feeney Patricia, Fine Larry, Ali Mohammed K., Simmons Debra L., Hire Don G., Sperl-Hillen JoAnn M., Katz Lois Anne, Margolis Karen L. and Sullivan Mark D.
Effect of Intensive Versus Standard Blood Pressure Control on Depression and Health-Related Quality of Life in Type 2 Diabetes. Diabetes Care 35. 1479-1481. 2012. ACCORD
http://care.diabetesjournals.org/content/35/7/1479.abstract
Ohkubo Yasuo, Kishikawa Hideki, Araki Eiichi, Miyata Takao, Isami Satoshi, Motoyoshi Sadatoshi, Kojima Yujiro, Furuyoshi Naohiko and Shichiri Motoaki
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes research and clinical practice 28. 103-117. 1995. Insulin
http://www.sciencedirect.com/science/article/pii/016882279501064K
Ojo O. O., Abdel-Wahab Y. H. A., Flatt P. R., Mechkarska M. and Conlon J. M.
Tigerinin-1R: a potent, non-toxic insulin-releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus. Diabetes, Obesity and Metabolism 13. 1114-1122. 2011. Tigerinin-1R
http://dx.doi.org/10.1111/j.1463-1326.2011.01470.x
Okada Hiroshi, Fukui Michiaki, Tanaka Muhei, Matsumoto Shinobu, Mineoka Yusuke, Nakanishi Naoko, Asano Mai, Yamazaki Masahiro, Hasegawa Goji and Nakamura Naoto
Visit-to-Visit Blood Pressure Variability Is a Novel Risk Factor for the Development and Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes. Diabetes Care 36. 1908-1912. 2013. Nephropathy
http://care.diabetesjournals.org/content/36/7/1908.abstract
Okada Sadanori, Morimoto Takeshi, Ogawa Hisao, Kanauchi Masao, Nakayama Masafumi, Uemura Shiro, Doi Naofumi, Jinnouchi Hideaki, Waki Masako, Soejima Hirofumi, Sakuma Mio, Saito Yoshihiko and Investigators for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes Trial
Differential Effect of Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Diabetes Management. Diabetes Care 34. 1277-1283. 2011. JPAD
http://care.diabetesjournals.org/content/34/6/1277.abstract
Oke J. L., Stevens R. J., Gaitskell K. and Farmer A. J.
Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model. Diabetic Medicine 29. 266-271. 2012. HbA1c
http://dx.doi.org/10.1111/j.1464-5491.2011.03412.x
Olsson J., Lindberg G., Gottsäter M., Lindwall K., Sjöstrand Å, Tisell A. and Melander A.
Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study. Diabetologia 43. 558-560. 2000. Epidemiology
http://dx.doi.org/10.1007/s001250051343
Olsson Lisa, Ahlbom Anders, Grill Valdemar, Midthjell Kristian and Carlsson Sofia
High Levels of Education Are Associated With an Increased Risk of Latent Autoimmune Diabetes in Adults. Diabetes Care 34. 102-107. 2011. LADA
http://care.diabetesjournals.org/content/34/1/102.abstract
Oomichi Takeshi, Emoto Masanori, Tabata Tsutomu, Morioka Tomoaki, Tsujimoto Yoshihiro, Tahara Hideki, Shoji Tetsuo and Nishizawa Yoshiki
Impact of Glycemic Control on Survival of Diabetic Patients on Chronic Regular Hemodialysis. Diabetes Care 29. 1496-1500. 2006. Haemodialysis
http://care.diabetesjournals.org/content/29/7/1496.abstract
Oranta Olli, Pahkala Katja, Ruottinen Soile, Niinikoski Harri, Lagström Hanna, Viikari Jorma S.A., Jula Antti, Loo Britt-Marie, Simell Olli, Rönnemaa Tapani and Raitakari Olli T.
Infancy-Onset Dietary Counseling of Low-Saturated-Fat Diet Improves Insulin Sensitivity in Healthy Adolescents 15–20 Years of Age: The Special Turku Coronary Risk Factor Intervention Project (STRIP) study. Diabetes Care 36. 2952-2959. 2013. STRIP Study
http://care.diabetesjournals.org/content/36/10/2952.abstract
Östenson C. G., Geelhoed-Duijvestijn P., Lahtela J., Weitgasser R., Markert Jensen M. and Pedersen-Bjergaard U.
Self-reported non-severe hypoglycaemic events in Europe. Diabetic Medicine 31. 92-101. 2014. Hypoglycaemia
http://dx.doi.org/10.1111/dme.12261
Östgren C. J., Sundström J., Svennblad B., Lohm L., Nilsson P. M. and Johansson G.
Associations of HbA1c and educational level with risk of cardiovascular events in 32 871 drug-treated patients with Type 2 diabetes: a cohort study in primary care. Diabetic Medicine 30. e170-e177. 2013. HbA1c
Pajunen P., Peltonen M., Eriksson J. G., Ilanne-Parikka P., Aunola S., Keinänen-Kiukaanniemi S., Uusitupa M., Tuomilehto J., Lindström J. and for the Finnish Diabetes Prevention Study
HbA1c in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabetic Medicine 28. 36-42. 2011. FDPS
http://dx.doi.org/10.1111/j.1464-5491.2010.03183.x
Parkin Christopher G., Hinnen Deborah A. and Tetrick David L.
Effective Use of Structured Self-Management of Blood Glucose in Type 2 Diabetes: Lessons From the STeP Study. Clinical Diabetes 29. 131-138. 2011. STeP Study
http://clinical.diabetesjournals.org/content/29/4/131.abstract
Parving Hans-Henrik, Lehnert Hendrik, Bröchner-Mortensen Jens, Gomis Ramon, Andersen Steen and Arner Peter
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes. New England Journal of Medicine 345. 870-878. 2001. ARB
http://www.nejm.org/doi/full/10.1056/NEJMoa011489
Parving Hans-Henrik, Persson Frederik, Lewis Julia B., Lewis Edmund J. and Hollenberg Norman K.
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy. New England Journal of Medicine 358. 2433-2446. 2008. Nephropathy
http://www.nejm.org/doi/full/10.1056/NEJMoa0708379
Patterson Chris, Guariguata Leonor, Dahlquist Gisela, Soltész Gyula, Ogle Graham and Silink Martin
Diabetes in the young – a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes research and clinical practice 103. 161-175. 2014. Epidemiology
http://linkinghub.elsevier.com/retrieve/pii/S0168822713003884?showall=true
Paul S., Best J., Klein K., Han J. and Maggs D.
Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide*. Diabetes, Obesity and Metabolism 14. 826-834. 2012. Obesity
http://dx.doi.org/10.1111/j.1463-1326.2012.01609.x
Pedersen Terje R., Olsson Anders G., Færgeman Ole, Kjekshus John, Wedel Hans, Berg Kare, Wilhelmsen Lars, Haghfelt Torben, Thorgeirsson Gudmundur, Pyorala Kalevi, Miettinen Tatu, Christophersen Bjorn, Tobert Jonathan A., Musliner Thomas A. and Cook Thomas J.
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S). Circulation 97. 1453-1460. 1998. 4S
http://circ.ahajournals.org/content/97/15/1453.abstract
Pedersen TR, Kjekshus J., Berg K., Haghfelt T., Faergeman O. and Thorgeirsson G.
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344. 1383-1389. 1994. 4S
http://fisher.nhri.org.tw/~Chinfu/course/2007spr/reference/084S.pdf
Pendergrass M., Fenton C., Haffner S. M. and Chen W.
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis. Diabetes, Obesity and Metabolism 14. 596-600. 2012. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2012.01567.x
Penfornis A., Bourdel-Marchasson I., Quere S. and Dejager S.
Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: The HYPOCRAS study. Diabetes & Metabolism 38. 550-557. 2012. HYPOCRAS Study
http://www.sciencedirect.com/science/article/pii/S1262363612001218
Penno Giuseppe, Solini Anna, Bonora Enzo, Fondelli Cecilia, Orsi Emanuela, Zerbini Gianpaolo, Morano Susanna, Cavalot Franco, Lamacchia Olga, Laviola Luigi, Nicolucci Antonio, Pugliese Giuseppe, Insufficiency for the Renal and Group Cardiovascular Events Study
HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Care 36. 2301-2310. 2013. HbA1c
http://care.diabetesjournals.org/content/36/8/2301.abstract
Peyrot M., Harshaw Q., Shillington A. C., Xu Y. and Rubin R. R.
Validation of a tool to assess medication treatment satisfaction in patients with Type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ). Diabetic Medicine 29. 1060-1066. 2012. Assessment
http://dx.doi.org/10.1111/j.1464-5491.2011.03538.x
Pfister R., Cairns R., Erdmann E., Schneider C. A. and on behalf of the PROactive investigators
Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study. Diabetic Medicine 28. 1206-1212. 2011. PROactive
http://dx.doi.org/10.1111/j.1464-5491.2011.03281.x
Phung O. J., Sood N. A., Sill B. E. and Coleman C. I.
Oral anti-diabetic drugs for the prevention of Type 2 diabetes. Diabetic Medicine 28. 948-964. 2011. Prevention
http://dx.doi.org/10.1111/j.1464-5491.2011.03303.x
Pignone M.
Bariatric Surgery Reduces the Need for Glycemic Control Medications and Related Health Care Costs. Clinical Diabetes 29. 34. 2011. Bariatric
http://clinical.diabetesjournals.org/content/29/1/34.extract
Pignone Michael
High-Protein and Low-Glycemic Diets Improve Weight Maintenance Among Overweight Adults. Clinical Diabetes 29. 73-74. 2011. Diet
http://clinical.diabetesjournals.org/content/29/2/73.short
Pirags V., Lebovitz H. and Fouqueray P.
Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients. Diabetes, Obesity and Metabolism 14. 852-858. 2012. Glimin
http://dx.doi.org/10.1111/j.1463-1326.2012.01611.x
Pollock R. F., Muduma G. and Valentine W. J.
Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK. Diabetes, Obesity and Metabolism 15. 121-129. 2013. Bariatric
http://dx.doi.org/10.1111/j.1463-1326.2012.01692.x
Polonsky William H., Fisher Lawrence, Schikman Charles H., Hinnen Deborah A., Parkin Christopher G., Jelsovsky Zhihong, Petersen Bettina, Schweitzer Matthias and Wagner Robin S.
Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes. Diabetes Care 34. 262-267. 2011. Monitoring
http://care.diabetesjournals.org/content/34/2/262.abstract
Pontiroli A. E., Miele L. and Morabito A.
Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis. Diabetes, Obesity and Metabolism 14. 433-446. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1463-1326.2011.01543.x
Pop-Busui Rodica, Evans Gregory W., Gerstein Hertzel C., Fonseca Vivian, Fleg Jerome L., Hoogwerf Byron J., Genuth Saul, Grimm Richard H., Corson Marshall A., Prineas Ronald and Group the ACCORD Study
Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Diabetes Care 33. 1578-1584. 2010. ACCORD
http://care.diabetesjournals.org/content/33/7/1578.abstract
Pornet Carole, Bourdel-Marchasson Isabelle, Lecomte Pierre, Eschwège Eveline, Romon Isabelle, Fosse Sandrine, Assogba Frank, Roudier Candice and Fagot-Campagna Anne
Trends in the quality of care for elderly people with type 2 diabetes: The need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys). Diabetes & Metabolism 37. 152-161. 2011. ENTRED
http://www.sciencedirect.com/science/article/pii/S1262363611000371
Power Chris and Thomas Claudia
Changes in BMI, Duration of Overweight and Obesity, and Glucose Metabolism: 45 Years of Follow-up of a Birth Cohort. Diabetes Care 34. 1986-1991. 2011. Obesity
http://care.diabetesjournals.org/content/34/9/1986.abstract
Pratley Richard E., Nauck Michael A., Bailey Timothy, Montanya Eduard, Filetti Sebastiano, Garber Alan J., Thomsen Anne B., Furber Sabina, Davies Melanie and Group for the -LIRA-DPP-4 Study
Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes. Diabetes Care 35. 1986-1993. 2012. GLP-1
http://care.diabetesjournals.org/content/35/10/1986.abstract
Pratley Richard E., Nauck Michael, Bailey Timothy, Montanya Eduard, Cuddihy Robert, Filetti Sebastiano, Thomsen Anne Bloch, Søndergaard Rie Elvang and Davies Melanie
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. The Lancet 375. 1447-1456. 2010. GLP-1
http://www.sciencedirect.com/science/article/pii/S0140673610603078
Pruhova Stepanka, Dusatkova Petra, Neumann David, Hollay Erik, Cinek Ondrej, Lebl Jan and Sumnik Zdenek
Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: Is it time to change the diagnostic criteria for MODY? Diabetes Care 36. 2573-2574. 2013. MODY
http://care.diabetesjournals.org/content/36/9/2573.abstract
Punthakee Zubin, Miller Michael E., Launer Lenore J., Williamson Jeff D., Lazar Ronald M., Cukierman-Yaffee Tali, Seaquist Elizabeth R., Ismail-Beigi Faramarz, Sullivan Mark D., Lovato Laura C., Bergenstal Richard M., Gerstein Hertzel C., Investigators for the ACCORD Group of and Investigators the ACCORD-MIND
Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes. Diabetes Care 35. 787-793. 2012. Hypoglycaemia
http://care.diabetesjournals.org/content/35/4/787.abstract
Punthakee Zubin, Miller MichaelE, Simmons DebraL, Riddle MatthewC, Ismail-Beigi Faramarz, Brillon DavidJ, Bergenstal RichardM, Savage PeterJ, Hramiak Irene, Largay JosephF, Sood Ajay and Gerstein HertzelC
Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial. Diabetologia 57. 2030-2037. 2014. ACCORD
Raccah D., Haak T. J., Huet D., Monnier L., Robertson D., Labard P., Soler J. and Penfornis A.
Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: Results of the OSIRIS study. Diabetes & Metabolism 38. 507-514. 2012. OSIRIS Study
http://www.sciencedirect.com/science/article/pii/S1262363612001577
Radermecker R. P., Fayolle C., Brun J. F., Bringer J. and Renard E.
Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion. Diabetes & Metabolism 39. 258-262. 2013. CSII
http://www.sciencedirect.com/science/article/pii/S1262363613000116
Rahman M., Simmons R., Hennings S., Wareham N. and Griffin S.
How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort. Diabetologia 55. 1651-1659. 2012. Ely
http://dx.doi.org/10.1007/s00125-011-2441-9
Rajput Rajesh, YogeshYadav, Rajput Meena and Nanda Smiti
Utility of HbA1c for diagnosis of gestational diabetes mellitus. Diabetes research and clinical practice 98. 104-107. 2012. HbA1c
http://linkinghub.elsevier.com/retrieve/pii/S0168822712000861?showall=true
Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes. Diabetes Care 35. 749-753. 2012. HbA1c
http://care.diabetesjournals.org/content/35/4/749.abstract
Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population: Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Diabetes Care 35. 2527-2532. 2012. HbA1c
http://care.diabetesjournals.org/content/35/12/2527.abstract
Differences in Prevalence, Extent, Severity, and Prognosis of Coronary Artery Disease Among Patients With and Without Diabetes Undergoing Coronary Computed Tomography Angiography. Diabetes Care 35. 1787-1794. 2012. Cardiovascular
http://care.diabetesjournals.org/content/35/8/1787.abstract
How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients’ self-management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) course. Diabetic Medicine 28. 532-538. 2011. DAFNE
http://dx.doi.org/10.1111/j.1464-5491.2011.03243.x
Rathmann W., Kostev K., Gruenberger J. B., Dworak M., Bader G. and Giani G.
Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis. Diabetes, Obesity and Metabolism 15. 55-61. 2013. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2012.01674.x
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes, Obesity and Metabolism 15. 175-184. 2013. Insulin
http://dx.doi.org/10.1111/dom.12032
Ratner R., Wynne A., Nakhle S., Brusco O., Vlajnic A. and Rendell M.
Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096). Diabetes, Obesity and Metabolism 13. 1142-1148. 2011. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01478.x
Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D project. Diabetic Medicine 29. 207-211. 2012. FIN-D2D Project
http://dx.doi.org/10.1111/j.1464-5491.2011.03388.x
Ravid Mordchai, Lang Ruth, Rachmani Rita and Lishner Michael
Long-term Renoprotective Effect of Angiotensin-converting Enzyme Inhibition in Non--insulin-dependent Diabetes Mellitus: A 7-Year Follow-up Study. Archives of internal medicine 156. 286-289. 1996. ACE
http://archinte.ama-assn.org/cgi/content/abstract/156/3/286
The Ipswich Touch Test. Diabetes Care 34. 1517-1518. 2011. IpTT
http://care.diabetesjournals.org/content/34/7/1517.abstract
Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment. Diabetes Care 35. 485-487. 2012. Taspoglutide
http://care.diabetesjournals.org/content/35/3/485.abstract
Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial. Diabetes Care 32. 381-386. 2009. HEART2D
http://care.diabetesjournals.org/content/32/3/381.abstract
Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: The SWING study. Diabetes research and clinical practice 97. 231-241. 2012. SWING Study
http://linkinghub.elsevier.com/retrieve/pii/S0168822712000927?showall=true
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects. Diabetes 60. 1938-1945. 2011. RISC
http://diabetes.diabetesjournals.org/content/60/7/1938.abstract
Reichard Per, Nilsson Bengt-Yngve and Rosenqvist Urban
The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus. New England Journal of Medicine 329. 304-309. 1993. Insulin
http://www.nejm.org/doi/full/10.1056/NEJM199307293290502
Duration of Abdominal Obesity Beginning in Young Adulthood and Incident Diabetes Through Middle Age: The CARDIA Study. Diabetes Care 36. 1241-1247. 2013. Obesity
http://care.diabetesjournals.org/content/36/5/1241.abstract
Retnakaran Ravi, Cull Carole A., Thorne Kerensa I., Adler Amanda I. and Holman Rury R.
Risk Factors for Renal Dysfunction in Type 2 Diabetes. UKPDS 74. Diabetes 55. 1832-1839. 2006. UKPDS 74
http://diabetes.diabetesjournals.org/content/55/6/1832.abstract
The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice. Diabetes research and clinical practice 98. 38-45. 2012. GIANT Study
http://linkinghub.elsevier.com/retrieve/pii/S0168822712002173?showall=true
Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial. Diabetes Care 36. 422-428. 2013. ACCORD
http://care.diabetesjournals.org/content/36/2/422.abstract
Rhee N. A., Vilsbøll T. and Knop F. K.
Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes. Diabetes, Obesity and Metabolism 14. 291-298. 2012. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2011.01505.x
Rhoads G. G., Dain M. P., Zhang Q. and Kennedy L.
Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes. Diabetes, Obesity and Metabolism 13. 711-717. 2011. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01394.x
Richard J. L., Almasri M. and Schuldiner S.
Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia 55. 1258-1264. 2012. Review
http://dx.doi.org/10.1007/s00125-012-2507-3
Management of patients hospitalized for diabetic foot infection: Results of the French OPIDIA study. Diabetes & Metabolism 37. 208-215. 2011. Inpatient
http://www.sciencedirect.com/science/article/pii/S1262363610002429
Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes. Diabetes 61. 708-715. 2012. Nephropathy
http://diabetes.diabetesjournals.org/content/61/3/708.abstract
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L). Diabetes Care 36. 2489-2496. 2013. GLP-1
http://care.diabetesjournals.org/content/36/9/2489.abstract
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1). Diabetes Care 36. 2497-2503. 2013. GLP-1
http://care.diabetesjournals.org/content/36/9/2497.abstract
Riddle Matthew C. and Karl Diane M.
Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes. Diabetes Care 35. 2100-2107. 2012. ACCORD
http://care.diabetesjournals.org/content/35/10/2100.short
Riddle Matthew C., Rosenstock Julio and Gerich John
The Treat-to-Target Trial. Diabetes Care 26. 3080-3086. 2003. Treat-to-Target Trial
http://care.diabetesjournals.org/content/26/11/3080.abstract
Ringholm L., Pedersen-Bjergaard U., Thorsteinsson B., Damm P. and Mathiesen E. R.
Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabetic Medicine 29. 558-566. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1464-5491.2012.03604.x
Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens. Diabetes Care 35. 965-971. 2012. Insulin
http://care.diabetesjournals.org/content/35/5/965.abstract
The effect of the Talking Diabetes consulting skills intervention on glycaemic control and quality of life in children with type 1 diabetes: cluster randomised controlled trial (DEPICTED study). British Medical Journal 344. 2012. DEPICTED
http://www.bmj.com/content/344/bmj.e2359
Roche Madonna M. and Wang Peizhong Peter
Sex Differences in All-Cause and Cardiovascular Mortality, Hospitalization for Individuals With and Without Diabetes, and Patients With Diabetes Diagnosed Early and Late. Diabetes Care 36. 2582-2590. 2013. CVD
http://care.diabetesjournals.org/content/36/9/2582.abstract
Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial. Diabetic Medicine 30. 1298-1304. 2013. Insulin
http://dx.doi.org/10.1111/dme.12303
Use of an Automated Decision Support Tool Optimizes Clinicians’ Ability to Interpret and Appropriately Respond to Structured Self-Monitoring of Blood Glucose Data. Diabetes Care 35. 693-698. 2012. Decision Support Tool
http://care.diabetesjournals.org/content/35/4/693.abstract
Estimation of the Glycation Gap in Diabetic Patients With Stable Glycemic Control. Diabetes Care 35. 2447-2450. 2012. HbA1c
http://care.diabetesjournals.org/content/35/12/2447.abstract
Rogers H. A., de Zoysa N. and Amiel S. A.
Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned? Diabetic Medicine 29. 321-327. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1464-5491.2011.03444.x
Romain A. J., Bernard P., Attalin V., Gernigon C., Ninot G. and Avignon A.
Health-related quality of life and stages of behavioural change for exercise in overweight/obese individuals. Diabetes & Metabolism 38. 352-358. 2012. QoL
http://www.sciencedirect.com/science/article/pii/S1262363612000511
Cardiovascular Events After Bariatric Surgery in Obese Subjects With Type 2 Diabetes. Diabetes Care 35. 2613-2617. 2012. Bariatric
http://care.diabetesjournals.org/content/35/12/2613.abstract
Ten-year incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes. Diabetes research and clinical practice 94. 126-132. 2011. Retinopathy
http://linkinghub.elsevier.com/retrieve/pii/S0168822711003548?showall=true
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes. Diabetic Medicine 28. 464-469. 2011. DPP4
http://dx.doi.org/10.1111/j.1464-5491.2010.03181.x
Rosenstock J., Seman L. J., Jelaska A., Hantel S., Pinnetti S., Hach T. and Woerle H. J.
Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia. Diabetes, Obesity and Metabolism 15. 1154-1160. 2013. SGLT2
http://dx.doi.org/10.1111/dom.12185
The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes: The T-emerge 2 trial. Diabetes Care 36. 498-504. 2013. GLP-1
http://care.diabetesjournals.org/content/36/3/498.abstract
Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study. Diabetes Care 36. 522-528. 2013. Insulin
http://care.diabetesjournals.org/content/36/3/522.abstract
Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X). Diabetes Care 36. 2945-2951. 2013. GLP-1
http://care.diabetesjournals.org/content/36/10/2945.abstract
Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes. Diabetes Care 35. 955-958. 2012. GLP-1
http://care.diabetesjournals.org/content/35/5/955.abstract
Rosenstock Julio, Vico Marisa, Wei Li, Salsali Afshin and List James F.
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy. Diabetes Care 35. 1473-1478. 2012. SGLT2
http://care.diabetesjournals.org/content/35/7/1473.abstract
Quality of Diabetes Care Predicts the Development of Cardiovascular Events: Results of the AMD-QUASAR Study. Diabetes Care 34. 347-352. 2011. AMD-QUASAR
http://care.diabetesjournals.org/content/34/2/347.abstract
The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We? Clinical Diabetes 30. 44-53. 2012. Review
http://clinical.diabetesjournals.org/content/30/2/44.abstract
Rothberg Amy E., McEwen Laura N., Fraser Tom, Burant Charles F. and Herman William H.
The impact of a managed care obesity intervention on clinical outcomes and costs: A prospective observational study. Obesity 21. 2157-2162. 2013. Obesity
http://dx.doi.org/10.1002/oby.20597
Rowe Michael W., Bergman Richard N., Wagenknecht Lynne E. and Kolberg Janice A.
Performance of a multi-marker Diabetes Risk Score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi-ethnic US cohort. Diabetes/Metabolism Research and Reviews 28. 519-526. 2012. IRAS
http://dx.doi.org/10.1002/dmrr.2305
Roy T., Lloyd C. E., Pouwer F., Holt R. I. G. and Sartorius N.
Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabetic Medicine 29. 164-175. 2012. Review
http://dx.doi.org/10.1111/j.1464-5491.2011.03401.x
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia 55. 51-62. 2012. Insulin
http://dx.doi.org/10.1007/s00125-011-2312-4
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia 52. 2046-2055. 2009. LEAD 5
http://dx.doi.org/10.1007/s00125-009-1472-y
Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4). Diabetes Care 35. 252-258. 2012. DURATION-4
http://care.diabetesjournals.org/content/35/2/252.abstract
Ryder REJ, T
Raccah D., Haak T. J., Huet D., Monnier L., Robertson D., Labard P., Soler J. and Penfornis A.
Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: Results of the OSIRIS study. Diabetes & Metabolism 38. 507-514. 2012. OSIRIS Study
http://www.sciencedirect.com/science/article/pii/S1262363612001577
Radermecker R. P., Fayolle C., Brun J. F., Bringer J. and Renard E.
Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion. Diabetes & Metabolism 39. 258-262. 2013. CSII
http://www.sciencedirect.com/science/article/pii/S1262363613000116
Rahman M., Simmons R., Hennings S., Wareham N. and Griffin S.
How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort. Diabetologia 55. 1651-1659. 2012. Ely
http://dx.doi.org/10.1007/s00125-011-2441-9
Rajendran R. and Rayman G.
Serious harm from inpatient hypoglycaemia: a survey of hospitals in the UK. Diabetic Medicine 31. 1218-1221. 2014. Hypoglycaemia
http://dx.doi.org/10.1111/dme.12457
Rajput Rajesh, YogeshYadav, Rajput Meena and Nanda Smiti
Utility of HbA1c for diagnosis of gestational diabetes mellitus. Diabetes research and clinical practice 98. 104-107. 2012. HbA1c
http://linkinghub.elsevier.com/retrieve/pii/S0168822712000861?showall=true
Ramachandran Ambady, Riddle Matthew C., Kabali Conrad, Gerstein Hertzel C. and Investigators on behalf of the ORIGIN
Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes. Diabetes Care 35. 749-753. 2012. HbA1c
http://care.diabetesjournals.org/content/35/4/749.abstract
Ramirez Sylvia Paz B., McCullough Keith P., Thumma Jyothi R., Nelson Robert G., Morgenstern Hal, Gillespie Brenda W., Inaba Masaaki, Jacobson Stefan H., Vanholder Raymond, Pisoni Ronald L., Port Fritz K. and Robinson Bruce M.
Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population: Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Diabetes Care 35. 2527-2532. 2012. HbA1c
http://care.diabetesjournals.org/content/35/12/2527.abstract
Rana Jamal S., Dunning Allison, Achenbach Stephan, Al-Mallah Mouaz, Budoff Matthew J., Cademartiri Filippo, Callister Tracy Q., Chang Hyuk-Jae, Cheng Victor Y., Chinnaiyan Kavitha, Chow Benjamin J.W., Cury Ricardo, Delago Augustin, Feuchtner Gudrun, Hadamitzky Martin, Hausleiter Jörg, Kaufmann Philipp, Karlsberg Ronald P., Kim Yong-Jin, Leipsic Jonathon, Labounty Troy M., Lin Fay Y., Maffei Erica, Raff Gilbert, Villines Todd C., Shaw Leslee J., Berman Daniel S. and Min James K.
Differences in Prevalence, Extent, Severity, and Prognosis of Coronary Artery Disease Among Patients With and Without Diabetes Undergoing Coronary Computed Tomography Angiography. Diabetes Care 35. 1787-1794. 2012. Cardiovascular
http://care.diabetesjournals.org/content/35/8/1787.abstract
Rankin D., Cooke D. D., Clark M., Heller S., Elliott J., Lawton J. and for the U. K. Nihr Dafne Study Group
How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients’ self-management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) course. Diabetic Medicine 28. 532-538. 2011. DAFNE
http://dx.doi.org/10.1111/j.1464-5491.2011.03243.x
Rathmann W., Kostev K., Gruenberger J. B., Dworak M., Bader G. and Giani G.
Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis. Diabetes, Obesity and Metabolism 15. 55-61. 2013. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2012.01674.x
Ratner R. E., Gough S. C. L., Mathieu C., Del Prato S., Bode B., Mersebach H., Endahl L. and Zinman B.
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes, Obesity and Metabolism 15. 175-184. 2013. Insulin
http://dx.doi.org/10.1111/dom.12032
Ratner R., Wynne A., Nakhle S., Brusco O., Vlajnic A. and Rendell M.
Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096). Diabetes, Obesity and Metabolism 13. 1142-1148. 2011. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01478.x
Rautio N., Jokelainen J., Oksa H., Saaristo T., Peltonen M., Puolijoki H., Tuomilehto J., Vanhala M., Moilanen L., Uusitupa M. and Keinänen-Kiukaanniemi S.
Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D project. Diabetic Medicine 29. 207-211. 2012. FIN-D2D Project
http://dx.doi.org/10.1111/j.1464-5491.2011.03388.x
Ravid Mordchai, Lang Ruth, Rachmani Rita and Lishner Michael
Long-term Renoprotective Effect of Angiotensin-converting Enzyme Inhibition in Non--insulin-dependent Diabetes Mellitus: A 7-Year Follow-up Study. Archives of internal medicine 156. 286-289. 1996. ACE
http://archinte.ama-assn.org/cgi/content/abstract/156/3/286
Rayman Gerry, Vas Prashanth R., Baker Neil, Taylor, Charles G., Gooday Catherine, Alder Amanda I. and Donohoe Mollie
The Ipswich Touch Test. Diabetes Care 34. 1517-1518. 2011. IpTT
http://care.diabetesjournals.org/content/34/7/1517.abstract
Raz Itamar, Bhatt Deepak L., Hirshberg Boaz, Mosenzon Ofri, Scirica Benjamin M., Umez-Eronini Amarachi, Im KyungAh, Stahre Christina, Buskila Alona, Iqbal Nayyar, Greenberger Norton and Lerch Markus M.
Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin. Diabetes Care 37. 2435-2441. 2014. SAVOR-TIMI 53
http://care.diabetesjournals.org/content/37/9/2435.abstract
Raz Itamar, Fonseca Vivian, Kipnes Mark, Durrwell Laurence, Hoekstra John, Boldrin Mark and Balena Raffaella
Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment. Diabetes Care 35. 485-487. 2012. Taspoglutide
http://care.diabetesjournals.org/content/35/3/485.abstract
Raz Itamar, Wilson Peter W.F., Strojek Krzysztof, Kowalska Irina, Bozikov Velimir, Gitt Anselm K., Jermendy Gyorgy, Campaigne Barbara N., Kerr Lisa, Milicevic Zvonko and Jacober Scott J.
Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial. Diabetes Care 32. 381-386. 2009. HEART2D
http://care.diabetesjournals.org/content/32/3/381.abstract
Reaney Matthew, Cypryk Katarzyna, Tentolouris Nicholas, Jecht Michael, Cleall Simon, Petzinger Ute and Koivisto Veikko
Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: The SWING study. Diabetes research and clinical practice 97. 231-241. 2012. SWING Study
http://linkinghub.elsevier.com/retrieve/pii/S0168822712000927?showall=true
Rebelos Eleni, Muscelli Elza, Natali Andrea, Balkau Beverley, Mingrone Geltrude, Piatti Piermarco, Konrad Thomas, Mari Andrea, Ferrannini Ele and Investigators on behalf of the RISC Study
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects. Diabetes 60. 1938-1945. 2011. RISC
http://diabetes.diabetesjournals.org/content/60/7/1938.abstract
Reichard Per, Nilsson Bengt-Yngve and Rosenqvist Urban
The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus. New England Journal of Medicine 329. 304-309. 1993. Insulin
http://www.nejm.org/doi/full/10.1056/NEJM199307293290502
Reis Jared P., Hankinson Arlene L., Loria Catherine M., Lewis Cora E., Powell-Wiley Tiffany, Wei Gina S. and Liu Kiang
Duration of Abdominal Obesity Beginning in Young Adulthood and Incident Diabetes Through Middle Age: The CARDIA Study. Diabetes Care 36. 1241-1247. 2013. Obesity
http://care.diabetesjournals.org/content/36/5/1241.abstract
Retnakaran Ravi, Cull Carole A., Thorne Kerensa I., Adler Amanda I. and Holman Rury R.
Risk Factors for Renal Dysfunction in Type 2 Diabetes. UKPDS 74. Diabetes 55. 1832-1839. 2006. UKPDS 74
http://diabetes.diabetesjournals.org/content/55/6/1832.abstract
Reutens Anne T., Hutchinson Richard, Van Binh Ta, Cockram Clive, Deerochanawong Chaicharn, Ho Low-Tone, Ji Linong, Khalid Bin Abdul Kadir, Kong Alice Pik Shan, Lim-Abrahan Mary Ann, Tan Chee-Eng, Tjokroprawiro Askandar, Yoon Kun-Ho, Zimmet Paul Z. and Shaw Jonathan E.
The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice. Diabetes research and clinical practice 98. 38-45. 2012. GIANT Study
http://linkinghub.elsevier.com/retrieve/pii/S0168822712002173?showall=true
Reyes-Soffer Gissette, Ngai Colleen I., Lovato Laura, Karmally Wahida, Ramakrishnan Rajasekhar, Holleran Stephen and Ginsberg Henry N.
Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial. Diabetes Care 36. 422-428. 2013. ACCORD
http://care.diabetesjournals.org/content/36/2/422.abstract
Reznik Yves, Cohen Ohad, Aronson Ronnie, Conget Ignacio, Runzis Sarah, Castaneda Javier and Lee Scott W.
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. The Lancet 384. 1265-1272. 2014. OpT2mise
http://linkinghub.elsevier.com/retrieve/pii/S0140673614610370
Rhee N. A., Vilsbøll T. and Knop F. K.
Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes. Diabetes, Obesity and Metabolism 14. 291-298. 2012. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2011.01505.x
Rhoads G. G., Dain M. P., Zhang Q. and Kennedy L.
Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes. Diabetes, Obesity and Metabolism 13. 711-717. 2011. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01394.x
Richard J. L., Almasri M. and Schuldiner S.
Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia 55. 1258-1264. 2012. Review
http://dx.doi.org/10.1007/s00125-012-2507-3
Richard J. L., Lavigne J. P., Got I., Hartemann A., Malgrange D., Tsirtsikolou D., Baleydier A. and Senneville E.
Management of patients hospitalized for diabetic foot infection: Results of the French OPIDIA study. Diabetes & Metabolism 37. 208-215. 2011. Inpatient
http://www.sciencedirect.com/science/article/pii/S1262363610002429
Ricks Joni, Molnar Miklos Z., Kovesdy Csaba P., Shah Anuja, Nissenson Allen R., Williams Mark and Kalantar-Zadeh Kamyar
Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes. Diabetes 61. 708-715. 2012. Nephropathy
http://diabetes.diabetesjournals.org/content/61/3/708.abstract
Riddle Matthew C., Aronson Ronnie, Home Philip, Marre Michel, Niemoeller Elisabeth, Miossec Patrick, Ping Lin, Ye Jenny and Rosenstock Julio
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L). Diabetes Care 36. 2489-2496. 2013. GLP-1
http://care.diabetesjournals.org/content/36/9/2489.abstract
Riddle Matthew C., Bolli Geremia B., Ziemen Monika, Muehlen-Bartmer Isabel, Bizet Florence and Home Philip D.
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1). Diabetes Care 37. 2755-2762. 2014. EDITION 1
http://care.diabetesjournals.org/content/37/10/2755.abstract
Riddle Matthew C., Forst Thomas, Aronson Ronnie, Sauque-Reyna Leobardo, Souhami Elisabeth, Silvestre Louise, Ping Lin and Rosenstock Julio
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1). Diabetes Care 36. 2497-2503. 2013. GLP-1
http://care.diabetesjournals.org/content/36/9/2497.abstract
Riddle Matthew C. and Karl Diane M.
Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes. Diabetes Care 35. 2100-2107. 2012. ACCORD
http://care.diabetesjournals.org/content/35/10/2100.short
Riddle Matthew C., Rosenstock Julio and Gerich John
The Treat-to-Target Trial. Diabetes Care 26. 3080-3086. 2003. Treat-to-Target Trial
http://care.diabetesjournals.org/content/26/11/3080.abstract
Ringholm L., Pedersen-Bjergaard U., Thorsteinsson B., Damm P. and Mathiesen E. R.
Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabetic Medicine 29. 558-566. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1464-5491.2012.03604.x
Riveline Jean-Pierre, Schaepelynck Pauline, Chaillous Lucy, Renard Eric, Sola-Gazagnes Agnès, Penfornis Alfred, Tubiana-Rufi Nadia, Sulmont Véronique, Catargi Bogdan, Lukas Céline, Radermecker Régis P., Thivolet Charles, Moreau François, Benhamou Pierre-Yves, Guerci Bruno, Leguerrier Anne-Marie, Millot Luc, Sachon Claude, Charpentier Guillaume, Hanaire Hélène and Group for the EVADIAC Sensor Study
Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens. Diabetes Care 35. 965-971. 2012. Insulin
http://care.diabetesjournals.org/content/35/5/965.abstract
Robling Mike, McNamara Rachel, Bennert Kristina, Butler Christopher C, Channon Sue, Cohen David, Crowne Elizabeth, Hambly Helen, Hawthorne Kamila, Hood Kerenza, Longo Mirella, Lowes Lesley, Pickles Tim, Playle Rebecca, Rollnick Stephen, Thomas-Jones Emma and Gregory John W
The effect of the Talking Diabetes consulting skills intervention on glycaemic control and quality of life in children with type 1 diabetes: cluster randomised controlled trial (DEPICTED study). British Medical Journal 344. 2012. DEPICTED
http://www.bmj.com/content/344/bmj.e2359
Roche Madonna M. and Wang Peizhong Peter
Sex Differences in All-Cause and Cardiovascular Mortality, Hospitalization for Individuals With and Without Diabetes, and Patients With Diabetes Diagnosed Early and Late. Diabetes Care 36. 2582-2590. 2013. CVD
http://care.diabetesjournals.org/content/36/9/2582.abstract
Rodbard H. W., Cariou B., Zinman B., Handelsman Y., Philis-Tsimikas A., Skjøth T. V., Rana A., Mathieu C. and The Begin Once Long Trial Investigators
Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial. Diabetic Medicine 30. 1298-1304. 2013. Insulin
http://dx.doi.org/10.1111/dme.12303
Rodbard Helena W., Schnell Oliver, Unger Jeffrey, Rees Christen, Amstutz Linda, Parkin Christopher G., Jelsovsky Zhihong, Wegmann Nathan, Axel-Schweitzer Matthias and Wagner Robin S.
Use of an Automated Decision Support Tool Optimizes Clinicians’ Ability to Interpret and Appropriately Respond to Structured Self-Monitoring of Blood Glucose Data. Diabetes Care 35. 693-698. 2012. Decision Support Tool
http://care.diabetesjournals.org/content/35/4/693.abstract
Rodríguez-Segade Santiago, Rodríguez Javier, García Lopez José M., Casanueva Felipe F. and Camiña Félix
Estimation of the Glycation Gap in Diabetic Patients With Stable Glycemic Control. Diabetes Care 35. 2447-2450. 2012. HbA1c
http://care.diabetesjournals.org/content/35/12/2447.abstract
Rogers H. A., de Zoysa N. and Amiel S. A.
Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned? Diabetic Medicine 29. 321-327. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1464-5491.2011.03444.x
Romain A. J., Bernard P., Attalin V., Gernigon C., Ninot G. and Avignon A.
Health-related quality of life and stages of behavioural change for exercise in overweight/obese individuals. Diabetes & Metabolism 38. 352-358. 2012. QoL
http://www.sciencedirect.com/science/article/pii/S1262363612000511
Romeo Stefano, Maglio Cristina, Burza Maria Antonella, Pirazzi Carlo, Sjöholm Kajsa, Jacobson Peter, Svensson Per-Arne, Peltonen Markku, Sjöström Lars and Carlsson Lena M.S.
Cardiovascular Events After Bariatric Surgery in Obese Subjects With Type 2 Diabetes. Diabetes Care 35. 2613-2617. 2012. Bariatric
http://care.diabetesjournals.org/content/35/12/2613.abstract
Romero-Aroca Pedro, Baget-Bernaldiz Marc, Fernandez-Ballart Juan, Plana-Gil Nuria, Soler-Lluis Nuria, Mendez-Marin Isabel and Bautista-Perez Angel
Ten-year incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes. Diabetes research and clinical practice 94. 126-132. 2011. Retinopathy
http://linkinghub.elsevier.com/retrieve/pii/S0168822711003548?showall=true
Rosenstock J., Lewin A. J., Norwood P., Somayaji V., Nguyen T. T., Teeter J. G., Johnson S. L., Dai H. and Terra S. G.
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes. Diabetic Medicine 28. 464-469. 2011. DPP4
http://dx.doi.org/10.1111/j.1464-5491.2010.03181.x
Rosenstock J., Seman L. J., Jelaska A., Hantel S., Pinnetti S., Hach T. and Woerle H. J.
Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia. Diabetes, Obesity and Metabolism 15. 1154-1160. 2013. SGLT2
http://dx.doi.org/10.1111/dom.12185
Rosenstock Julio, Balas Bogdan, Charbonnel Bernard, Bolli Geremia B., Boldrin Mark, Ratner Robert, Balena Raffaella and Group for the T-emerge 2 Study
The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes: The T-emerge 2 trial. Diabetes Care 36. 498-504. 2013. GLP-1
http://care.diabetesjournals.org/content/36/3/498.abstract
Rosenstock Julio, Bergenstal Richard M., Blevins Thomas C., Morrow Linda A., Prince Melvin J., Qu Yongming, Sinha Vikram P., Howey Daniel C. and Jacober Scott J.
Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study. Diabetes Care 36. 522-528. 2013. Insulin
http://care.diabetesjournals.org/content/36/3/522.abstract
Rosenstock Julio, Raccah Denis, Korányi László, Maffei Laura, Boka Gabor, Miossec Patrick and Gerich John E.
Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X). Diabetes Care 36. 2945-2951. 2013. GLP-1
http://care.diabetesjournals.org/content/36/10/2945.abstract
Rosenstock Julio, Shenouda Sylvia K., Bergenstal Richard M., Buse John B., Glass Leonard C., Heilmann Cory R., Kwan Anita Y.M., MacConell Leigh A. and Hoogwerf Byron James
Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes. Diabetes Care 35. 955-958. 2012. GLP-1
http://care.diabetesjournals.org/content/35/5/955.abstract
Rosenstock Julio, Vico Marisa, Wei Li, Salsali Afshin and List James F.
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy. Diabetes Care 35. 1473-1478. 2012. SGLT2
http://care.diabetesjournals.org/content/35/7/1473.abstract
Rossi Maria C.E., Lucisano Giuseppe, Comaschi Marco, Coscelli Carlo, Cucinotta Domenico, Di Blasi Patrizia, Bader Giovanni, Pellegrini Fabio, Valentini Umberto, Vespasiani Giacomo, Nicolucci Antonio and Group on behalf of the AMD-QUASAR Study
Quality of Diabetes Care Predicts the Development of Cardiovascular Events: Results of the AMD-QUASAR Study. Diabetes Care 34. 347-352. 2011. AMD-QUASAR
http://care.diabetesjournals.org/content/34/2/347.abstract
Rotenstein Lisa S., Kozak Benjamin M., Shivers Joseph P., Yarchoan Mark, Close John and Close Kelly L.
The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We? Clinical Diabetes 30. 44-53. 2012. Review
http://clinical.diabetesjournals.org/content/30/2/44.abstract
Rothberg Amy E., McEwen Laura N., Fraser Tom, Burant Charles F. and Herman William H.
The impact of a managed care obesity intervention on clinical outcomes and costs: A prospective observational study. Obesity 21. 2157-2162. 2013. Obesity
http://dx.doi.org/10.1002/oby.20597
Rowe Michael W., Bergman Richard N., Wagenknecht Lynne E. and Kolberg Janice A.
Performance of a multi-marker Diabetes Risk Score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi-ethnic US cohort. Diabetes/Metabolism Research and Reviews 28. 519-526. 2012. IRAS
http://dx.doi.org/10.1002/dmrr.2305
Roy T., Lloyd C. E., Pouwer F., Holt R. I. G. and Sartorius N.
Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabetic Medicine 29. 164-175. 2012. Review
http://dx.doi.org/10.1111/j.1464-5491.2011.03401.x
Ruiter R., Visser L., van Herk-Sukel M., Coebergh J., Haak H., Geelhoed-Duijvestijn P., Straus S., Herings R. and Stricker B.
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia 55. 51-62. 2012. Insulin
http://dx.doi.org/10.1007/s00125-011-2312-4
Russell-Jones D., Vaag A., Schmitz O., Sethi B., Lalic N., Antic S., Zdravkovic M., Ravn G. and Simó R.
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia 52. 2046-2055. 2009. LEAD 5
http://dx.doi.org/10.1007/s00125-009-1472-y
Russell-Jones David, Cuddihy Robert M., Hanefeld Markolf, Kumar Ajay, González Jose G., Chan Melanie, Wolka Anne M., Boardman Marilyn K. and Group on behalf of the DURATION-4 Study
Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4). Diabetes Care 35. 252-258. 2012. DURATION-4
http://care.diabetesjournals.org/content/35/2/252.abstract
Ryder REJ, Thong KY, Blann AD, Phillips SM, Barwell ND, Kelly CJG, Semple C, Cull ML, Gupta P Sen and contributors for the ABCD nationwide liraglutide audit
Liraglutide pancreatitis: The ABCD nationwide liraglutide audit. The British Journal of Diabetes & Vascular Disease 13. 253-259. 2013. GLP-1
Saad Ahmed, Dalla Man Chiara, Nandy Debashis K., Levine James A., Bharucha Adil E., Rizza Robert A., Basu Rita, Carter Rickey E., Cobelli Claudio, Kudva Yogish C. and Basu Ananda
Diurnal Pattern to Insulin Secretion and Insulin Action in Healthy Individuals. Diabetes 61. 2691-2700. 2012. Insulin
http://diabetes.diabetesjournals.org/content/61/11/2691.abstract
Saad Farid, Haider Ahmad, Doros Gheorghe and Traish Abdulmaged
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity 21. 1975-1981. 2013. Obesity
http://dx.doi.org/10.1002/oby.20407
Sadek A. R., van Vlymen J., Khunti K. and de Lusignan S.
Automated identification of miscoded and misclassified cases of diabetes from computer records. Diabetic Medicine 29. 410-414. 2012. EPR
http://dx.doi.org/10.1111/j.1464-5491.2011.03457.x
Saito Isao, Folsom Aaron R., Brancati Frederick L., Duncan Bruce B., Chambless Lloyd E. and McGovern Paul G.
Nontraditional Risk Factors for Coronary Heart Disease Incidence among Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Annals of Internal Medicine 133. 81-91. 2000. ARIC
http://www.annals.org/content/133/2/81.1.abstract
Saito Yoshihiko, Morimoto Takeshi, Ogawa Hisao, Nakayama Masafumi, Uemura Shiro, Doi Naofumi, Jinnouchi Hideaki, Waki Masako, Soejima Hirofumi, Sugiyama Seigo, Okada Sadanori, Akai Yasuhiro and Investigators on behalf of the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes Trial
Low-Dose Aspirin Therapy in Patients With Type 2 Diabetes and Reduced Glomerular Filtration Rate. Diabetes Care 34. 280-285. 2011. JPAD
http://care.diabetesjournals.org/content/34/2/280.abstract
Saker P. J., Hattersley A. T., Barrow B., Hammersley M. S., Horton V., Gillmer M. D. and Turner R. C.
UKPDS 21: Low Prevalence of the Mitochondrial Transfer RNA gene (tRNA Leu(UUR)) Mutation at Position 3243bp in UK Caucasian Type 2 Diabetic Patients. Diabetic Medicine 14. 42-45. 1997. UKPDS 21
http://dx.doi.org/10.1002/(SICI)1096-9136(199701)14:1<42::AID-DIA295>3.0.CO;2-T
Sakurai Masaru, Saitoh Shigeyuki, Miura Katsuyuki, Nakagawa Hideaki, Ohnishi Hirofumi, Akasaka Hiroshi, Kadota Aya, Kita Yoshikuni, Hayakawa Takehito, Ohkubo Takayoshi, Okayama Akira, Okamura Tomonori, Ueshima Hirotsugu and Group for the NIPPON DATA90 Research
HbA1c and the Risks for All-Cause and Cardiovascular Mortality in the General Japanese Population: NIPPON DATA90. Diabetes Care 36. 3759-3765. 2013. NIPPON DATA90
http://care.diabetesjournals.org/content/36/11/3759.abstract
Salas-Salvadó J., Bulló M., Babio N., Martínez-González M.Á., Ibarrola-Jurado N., Basora J., Estruch R., Covas M.I., Corella D. and Arós F.
Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet. Results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34. 14. 2011. PREDIMED
http://care.diabetesjournals.org/content/34/1/14.abstract
Salehi Marzieh, Aulinger Benedict and D’Alessio David A.
Effect of Glycemia on Plasma Incretins and the Incretin Effect During Oral Glucose Tolerance Test. Diabetes 61. 2728-2733. 2012. GLP-1
http://diabetes.diabetesjournals.org/content/61/11/2728.abstract
Salehpour A., Shidfar F., Hosseinpanah F., Vafa M., Razaghi M. and Amiri F.
Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial. Diabetic Medicine 30. 1477-1481. 2013. Vitamin D
http://dx.doi.org/10.1111/dme.12273
Saltevo J. T., Kautiainen H., Niskanen L., Oksa H., Puolijoki H., Sundvall J., Keinänen-Kiukaanniemi S., Peltonen M., Tuomilehto J., Uusitupa M., Mäntyselkä P. and Vanhala M. J.
Ageing and associations of fasting plasma glucose and 2h plasma glucose with HbA1C in apparently healthy population. “FIN-D2D” study. Diabetes research and clinical practice 93. 344-349. 2011. FIN-D2D study
http://linkinghub.elsevier.com/retrieve/pii/S0168822711002336?showall=true
Samaropoulos Xanthia F., Light Laney, Ambrosius Walter T., Marcovina Santica M., Probstfield Jeffrey and Jr David C. Goff
The effect of intensive risk factor management in type 2 diabetes on inflammatory biomarkers. Diabetes research and clinical practice 95. 389-398. 2012. Biomarkers
http://www.sciencedirect.com/science/article/pii/S0168822711005298
Sasongko Muhammad Bayu, Wong Tien Y., Nguyen Thanh T., Kawasaki Ryo, Jenkins Alicia J., Shaw Jonathan, Robinson Carol and Wang Jie Jin
Serum Apolipoproteins Are Associated With Systemic and Retinal Microvascular Function in People With Diabetes. Diabetes 61. 1785-1792. 2012. Retinopathy
http://diabetes.diabetesjournals.org/content/61/7/1785.abstract
Satoh J., Yagihashi S., Baba M., Suzuki M., Arakawa A., Yoshiyama T. and Shoji S.
Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabetic Medicine 28. 109-116. 2011. Pregabalin
http://dx.doi.org/10.1111/j.1464-5491.2010.03152.x
Sattar N.
Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. Diabetic Medicine 29. 5-13. 2012. Predicting Diabetes
http://dx.doi.org/10.1111/j.1464-5491.2011.03480.x
Scandinavian Simvastatin Survival Study Group
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Lancet 344. 1383-1389. 1994. 4S
http://www.sciencedirect.com/science/article/pii/S0140673694905665
Scheen A. J.
DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials. Diabetes & Metabolism 38. 89-101. 2012. Review
http://www.sciencedirect.com/science/article/pii/S1262363611002060
Scheen A. J. and Paquot N.
Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism 39. 179-190. 2013. OHGA
http://www.sciencedirect.com/science/article/pii/S1262363613000414
Schernthaner G., Barnett A. H., Emser A., Patel S., Troost J., Woerle H. J. and von Eynatten M.
Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 14. 470-478. 2012. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2012.01565.x
Schernthaner Guntram, Gross Jorge L., Rosenstock Julio, Guarisco Michael, Fu Min, Yee Jacqueline, Kawaguchi Masato, Canovatchel William and Meininger Gary
Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial. Diabetes Care 36. 2508-2515. 2013. DPP4
http://care.diabetesjournals.org/content/36/9/2508.abstract
Schlatzer Daniela, Maahs David M., Chance Mark R., Dazard Jean-Eudes, Li Xiaolin, Hazlett Fred, Rewers Marian and Snell-Bergeon Janet K.
Novel Urinary Protein Biomarkers Predicting the Development of Microalbuminuria and Renal Function Decline in Type 1 Diabetes. Diabetes Care 35. 549-555. 2012. Nephropathy
http://care.diabetesjournals.org/content/35/3/549.abstract
Schmid Rémy, Vollenweider Peter, Waeber Gérard and Marques-Vidal Pedro
Estimating the Risk of Developing Type 2 Diabetes: A Comparison of Several Risk Scores. Diabetes Care 34. 1863-1868. 2011. Risk Scores
http://care.diabetesjournals.org/content/34/8/1863.abstract
Schmidt Signe, Meldgaard Merete, Serifovski Nermin, Storm Camilla, Christensen Tomas Møller, Gade-Rasmussen Birthe and Nørgaard Kirsten
Use of an Automated Bolus Calculator in MDI-Treated Type 1 Diabetes. Diabetes Care 35. 984-990. 2012. Insulin
http://care.diabetesjournals.org/content/35/5/984.abstract
Schmidt W. E., Christiansen J. S., Hammer M., Zychma M. J. and Buse J. B.
Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study. Diabetic Medicine 28. 715-723. 2011. GLP-1
http://dx.doi.org/10.1111/j.1464-5491.2011.03276.x
Schmieder RolandE, Schutte Rudolph, Schumacher Helmut, Böhm Michael, Mancia Giuseppe, Weber MichaelA, McQueen Matthew, Teo Koon and Yusuf Salim
Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies. Diabetologia 57. 2019-2029. 2014. Meta-analysis
http://dx.doi.org/10.1007/s00125-014-3330-9
Schoenaker D., Toeller M., Chaturvedi N., Fuller J., Soedamah-Muthu S. and Group the Eurodiab Prospective Complications Study
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 55. 2132-2141. 2012. EURODIAB
http://dx.doi.org/10.1007/s00125-012-2550-0
Schofield C. J. and Sutherland C.
Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes. Diabetic Medicine 29. 972-979. 2012. Insulin
http://dx.doi.org/10.1111/j.1464-5491.2012.03655.x
Schunk M., Reitmeir P., Schipf S., Völzke H., Meisinger C., Thorand B., Kluttig A., Greiser K. H., Berger K., Müller G., Ellert U., Neuhauser H., Tamayo T., Rathmann W. and Holle R.
Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in Germany. Diabetic Medicine 29. 646-653. 2012. QoL
http://dx.doi.org/10.1111/j.1464-5491.2011.03465.x
Scott D. A., Boye K. S., Timlin L., Clark J. F. and Best J. H.
A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo. Diabetes, Obesity and Metabolism 15. 213-223. 2013. GLP-1
http://dx.doi.org/10.1111/dom.12007
Seaquist Elizabeth R., Miller Michael E., Bonds Denise E., Feinglos Mark, Goff David C., Peterson Kevin, Senior Peter and Investigators for the ACCORD
The Impact of Frequent and Unrecognized Hypoglycemia on Mortality in the ACCORD Study. Diabetes Care 35. 409-414. 2012. ACCORD
http://care.diabetesjournals.org/content/35/2/409.abstract
Secher Anna L., Ringholm Lene, Andersen Henrik U., Damm Peter and Mathiesen Elisabeth R.
The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes: A randomized controlled trial. Diabetes Care 36. 1877-1883. 2013. Pregnancy
http://care.diabetesjournals.org/content/36/7/1877.abstract
Selvin Elizabeth, Ning Yang, Steffes Michael W., Bash Lori D., Klein Ronald, Wong Tien Y., Astor Brad C., Sharrett A. Richey, Brancati Frederick L. and Coresh Josef
Glycated Hemoglobin and the Risk of Kidney Disease and Retinopathy in Adults With and Without Diabetes. Diabetes 60. 298-305. 2011. HbA1c
http://diabetes.diabetesjournals.org/content/60/1/298.abstract
Selvin Elizabeth, Steffes Michael W., Gregg Edward, Brancati Frederick L. and Coresh Josef
Performance of A1C for the Classification and Prediction of Diabetes. Diabetes Care 34. 84-89. 2011. HbA1c
http://care.diabetesjournals.org/content/34/1/84.abstract
Shah Siddharth, Zilov Alexey, Malek Rachid, Soewondo Pradana, Bech Ole and Litwak Leon
Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: Results from the A1chieve observational study. Diabetes research and clinical practice 94. 364-370. 2011. The A1chieve study
http://www.sciencedirect.com/science/article/pii/S0168822711005626
Shao Ning, Kuang Hong Yu, Hao Ming, Gao Xin Yuan, Lin Wen Jian and Zou Wei
Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 30. 521-529. 2014. GLP-1
http://dx.doi.org/10.1002/dmrr.2561
Sharma D., Morrison G., Joseph F., Purewal T. and Weston P.
The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis. Diabetologia. 1-3. 2011. CSII
http://dx.doi.org/10.1007/s00125-011-2282-6
Sharma S., Kerry C., Atkins H. and Rayman G.
The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Diabetic Medicine 31. 1100-1103. 2014. Footcare
http://dx.doi.org/10.1111/dme.12450
Shehab D., Al-Jarallah K., Mojiminiyi O. A., Al Mohamedy H. and Abdella N. A.
Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? Diabetic Medicine 29. 43-49. 2012. Neuropathy
http://dx.doi.org/10.1111/j.1464-5491.2011.03510.x
Sherry Nicole, Hagopian William, Ludvigsson Johnny, Jain Sunil M., Wahlen Jack, Ferry Robert J., Bode Bruce, Aronoff Stephen, Holland Christopher, Carlin David, King Karen L., Wilder Ronald L., Pillemer Stanley, Bonvini Ezio, Johnson Syd, Stein Kathryn E., Koenig Scott, Herold Kevan C. and Daifotis Anastasia G.
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial. The Lancet 378. 487-497. 2011. Protege Study
http://linkinghub.elsevier.com/retrieve/pii/S0140673611609318
Shi Lizheng, Ye Xin, Lu Mei, Wu Eric Q., Sharma Hari, Thomason Darren and Fonseca Vivian A.
Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes. Diabetes Care 36. 3297-3304. 2013. HbA1c
http://care.diabetesjournals.org/content/36/10/3297.abstract
Shields B., McDonald T., Ellard S., Campbell M., Hyde C. and Hattersley A.
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 55. 1265-1272. 2012. MODY
http://dx.doi.org/10.1007/s00125-011-2418-8
Shin Andrea S. and Camilleri Michael
Diagnostic Assessment of Diabetic Gastroparesis. Diabetes 62. 2667-2673. 2013. Neuropathy
http://diabetes.diabetesjournals.org/content/62/8/2667.short
Shore Supriya, Borgerding Joleen A., Gylys-Colwell Ina, McDermott Kelly, Ho P. Michael, Tillquist Maggie N., Lowy Elliott, McGuire Darren K., Stolker Joshua M., Arnold Suzanne V., Kosiborod Mikhail and Maddox Thomas M.
Association Between Hyperglycemia at Admission During Hospitalization for Acute Myocardial Infarction and Subsequent Diabetes: Insights From the Veterans Administration Cardiac Care Follow-up Clinical Study. Diabetes Care 37. 409-418. 2014. Cardiovascular
http://care.diabetesjournals.org/content/37/2/409.abstract
Siegelaar Sarah E., Kerr Lisa, Jacober Scott J. and Devries J. Hans
A Decrease in Glucose Variability Does Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After Acute Myocardial Infarction. Diabetes Care 34. 855-857. 2011. MI
http://care.diabetesjournals.org/content/34/4/855.abstract
Simmons D. and Hlaing T.
Interpretation of HbA1c : association with mean cell volume and haemoglobin concentration. Diabetic Medicine 31. 1387-1392. 2014. HbA1c
http://dx.doi.org/10.1111/dme.12518
Simmons David, English Patrick, Robins Peter, Craig Andrew and Addicott Rachael
Should diabetes be commissioned through multidisciplinary networks, rather than Practice Based Commissioning? Primary Care Diabetes 5. 39-44. 2011. Networks
http://www.sciencedirect.com/science/article/pii/S1751991810001282
Simpson Scot H., Majumdar Sumit R., Tsuyuki Ross T., Lewanczuk Richard Z., Spooner Richard and Johnson Jeffrey A.
Effect of Adding Pharmacists to Primary Care Teams on Blood Pressure Control in Patients With Type 2 Diabetes. Diabetes Care 34. 20-26. 2011. BP
http://care.diabetesjournals.org/content/34/1/20.abstract
Simsek S., Schalkwijk C. G. and Wolffenbuttel B. H. R.
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes—the CORALL study. Diabetic Medicine 29. 628-631. 2012. CORALL study
http://dx.doi.org/10.1111/j.1464-5491.2011.03553.x
Singh-Franco D., McLaughlin-Middlekauff J., Elrod S. and Harrington C.
The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes, Obesity and Metabolism 14. 694-708. 2012. Meta-analysis
http://dx.doi.org/10.1111/j.1463-1326.2012.01586.x
Sjöblom P., Nystrom F. H., Länne T., Engvall J. and Östgren C. J.
Microalbuminuria, but not reduced eGFR, is associated with cardiovascular subclinical organ damage in type 2 diabetes. Diabetes & Metabolism 40. 49-55. 2014. Cardiovascular
http://www.sciencedirect.com/science/article/pii/S126236361300181X
Sjølie A. K., Klein R., Porta M., Orchard T., Fuller J., Parving H. H., Bilous R., Aldington S. and Chaturvedi N.
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabetic Medicine 28. 345-351. 2011. DIRECT
http://dx.doi.org/10.1111/j.1464-5491.2010.03210.x
Skyler Jay S., Bergenstal Richard, Bonow Robert O., Buse John, Deedwania Prakash, Gale Edwin A.M., Howard Barbara V., Kirkman M. Sue, Kosiborod Mikhail, Reaven Peter and Sherwin Robert S.
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials. Circulation 119. 351-357. 2009. ACCORD
http://circ.ahajournals.org/content/119/2/351.short
Smith Steven R., O'Neil Patrick M., Astrup Arne, Finer Nicholas, Sanchez-Kam Matilde, Fraher Kyle, Fain Randi and Shanahan William R.
Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes. Obesity 22. 2137-2146. 2014. Obesity
http://dx.doi.org/10.1002/oby.20841
Soderstrom L. H., Johnson S. P., Diaz V. A. and Mainous A. G.
Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabetic Medicine 29. 50-55. 2012. Neuropathy
http://dx.doi.org/10.1111/j.1464-5491.2011.03379.x
Solis-Herrera Carolina, Triplitt Curtis, Garduno-Garcia Jose de Jesús, Adams John, DeFronzo Ralph A. and Cersosimo Eugenio
Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes: A double-tracer study. Diabetes Care 36. 2756-2762. 2013. DPP4
http://care.diabetesjournals.org/content/36/9/2756.abstract
Sone H., Tanaka S., Suzuki S., Seino H., Hanyu O., Sato A., Toyonaga T., Okita K., Ishibashi S., Kodama S., Akanuma Y. and Yamada N.
Leisure-time physical activity is a significant predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis from the Japan Diabetes Complications Study (JDCS). Diabetologia 56. 1021-1030. 2013. Exercise
http://dx.doi.org/10.1007/s00125-012-2810-z
Sone Hirohito, Tanaka Sachiko, Tanaka Shiro, Iimuro Satoshi, Ishibashi Shun, Oikawa Shinichi, Shimano Hitoshi, Katayama Shigehiro, Ohashi Yasuo, Akanuma Yasuo, Yamada Nobuhiro and Group on behalf of the Japan Diabetes Complications Study
Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes. Diabetes Care 35. 1150-1157. 2012. Cardiovascular
http://care.diabetesjournals.org/content/35/5/1150.abstract
Song Yiqing, Wang Lu, Pittas Anastassios G., Del Gobbo Liana C., Zhang Cuilin, Manson JoAnn E. and Hu Frank B.
Blood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes: A meta-analysis of prospective studies. Diabetes Care 36. 1422-1428. 2013. Meta-analysis
http://care.diabetesjournals.org/content/36/5/1422.abstract
Spallone Vincenza, Ziegler Dan, Freeman Roy, Bernardi Luciano, Frontoni Simona, Pop-Busui Rodica, Stevens Martin, Kempler Peter, Hilsted Jannik, Tesfaye Solomon, Low Phillip, Valensi Paul and on behalf of The Toronto Consensus Panel on Diabetic Neuropathy
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes/Metabolism Research and Reviews 27. 639-653. 2011. Consensus
http://dx.doi.org/10.1002/dmrr.1239
Sparring V., Nyström L., Östman J., Wahlström R., Burström K. and Jonsson P. M.
Changing healthcare utilization patterns in diabetes mellitus: case–control studies 1 year and 8 years after diagnosis. Diabetic Medicine 29. 784-791. 2012. SNDR
http://dx.doi.org/10.1111/j.1464-5491.2011.03514.x
Stahn Annett, Pistrosch Frank, Ganz Xenia, Teige Madlen, Koehler Carsta, Bornstein Stefan and Hanefeld Markolf
Relationship Between Hypoglycemic Episodes and Ventricular Arrhythmias in Patients With Type 2 Diabetes and Cardiovascular Diseases: Silent Hypoglycemias and Silent Arrhythmias. Diabetes Care 37. 516-520. 2014. Hypoglycaemia
http://care.diabetesjournals.org/content/37/2/516.abstract
Stalenhoef A. F. H., Davidson M. H., Robinson J. G., Burgess T., Duttlinger-Maddux R., Kallend D., Goldberg A. C. and Bays H.
Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk. Diabetes, Obesity and Metabolism 14. 30-39. 2012. Dalcitrapib
http://dx.doi.org/10.1111/j.1463-1326.2011.01485.x
Stamler J, Vaccaro O, Neaton J D and Wentworth D
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16. 434-444. 1993. MRFIT
http://care.diabetesjournals.org/content/16/2/434.abstract
Stamler Jeremiah, Caggiula Arlene, Grandits Greg A., Kjelsberg Marcus and Cutler Jeffrey A.
Relationship to Blood Pressure of Combinations of Dietary Macronutrients: Findings of the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 94. 2417-2423. 1996. MRFIT
http://circ.ahajournals.org/content/94/10/2417.short
Stark Casagrande Sarah, Fradkin Judith E., Saydah Sharon H., Rust Keith F. and Cowie Catherine C.
The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010. Diabetes Care 36. 2271-2279. 2013. HbA1c
http://care.diabetesjournals.org/content/36/8/2271.abstract
Stefansdottir G., Zoungas S., Chalmers J., Kengne A., Knol M., Leufkens H., Patel A., Woodward M., Grobbee D. and De Bruin M.
Intensive glucose control and risk of cancer in patients with type 2 diabetes. Diabetologia 54. 1608-1614. 2011. Cancer
http://dx.doi.org/10.1007/s00125-011-2104-x
Stettler Christoph, Allemann Sabin, Juni Peter, Cull Carole A., Holman Rury R., Egger Matthias, Krahenbuhl Stephan and Diem Peter
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. American Heart Journal 152. 27-38. 2006. Meta-analysis
http://www.sciencedirect.com/science/article/pii/S0002870305008707
Stevens R., Adler A., Gray A., Briggs A. and Holman R.
Life-expectancy projection by modelling and computer simulation (UKPDS 46). Diabetes research and clinical practice 50. S5-S13. 2000. UKPDS 46
http://www.diabetesresearchclinicalpractice.com/article/S0168-8227%2800%2900214-X/abstract
Stevens R., Ali R., Bankhead C., Bethel M., Cairns B., Camisasca R., Crowe F., Farmer A., Harrison S., Hirst J., Home P., Kahn S., McLellan J., Perera R., Plüddemann A., Ramachandran A., Roberts N., Rose P., Schweizer A., Viberti G. and Holman R.
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia 55. 2593-2603. 2012. Meta-analysis
http://dx.doi.org/10.1007/s00125-012-2653-7
Stevens R.J., Kothari V., Adler A.I., Stratton I.M. and Holman RR
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clinical Science 101. 671-679. 2001. UKPDS 56
http://www.westhertshospitals.nhs.uk/whc/archive/calculators/UKPDS56%20Risk%20Engine.pdf
Stevens Richard J., Coleman Ruth L., Adler Amanda I., Stratton Irene M., Matthews David R. and Holman Rury R.
Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes. UKPDS 66. Diabetes Care 27. 201-207. 2004. UKPDS 66
http://care.diabetesjournals.org/content/27/1/201.abstract
Stevens Richard J., Stratton Irene M. and Holman Rury R.
Modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes. UKPDS 58. Journal of Diabetes and its Complications 16. 371-376. 2002. UKPDS 58
http://www.sciencedirect.com/science/article/pii/S1056872702001617
Stolker Joshua M., Spertus John A., McGuire Darren K., Lind Marcus, Tang Fengming, Jones Philip G., Inzucchi Silvio E., Rathore Saif S., Maddox Thomas M., Masoudi Frederick A. and Kosiborod Mikhail
Relationship Between Glycosylated Hemoglobin Assessment and Glucose Therapy Intensification in Patients With Diabetes Hospitalized for Acute Myocardial Infarction. Diabetes Care 35. 991-993. 2012. MI
http://care.diabetesjournals.org/content/35/5/991.abstract
Stratton I., Cull C., Adler A., Matthews D., Neil H. and Holman R.
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 49. 1761-1769. 2006. UKPDS 75
http://dx.doi.org/10.1007/s00125-006-0297-1
Stratton I., Manley S., Holman R. and Turner R.
Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control Hypertension in Diabetes Study Group*. Diabetologia 39. 1554-1561. 1996. HDS
http://dx.doi.org/10.1007/s001250050614
Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE and Matthews DR
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44. 156-163. 2001. UKPDS 50
http://www.springerlink.com/content/bnc8jpfpu6n8983u/
Stratton Irene M, Adler Amanda I, Neil H Andrew W, Matthews David R, Manley Susan E, Cull Carole A, Hadden David, Turner Robert C and Holman Rury R
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal 321. 405-412. 2000. UKPDS 35
http://www.bmj.com/content/321/7258/405.abstract
Straznicky Nora E., Grima Mariee T., Sari Carolina I., Eikelis Nina, Lambert Elisabeth A., Nestel Paul J., Esler Murray D., Dixon John B., Chopra Reena, Tilbrook Alan J., Schlaich Markus P. and Lambert Gavin W.
Neuroadrenergic Dysfunction Along the Diabetes Continuum. Diabetes 61. 2506-2516. 2012. Obesity
http://diabetes.diabetesjournals.org/content/61/10/2506.abstract
Strippoli Giovanni F M, Craig Maria, Deeks Jonathan J, Schena Francesco Paolo and Craig Jonathan C
Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. British Medical Journal 329. 828. 2004. ACE
http://www.bmj.com/content/329/7470/828.abstract
Strojek K., Yoon K. H., Hruba V., Elze M., Langkilde A. M. and Parikh S.
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial. Diabetes, Obesity and Metabolism 13. 928-938. 2011. SGLT2
http://dx.doi.org/10.1111/j.1463-1326.2011.01434.x
Su Gong, Mi Shu-hua, Tao Hong, Li Zhao, Yang Hong-Xia, Zheng Hong, Zhou Yun and Tian Lei
Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction. Diabetes Care 36. 1026-1032. 2013. HbA1c
http://care.diabetesjournals.org/content/36/4/1026.abstract
Suh S., Joung J. Y., Jin S. M., Kim M. Y., Bae J. C., Park H. D., Lee M. S., Lee M. K. and Kim J. H.
Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control. Diabetes & Metabolism 40. 272-277. 2014. Glycaemic variability
http://www.sciencedirect.com/science/article/pii/S1262363614000330
Suissa S., Azoulay L., Dell’Aniello S., Evans M., Vora J. and Pollak M.
Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia 54. 2254-2262. 2011. Insulin
http://dx.doi.org/10.1007/s00125-011-2190-9
Svensson Per, de Faire Ulf, Sleight Peter, Yusuf Salim and Östergren Jan
Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures. Hypertension 38. e28-e32. 2001. HOPE
Tan H. K. and Flanagan D.
The impact of hypoglycaemia on patients admitted to hospital with medical emergencies. Diabetic Medicine 30. 574-580. 2013. Hypoglycaemia
http://dx.doi.org/10.1111/dme.12123
Tanaka Shiro, Tanaka Sachiko, Iimuro Satoshi, Yamashita Hidetoshi, Katayama Shigehiro, Akanuma Yasuo, Yamada Nobuhiro, Araki Atsushi, Ito Hideki, Sone Hirohito, Ohashi Yasuo, Group for the Japan Diabetes Complications Study and Group the Japanese Elderly Diabetes Intervention Trial
Predicting Macro- and Microvascular Complications in Type 2 Diabetes: The Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine. Diabetes Care 36. 1193-1199. 2013. JDCS
http://care.diabetesjournals.org/content/36/5/1193.abstract
Tansey M., Laffel L., Cheng J., Beck R., Coffey J., Huang E., Kollman C., Lawrence J., Lee J., Ruedy K., Tamborlane W., Wysocki T., Xing D. and on behalf of Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabetic Medicine 28. 1118-1122. 2011. CGM
http://dx.doi.org/10.1111/j.1464-5491.2011.03368.x
Tertti K., Ekblad U., Koskinen P., Vahlberg T. and Rönnemaa T.
Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes, Obesity and Metabolism 15. 246-251. 2013. Gestational
http://dx.doi.org/10.1111/dom.12017
Tesfaye S., Vileikyte L., Rayman G., Sindrup S. H., Perkins B. A., Baconja M., Vinik A. I., Boulton A. J. M. and on behalf of The Toronto Expert Panel on Diabetic Neuropathy
Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes/Metabolism Research and Reviews 27. 629-638. 2011. Consensus
http://dx.doi.org/10.1002/dmrr.1225
The Diabetes Prevention Program Outcomes Study Research Group, prepared on behalf of the Dppos Research Group, Orchard T. J., Temprosa M., Barrett-Connor E., Fowler S. E., Goldberg R. B., Mather K. J., Marcovina S. M., Montez M., Ratner R. E., Saudek C. D., Sherif H. and Watson K. E.
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabetic Medicine 30. 46-55. 2013. Diabetes Prevention Program
http://dx.doi.org/10.1111/j.1464-5491.2012.03750.x
Thomas G. Neil, ó Hartaigh Bríain, Bosch Jos A., Pilz Stefan, Loerbroks Adrian, Kleber Marcus E., Fischer Joachim E., Grammer Tanja B., Böhm Bernhard O. and März Winfried
Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome. Diabetes Care 35. 1158-1164. 2012. Mortality
http://care.diabetesjournals.org/content/35/5/1158.abstract
Thomas R L, Dunstan F, Luzio S D, Chowdury S Roy, Hale S L, North R V, Gibbins R L and Owens D R
Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. British Medical Journal 344. 2012. Retinopathy
Thompson R. J., Agostini K., Potts L., Luscombe J., Christie D., Viner R., White B. and Hindmarsh P. C.
Deprivation and ethnicity impact on diabetes control and use of treatment regimen. Diabetic Medicine 30. 491-494. 2013. Paediatric
http://dx.doi.org/10.1111/dme.12023
Thong K. Y., Jose B., Sukumar N., Cull M. L., Mills A. P., Sathyapalan T., Shafiq W., Rigby A. S., Walton C., Ryder R. E. J. and on behalf of the Abcd nationwide exenatide audit contributors
Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*. Diabetes, Obesity and Metabolism 13. 703-710. 2011. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2011.01393.x
Thorand Barbara, Zierer Astrid, Huth Cornelia, Linseisen Jakob, Meisinger Christa, Roden Michael, Peters Annette, Koenig Wolfgang and Herder Christian
Effect of Serum 25-Hydroxyvitamin D on Risk for Type 2 Diabetes May Be Partially Mediated by Subclinical Inflammation. Diabetes Care 34. 2320-2322. 2011. MONICA/KORA Study
http://care.diabetesjournals.org/content/34/10/2320.abstract
Ting Ru-Dee, Keech Anthony C., Drury Paul L., Donoghoe Mark W., Hedley John, Jenkins Alicia J., Davis Timothy M.E., Lehto Seppo, Celermajer David, Simes R. John, Rajamani Kushwin, Stanton Kim and Investigators on behalf of the FIELD Study
Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment. Diabetes Care 35. 218-225. 2012. FIELD
http://care.diabetesjournals.org/content/35/2/218.abstract
Tobias Deirdre K., Hu Frank B., Forman John P., Chavarro Jorge and Zhang Cuilin
Increased Risk of Hypertension After Gestational Diabetes Mellitus. Diabetes Care 34. 1582-1584. 2011. Gestational
http://care.diabetesjournals.org/content/34/7/1582.abstract
Tobias Deirdre K., Zhang Cuilin, van Dam Rob M., Bowers Katherine and Hu Frank B.
Physical Activity Before and During Pregnancy and Risk of Gestational Diabetes Mellitus. Diabetes Care 34. 223-229. 2011. Gestational
http://care.diabetesjournals.org/content/34/1/223.abstract
Todd J. A., Knip M. and Mathieu C.
Strategies for the prevention of autoimmune Type 1 diabetes. Diabetic Medicine 28. 1141-1143. 2011. Epidemiology
http://dx.doi.org/10.1111/j.1464-5491.2011.03400.x
Tolonen Nina, Forsblom Carol, Mäkinen Ville-Petteri, Harjutsalo Valma, Gordin Daniel, Feodoroff Maija, Sandholm Niina, Thorn Lena M., Wadén Johan, Taskinen Marja-Riitta and Groop Per-Henrik
Different Lipid Variables Predict Incident Coronary Artery Disease in Patients With Type 1 Diabetes With or Without Diabetic Nephropathy: The FinnDiane Study. Diabetes Care 37. 2374-2382. 2014. FinnDianne Study
http://care.diabetesjournals.org/content/37/8/2374.abstract
Tsugawa Yusuke, Takahashi Osamu, Meigs James B., Davis Roger B., Imamura Fumiaki, Fukui Tsuguya, Taylor William C. and Wee Christina C.
New Diabetes Diagnostic Threshold of Hemoglobin A1c and the 3-Year Incidence of Retinopathy. Diabetes 61. 3280-3284. 2012. HbA1c
http://diabetes.diabetesjournals.org/content/61/12/3280.abstract
Turer A. and Scherer P.
Adiponectin: mechanistic insights and clinical implications. Diabetologia 55. 2319-2326. 2012. Adiponectin
http://dx.doi.org/10.1007/s00125-012-2598-x
Turner R., Mann J., Iceton G., Oakes S., Smith A., Moore J., Hockaday T., Holman R., Stowers J., Stowers M., Murchison L., Borthwick L., Wright D., Fitzgerald M., Gyde S., Pilkington T., Oakley N., Whitehead M., Kohner E., Lawson P., Hayes R., Henry W., Peto R., Moore A., Stark T. and Todd L.
UK prospective study of therapies of maturity-onset diabetes. Diabetologia 24. 404-411. 1983. UKPDS 1
http://dx.doi.org/10.1007/BF00257337
Turner R., Stratton I., Horton V., Manley S., Zimmet P., Mackay I.R., Shattock M., Bottazzo G.F. and Holman R.
UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. The Lancet 350. 1288-1293. 1997. UKPDS 25
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2897%2903062-6/fulltext
Turner RC, Mann J., Oakes S., Nugent Z., Moore J. and Peto R.
United Kingdom prospective diabetes study III. Prevalence of hypertension and of hypotensive therapy in patients with newly diagnosed diabetes. A Multicentre Study. Hypertension 7. 8-13. 1995. UKPDS 3
Turner RC, Millns H., Neil HAW, Stratton IM, Manley SE, Matthews DR and Holman RR
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). British Medical Journal 316. 823. 1998. UKPDS 23
http://www.bmj.com/content/316/7134/823.abstract
Turner Robert C., Cull Carole A., Frighi Valeria, Holman Rury R. and Group for the UK Prospective Diabetes Study
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus. The Journal of the American Medical Association 281. 2005-2012. 1999. UKPDS 49
http://jama.ama-assn.org/content/281/21/2005.abstract
Turner Robert, Cull Carole and Holman Rury
United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes Mellitus. Annals of Internal Medicine 124. 136-145. 1996. UKPDS 17
Umpierrez Guillermo E., Hellman Richard, Korytkowski Mary T., Kosiborod Mikhail, Maynard Gregory A., Montori Victor M., Seley Jane J. and Van den Berghe Greet
Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism 97. 16-38. 2012. Consensus
http://jcem.endojournals.org/content/97/1/16.abstract
Umpierrez Guillermo E., Reyes David, Smiley Dawn, Hermayer Kathie, Khan Amna, Olson Darin E., Pasquel Francisco, Jacobs Sol, Newton Christopher, Peng Limin and Fonseca Vivian
Hospital Discharge Algorithm Based on Admission HbA1c for the Management of Patients With Type 2 Diabetes. Diabetes Care 37. 2934-2939. 2014. HbA1c
http://care.diabetesjournals.org/content/37/11/2934.abstract
Umpierrez Guillermo E., Smiley Dawn, Jacobs Sol, Peng Limin, Temponi Angel, Mulligan Patrick, Umpierrez Denise, Newton Christopher, Olson Darin and Rizzo Monica
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery). Diabetes Care 34. 256-261. 2011. RABBIT 2
http://care.diabetesjournals.org/content/34/2/256.abstract
Umpierrez Guillermo, Tofé Povedano Santiago, Pérez Manghi Federico, Shurzinske Linda and Pechtner Valeria
Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3). Diabetes Care 37. 2168-2176. 2014. AWARD-3
http://care.diabetesjournals.org/content/37/8/2168.abstract
Vaccaro Olga, Franzini Laura, Miccoli Roberto, Cavalot Franco, Ardigò Diego, Boemi Massimo, De Feo Pierpaolo, Reboldi Gianpaolo, Rivellese Angela Albarosa, Trovati Mariella, Zavaroni Ivana and Group on behalf of the MIND.IT Study
Feasibility and Effectiveness in Clinical Practice of a Multifactorial Intervention for the Reduction of Cardiovascular Risk in Patients With Type 2 Diabetes: The 2-year interim analysis of the MIND.IT study: a cluster randomized trial. Diabetes Care 36. 2566-2572. 2013. MIND.IT
http://care.diabetesjournals.org/content/36/9/2566.abstract
Valentine W. J., Jendle J., Saraheimo M., Thorsteinsson B., Pollock R. F. and Lammert M.
Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. Diabetic Medicine 29. 303-312. 2012. Hypoglycaemia
http://dx.doi.org/10.1111/j.1464-5491.2011.03461.x
Vamos Eszter P., Millett Christopher, Parsons Camille, Aylin Paul, Majeed Azeem and Bottle Alex
Nationwide Study on Trends in Hospital Admissions for Major Cardiovascular Events and Procedures Among People With and Without Diabetes in England, 2004–2009. Diabetes Care 35. 265-272. 2012. Cardiovascular
http://care.diabetesjournals.org/content/35/2/265.abstract
van Dieren S., Czernichow S., Chalmers J., Kengne A. P., de Galan B. E., Poulter N., Woodward M., Beulens J. W. J., Grobbee D. E., van der Schouw Y. T. and Zoungas S.
Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial. Diabetes, Obesity and Metabolism 14. 464-469. 2012. ADVANCE
http://dx.doi.org/10.1111/j.1463-1326.2012.01556.x
van Dieren S., Peelen L., Nöthlings U., van der Schouw Y., Rutten G., Spijkerman A., van der A D., Sluik D., Boeing H., Moons K. and Beulens J.
External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 54. 264-270. 2011. UKPDS
http://dx.doi.org/10.1007/s00125-010-1960-0
van Dieren Susan, Kengne Andre P., Chalmers John, Beulens Joline W. J., Cooper Mark E., Grobbee Diederick E., Harrap Stephen, Mancia Giuseppe, Neal Bruce, Patel Anushka, Poulter Neil, van der Schouw Yvonne T., Woodward Mark and Zoungas Sophia
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. Diabetes research and clinical practice 98. 83-90. 2012. BP
http://linkinghub.elsevier.com/retrieve/pii/S0168822712001635?showall=true
van Eijk K. N. D., Blom J. W., Gussekloo J., Polak B. C. P. and Groeneveld Y.
Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. Diabetes research and clinical practice 96. 10-16. 2012. Retinopathy
http://www.sciencedirect.com/science/article/pii/S0168822711006267
van Son Jenny, Nyklíček Ivan, Pop Victor J., Blonk Marion C., Erdtsieck Ronald J., Spooren Pieter F., Toorians Arno W. and Pouwer François
The Effects of a Mindfulness-Based Intervention on Emotional Distress, Quality of Life, and HbA1c in Outpatients With Diabetes (DiaMind): A randomized controlled trial. Diabetes Care 36. 823-830. 2013. QoL
http://care.diabetesjournals.org/content/36/4/823.abstract
van Staa T., Patel D., Gallagher A. and de Bruin M.
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. Diabetologia. 1-12. 2011. Cancer
http://dx.doi.org/10.1007/s00125-011-2390-3
Varadi A., Lebel L., Hashim Y., Mehta Z., Ashcroft S. J. H. and Turner R.
Sequence variants of the sarco(endo)plasmic reticulum Ca2+-transport ATPase 3 gene (SERCA3) in Caucasian Type II diabetic patients (UK Prospective Diabetes Study 48). Diabetologia 42. 1240-1243. 1999. UKPDS 48
http://dx.doi.org/10.1007/s001250051298
Vehik Kendra, Cuthbertson David, Boulware David, Beam Craig A., Rodriguez Henry, Legault Laurent, Hyytinen Mila, Rewers Marian J., Schatz Desmond A., Krischer Jeffrey P., the TEDDY TRIGR, Diabetes Prevention Trial–Type 1, and Groups Type 1 Diabetes TrialNet Natural History Study
Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth. Diabetes Care 35. 1821-1825. 2012. HbA1c
http://care.diabetesjournals.org/content/35/9/1821.abstract
Vergès B., Avignon A., Bonnet F., Catargi B., Cattan S., Cosson E., Ducrocq G., Elbaz M., Fredenrich A., Gourdy P., Henry P., Lairez O., Leguerrier A. M., Monpère C., Moulin P., Vergès-Patois B., Roussel R., Steg G. and Valensi P.
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome. Diabetes & Metabolism 38. 113-127. 2012. Consensus
http://www.sciencedirect.com/science/article/pii/S1262363611002230
Vestberg Daniel, Rosengren Annika, Olsson Marita, Gudbjörnsdottir Soffia, Svensson Ann-Marie and Lind Marcus
Relationship Between Overweight and Obesity With Hospitalization for Heart Failure in 20,985 Patients With Type 1 Diabetes: A population-based study from the Swedish National Diabetes Registry. Diabetes Care 36. 2857-2861. 2013. SNDR
http://care.diabetesjournals.org/content/36/9/2857.abstract
Viazzi Francesca, Leoncini Giovanna, Vercelli Marina, Deferrari Giacomo and Pontremoli Roberto
Serum Uric Acid Levels Predict New-Onset Type 2 Diabetes in Hospitalized Patients With Primary Hypertension: The MAGIC Study. Diabetes Care 34. 126-128. 2011. MAGIC
http://care.diabetesjournals.org/content/34/1/126.abstract
Viberti Giancarlo, Kahn Steven E., Greene Douglas A., Herman William H., Zinman Bernard, Holman Rury R., Haffner Steven M., Levy Daniel, Lachin John M., Berry Rhona A., Heise Mark A., Jones Nigel P. and Freed Martin I.
A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care 25. 1737-1743. 2002. ADOPT
http://care.diabetesjournals.org/content/25/10/1737.abstract
Viberti Giancarlo, Wheeldon Nigel M. and Investigators for the MicroAlbuminuria Reduction With VALsartan Study
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus. Circulation 106. 672-678. 2002. MARVAL
http://circ.ahajournals.org/content/106/6/672.abstract
Vilsbøll T., Rosenstock J., Yki-Järvinen H., Cefalu W. T., Chen Y., Luo E., Musser B., Andryuk P. J., Ling Y., Kaufman K. D., Amatruda J. M., Engel S. S. and Katz L.
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 12. 167-177. 2010. GLP-1
http://dx.doi.org/10.1111/j.1463-1326.2009.01173.x
Wada Y., Hamamoto Y., Ikeda H., Honjo S., Kawasaki Y., Mori K. and Koshiyama H.
Seasonal variations of urinary albumin creatinine ratio in Japanese subjects with Type 2 diabetes and early nephropathy. Diabetic Medicine 29. 506-508. 2012. Nephropathy
http://dx.doi.org/10.1111/j.1464-5491.2011.03472.x
Wallin Alice, Di Giuseppe Daniela, Orsini Nicola, Patel Pinal S., Forouhi Nita G. and Wolk Alicja
Fish Consumption, Dietary Long-Chain n-3 Fatty Acids, and Risk of Type 2 Diabetes. Diabetes Care 35. 918-929. 2012. Diet
http://care.diabetesjournals.org/content/35/4/918.abstract
Wang Hong, Shara Nawar M., Lee Elisa T., Devereux Richard, Calhoun Darren, de Simone Giovanni, Umans Jason G. and Howard Barbara V.
Hemoglobin A1c, Fasting Glucose, and Cardiovascular Risk in a Population With High Prevalence of Diabetes. Diabetes Care 34. 1952-1958. 2011. HbA1c
http://care.diabetesjournals.org/content/34/9/1952.abstract
Wang Wenyu, Lee Elisa T., Howard Barbara V., Fabsitz Richard R., Devereux Richard B. and Welty Thomas K.
Fasting Plasma Glucose and Hemoglobin A1c in Identifying and Predicting Diabetes. Diabetes Care 34. 363-368. 2011. HbA1c
http://care.diabetesjournals.org/content/34/2/363.abstract
Wang Xia, Bao Wei, Liu Jun, OuYang Ying-Ying, Wang Di, Rong Shuang, Xiao Xiao, Shan Zhi-Lei, Zhang Yan, Yao Ping and Liu Lie-Gang
Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis. Diabetes Care 36. 166-175. 2013. Meta-analysis
http://care.diabetesjournals.org/content/36/1/166.abstract
Watson L., Wilson B. P., Alsop J. and Kumar S.
Weight and glycaemic control in type 2 diabetes: what is the outcome of insulin initiation? Diabetes, Obesity and Metabolism 13. 823-831. 2011. Insulin
http://dx.doi.org/10.1111/j.1463-1326.2011.01413.x
Webb D., Gray L., Khunti K., Srinivasan B., Taub N., Campbell S., Barnett J., Farooqi A., Echouffo-Tcheugui J., Griffin S., Wareham N. and Davies M.
Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 54. 2237-2246. 2011. ADDITION
http://dx.doi.org/10.1007/s00125-011-2189-2
Webb D. R., Khunti K., Gray L. J., Srinivasan B. T., Farooqi A., Wareham N., Griffin S. C., Davies M. J. and for the Addition-Leicester study group
Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial. Diabetic Medicine 29. 531-540. 2012. MI
http://dx.doi.org/10.1111/j.1464-5491.2011.03441.x
Wei Ming, Gaskill Sharon P, Haffner Steven M and Stern Michael P
Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study. Diabetes Care 21. 1167-1172. 1998. SAHS
http://care.diabetesjournals.org/content/21/7/1167.abstract
White H. D., Goenka N., Furlong N. J., Saunders S., Morrison G., Langridge P., Paul P., Ghatak A. and Weston P. J.
The UK service level audit of insulin pump therapy in adults. Diabetic Medicine 31. 412-418. 2014. CSII
http://dx.doi.org/10.1111/dme.12325
Whiting David R., Guariguata Leonor, Weil Clara and Shaw Jonathan
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes research and clinical practice 94. 311-321. 2011. Epidemiology IDF
http://www.sciencedirect.com/science/article/pii/S0168822711005912
WHO
Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes research and clinical practice 93. 299-309. 2011. HbA1c
http://linkinghub.elsevier.com/retrieve/pii/S0168822711001318?showall=true
WHO
Presidents’ statement on WHO recommendation on HbA1c for diabetes diagnosis. Diabetes research and clinical practice 93. 310-311. 2011. HbA1c
http://linkinghub.elsevier.com/retrieve/pii/S0168822711003482?showall=true
Widjaja A., Stratton I.M., Horn R., Holman R.R., Turner R. and Brabant G.
UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. Journal of Clinical Endocrinology & Metabolism 82. 654. 1997. UKPDS 20
http://jcem.endojournals.org/content/82/2/654.full.pdf+html
Wilding J. P. H.
PPAR agonists for the treatment of cardiovascular disease in patients with diabetes. Diabetes, Obesity and Metabolism 14. 973-982. 2012. PPAR
http://dx.doi.org/10.1111/j.1463-1326.2012.01601.x
Wilding J. P. H., Ferrannini E., Fonseca V. A., Wilpshaar W., Dhanjal P. and Houzer A.
Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study. Diabetes, Obesity and Metabolism 15. 403-409. 2013. SGLT2
http://dx.doi.org/10.1111/dom.12038
Wilding J. P. H., Woo V., Rohwedder K., Sugg J., Parikh S. and for the Dapagliflozin 006 Study Group
Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years. Diabetes, Obesity and Metabolism 16. 124-136. 2014. SGLT2
http://dx.doi.org/10.1111/dom.12187
Wilding John P H and Hardy Kevin
Glucagon-like peptide-1 analogues for type 2 diabetes. British Medical Journal 342. 2011. GLP-1
http://www.bmj.com/content/342/bmj.d410.short
Wilding John P.H., Norwood Paul, T'joen Caroline, Bastien Arnaud, List James F. and Fiedorek Fred T.
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers. Diabetes Care 32. 1656-1662. 2009. SGLT2
http://care.diabetesjournals.org/content/32/9/1656.abstract
Williams-Herman D., Xu L., Teng R., Golm G. T., Johnson J., Davies M. J., Kaufman K. D. and Goldstein B. J.
Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 14. 67-76. 2012. DPP4
http://dx.doi.org/10.1111/j.1463-1326.2011.01492.x
Williams Emily D., Magliano Dianna J., Zimmet Paul Z., Kavanagh Anne M., Stevenson Christopher E., Oldenburg Brian F. and Shaw Jonathan E.
Area-Level Socioeconomic Status and Incidence of Abnormal Glucose Metabolism. Diabetes Care 35. 1455-1461. 2012. QoL
http://care.diabetesjournals.org/content/35/7/1455.abstract
Williams Emily D., Rawal Lal, Oldenburg Brian F., Renwick Carla, Shaw Jonathan E. and Tapp Robyn J.
Risk of Cardiovascular and All-Cause Mortality: Impact of Impaired Health-Related Functioning and Diabetes. Diabetes Care 35. 1067-1073. 2012. Mortality
http://care.diabetesjournals.org/content/35/5/1067.abstract
Wing Rena R., Bond Dale S., Gendrano Isaias Noel, Wadden Thomas, Bahnson Judy, Lewis Cora E., Brancati Frederick, Schneider Stephen, Kitabchi Abbas E., Van Dorsten Brent, Rosen Raymond C. and Group the Sexual Dysfunction Subgroup of the Look AHEAD Research
Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results from an ancillary Look AHEAD study. Diabetes Care 36. 2937-2944. 2013. Look AHEAD Study
http://care.diabetesjournals.org/content/36/10/2937.abstract
Wing Rena R., Lang Wei, Wadden Thomas A., Safford Monika, Knowler William C., Bertoni Alain G., Hill James O., Brancati Frederick L., Peters Anne, Wagenknecht Lynne and Group the Look AHEAD Research
Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes. Diabetes Care 34. 1481-1486. 2011. Look AHEAD
http://care.diabetesjournals.org/content/34/7/1481.abstract
Woerle Hans Juergen, Carneiro Lucianno, Derani Ayman, Göke Burkhard and Schirra Jörg
The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes. Diabetes 61. 2349-2358. 2012. GLP-1
http://diabetes.diabetesjournals.org/content/61/9/2349.abstract
Wojtusciszyn A., Mourad G., Bringer J. and Renard E.
Continuous glucose monitoring after kidney transplantation in non-diabetic patients: Early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure. Diabetes & Metabolism 39. 404-410. 2013. CGM
http://www.sciencedirect.com/science/article/pii/S1262363612002145
Won H. K., Kim K. J., Lee B. W., Kang E. S., Cha B. S. and Lee H. C.
Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments. Diabetic Medicine 29. 74-79. 2012. Predicting Diabetes
http://dx.doi.org/10.1111/j.1464-5491.2011.03386.x
Woodfield Scott L., Lundergan Conor F., Reiner Jonathan S., Greenhouse Samuel W., Thompson Mark A., Rohrbeck Steven C., Deychak Yuri, Simoons Maarten L., Califf Robert M., Topol Eric J. and Ross Allan M.
Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience. Journal of the American College of Cardiology 28. 1661-1669. 1996. GUSTO 1
http://www.sciencedirect.com/science/article/pii/S073510979600397X
Wright Alex, Burden A.C. Felix, Paisey Richard B., Cull Carole A. and Holman Rury R.
Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57) Diabetes Care 25. 330-336. 2002. UKPDS 57
http://care.diabetesjournals.org/content/25/2/330.abstract
Wright Alex D., Cull Carole A., Macleod Kenneth M. and Holman Rury R.
Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. Journal of Diabetes and its Complications 20. 395-401. 2006. UKPDS 73
http://www.sciencedirect.com/science/article/pii/S1056872705001194
Wu D., Li L. and Liu C.
Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis. Diabetes, Obesity and Metabolism 16. 30-37. 2014. Meta-analysis
http://dx.doi.org/10.1111/dom.12174
Wu Hon-Yen, Huang Jenq-Wen, Lin Hung-Ju, Liao Wei-Chih, Peng Yu-Sen, Hung Kuan-Yu, Wu Kwan-Dun, Tu Yu-Kang and Chien Kuo-Liong
Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis. BMJ 347. 2013. Meta-analysis
Wysham C., Bergenstal R., Malloy J., Yan P., Walsh B., Malone J. and Taylor K.
DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide. Diabetic Medicine 28. 705-714. 2011. DURATION 2
http://dx.doi.org/10.1111/j.1464-5491.2011.03301.x
Wysham Carol, Blevins Thomas, Arakaki Richard, Colon Gildred, Garcia Pedro, Atisso Charles, Kuhstoss Debra and Lakshmanan Mark
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 37. 2159-2167. 2014. AWARD-1
Xu Na, Wu Hongfang, Li Daiqing and Wang Jianhua
Diagnostic accuracy of glycated hemoglobin compared with oral glucose tolerance test for diagnosing diabetes mellitus in Chinese adults: A meta-analysis. Diabetes research and clinical practice 106. 11-18 Meta-analysis
http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(14)00193-4/abstract
Xun Pengcheng and He Ka
Fish Consumption and Incidence of Diabetes. Diabetes Care 35. 930-938. 2012. Diet
Yale J. F., Bakris G., Cariou B., Nieto J., David-Neto E., Yue D., Wajs E., Figueroa K., Jiang J., Law G., Usiskin K., Meininger G. and on behalf of the D. I. A. Study Group
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease. Diabetes, Obesity and Metabolism 16. 1016-1027. 2014. DPP4
http://dx.doi.org/10.1111/dom.12348
Yale J. F., Bakris G., Cariou B., Yue D., David-Neto E., Xi L., Figueroa K., Wajs E., Usiskin K. and Meininger G.
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes, Obesity and Metabolism 15. 463-473. 2013. SGLT2
http://dx.doi.org/10.1111/dom.12090
Yang S. J., Min K. W., Gupta S. K., Park J. Y., Shivane V. K., Pitale S. U., Agarwal P. K., Sosale A., Gandhi P., Dharmalingam M., Mohan V., Mahesh U., Kim D. M., Kim Y. S., Kim J. A., Kim P. K. and Baik S. H.
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 15. 410-416. 2013. DPP4
http://dx.doi.org/10.1111/dom.12042
Yates T., Davies M. J., Sehmi S., Gorely T. and Khunti K.
The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years? Diabetic Medicine 28. 1268-1271. 2011. PREPARE Study
http://dx.doi.org/10.1111/j.1464-5491.2011.03357.x
Yau Joanne W.Y., Rogers Sophie L., Kawasaki Ryo, Lamoureux Ecosse L., Kowalski Jonathan W., Bek Toke, Chen Shih-Jen, Dekker Jacqueline M., Fletcher Astrid, Grauslund Jakob, Haffner Steven, Hamman Richard F., Ikram M. Kamran, Kayama Takamasa, Klein Barbara E.K., Klein Ronald, Krishnaiah Sannapaneni, Mayurasakorn Korapat, O’Hare Joseph P., Orchard Trevor J., Porta Massimo, Rema Mohan, Roy Monique S., Sharma Tarun, Shaw Jonathan, Taylor Hugh, Tielsch James M., Varma Rohit, Wang Jie Jin, Wang Ningli, West Sheila, Xu Liang, Yasuda Miho, Zhang Xinzhi, Mitchell Paul, Wong Tien Y. and Group for the Meta-Analysis for Eye Disease Study
Global Prevalence and Major Risk Factors of Diabetic Retinopathy. Diabetes Care 35. 556-564. 2012. Retinopathy
http://care.diabetesjournals.org/content/35/3/556.abstract
Yeh Fawn, Dixon Anne E., Marion Susan, Schaefer Carl, Zhang Ying, Best Lyle G., Calhoun Darren, Rhoades Everett R. and Lee Elisa T.
Obesity in Adults Is Associated With Reduced Lung Function in Metabolic Syndrome and Diabetes. Diabetes Care 34. 2306-2313. 2011. Strong Heart Study
http://care.diabetesjournals.org/content/34/10/2306.abstract
Yeo S. T., Edwards R. T., Fargher E. A., Luzio S. D., Thomas R. L. and Owens D. R.
Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experiment. Diabetic Medicine 29. 869-877. 2012. Retinopathy
http://dx.doi.org/10.1111/j.1464-5491.2012.03636.x
Yeo S. T., Edwards R. T., Luzio S. D., Charles J. M., Thomas R. L., Peters J. M. and Owens D. R.
Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screening. Diabetic Medicine 29. 878-885. 2012. Retinopathy
http://dx.doi.org/10.1111/j.1464-5491.2012.03637.x
Yokoyama H., Araki S., Haneda M., Matsushima M., Kawai K., Hirao K., Oishi M., Sugimoto K., Sone H., Maegawa H., Kashiwagi A. and Group for the Japan Diabetes Clinical Data Management Study
Chronic kidney disease categories and renal–cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Diabetologia 55. 1911-1918. 2012. JDDM
http://dx.doi.org/10.1007/s00125-012-2536-y
Yokoyama H., Matsushima M., Kawai K., Hirao K., Oishi M., Sugimoto H., Takeda H., Minami M., Kobayashi M., Sone H. and on behalf of the Japan Diabetes Clinical Data Management Study Group
Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20). Diabetic Medicine 28. 1221-1228. 2011. JDDM
http://dx.doi.org/10.1111/j.1464-5491.2011.03347.x
Yu D. and Simmons D.
Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetes. Diabetic Medicine 30. 1407-1411. 2013. Inpatient
Zachariah Sunil, Sheldon Ben, Shojaee-Moradie Fariba, Jackson Nicola C., Backhouse Katharine, Johnsen Sigurd, Jones Richard H., Umpleby A. Margot and Russell-Jones David L.
Insulin Detemir Reduces Weight Gain as a Result of Reduced Food Intake in Patients With Type 1 Diabetes. Diabetes Care 34. 1487-1491. 2011. Insulin
http://care.diabetesjournals.org/content/34/7/1487.abstract
Zamora Daisy, Gordon-Larsen Penny, He Ka, Jacobs David R., Shikany James M. and Popkin Barry M.
Are the 2005 Dietary Guidelines for Americans Associated With Reduced Risk of Type 2 Diabetes and Cardiometabolic Risk Factors? Diabetes Care 34. 1183-1185. 2011. Diet
http://care.diabetesjournals.org/content/34/5/1183.abstract
Zekry D., Frangos E., Graf C., Michel J. P., Gold G., Krause K. H., Herrmann F. R. and Vischer U. M.
Diabetes, comorbidities and increased long-term mortality in older patients admitted for geriatric inpatient care. Diabetes & Metabolism 38. 149-155. 2012. Mortality
http://www.sciencedirect.com/science/article/pii/S1262363611001741
Zethelius Björn, Eliasson Björn, Eeg-Olofsson Katarina, Svensson Ann-Marie, Gudbjörnsdottir Soffia and Cederholm Jan
A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR). Diabetes research and clinical practice 93. 276-284. 2011. SNDR
http://www.sciencedirect.com/science/article/pii/S0168822711002932
Zhang H., Xu W., Dahl A. K., Xu Z., Wang H. X. and Qi X.
Relation of socio-economic status to impaired fasting glucose and Type 2 diabetes: findings based on a large population-based cross-sectional study in Tianjin, China. Diabetic Medicine 30. e157-e162. 2013. Education
http://dx.doi.org/10.1111/dme.12156
Zhang Mei, Zhang Lin, Wu Bin, Song Haolan, An Zhenmei and Li Shuangqing
Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes/Metabolism Research and Reviews 30. 204-221. 2014. Metaanalysis
http://dx.doi.org/10.1002/dmrr.2479
Zhang Y., Wat N., Stratton I. M., Warren-Perry M. G., Orho M., Groop L. and Turner R. C.
UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. Diabetologia 39. 1505-1511. 1996. UKPDS 19
http://dx.doi.org/10.1007/s001250050605
Zhang Yifei, Hong Jie, Chi Jie, Gu Weiqiong, Ning Guang and Wang Weiqing
Head-to-head comparison of dipeptidyl peptidase-IV inhibitors and sulfonylureas – a meta-analysis from randomized clinical trials. Diabetes/Metabolism Research and Reviews 30. 241-256. 2014. Metanalysis
http://dx.doi.org/10.1002/dmrr.2482
Zhao Wenhui, Katzmarzyk Peter T., Horswell Ronald, Wang Yujie, Johnson Jolene and Hu Gang
HbA1c and Coronary Heart Disease Risk Among Diabetic Patients. Diabetes Care 37. 428-435. 2014. HbA1c
http://care.diabetesjournals.org/content/37/2/428.abstract
Ziegler Anette-G., Wallner Maike, Kaiser Imme, Rossbauer Michaela, Harsunen Minna H., Lachmann Lorenz, Maier Jörg, Winkler Christiane and Hummel Sandra
Long-Term Protective Effect of Lactation on the Development of Type 2 Diabetes in Women With Recent Gestational Diabetes Mellitus. Diabetes 61. 3167-3171. 2012. Gestational
http://diabetes.diabetesjournals.org/content/61/12/3167.abstract
Ziegler Ralph, Cavan David A., Cranston Iain, Barnard Katharine, Ryder Jacqueline, Vogel Claudia, Parkin Christopher G., Koehler Walter, Vesper Iris, Petersen Bettina, Schweitzer Matthias A. and Wagner Robin S.
Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial. Diabetes Care 36. 3613-3619. 2013. ABACUS Trial
http://care.diabetesjournals.org/content/36/11/3613.abstract
Zinman Bernard, Gerich John, Buse John B., Lewin Andrew, Schwartz Sherwyn, Raskin Philip, Hale Paula M., Zdravkovic Milan, Blonde Lawrence and Investigators the LEAD-4 Study
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD). Diabetes Care 32. 1224-1230. 2009. LEAD 4
http://care.diabetesjournals.org/content/32/7/1224.abstract
Zinman Bernard, Haffner Steven M., Herman William H., Holman Rury R., Lachin John M., Kravitz Barbara G., Paul Gitanjali, Jones Nigel P., Aftring R. Paul, Viberti Giancarlo, Kahn Steven E. and Group the A Diabetes Outcome Progression Trial Study
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes. Journal of Clinical Endocrinology & Metabolism 95. 134-142. 2010. OHGA
http://jcem.endojournals.org/content/95/1/134.abstract
Zinman Bernard, Philis-Tsimikas Athena, Cariou Bertrand, Handelsman Yehuda, Rodbard Helena W., Johansen Thue, Endahl Lars, Mathieu Chantal and Investigators on behalf of the NN- Trial
Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long). Diabetes Care 35. 2464-2471. 2012. Insulin
http://care.diabetesjournals.org/content/35/12/2464.abstract
Zoungas S., Chalmers J., Ninomiya T., Li Q., Cooper M., Colagiuri S., Fulcher G., de Galan B., Harrap S., Hamet P., Heller S., MacMahon S., Marre M., Poulter N., Travert F., Patel A., Neal B., Woodward M. and Group for the Advance Collaborative
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 55. 636-643. 2012. ADVANCE
http://dx.doi.org/10.1007/s00125-011-2404-1